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1 Abstract 
Clonal expansion of antigen specific T cells is a major prerequisite for adaptive immune 
responses. Even though hints of differential requirements in the duration of antigen 
stimulation for CD4+ and CD8+ T cell proliferation are scattered through the literature, a 
careful side-by-side analysis of both subsets has only rarely been done.  
A previous study showed that following a strong in vitro activation step, CD8+ but not 
CD4+ T cells proliferate in the absence of further antigen stimulation. The same experimental 
setup, consisting of an in vitro priming phase followed by adoptive transfer of TCR transgenic 
CD4+ and CD8+ T cells into mice expressing or not expressing the cognate antigen, was 
utilized for a deeper analysis of this phenomenon in the present study. The key finding was 
reproduced and potential methodological caveats such as cell number transferred or high O2 
concentration in the in vitro priming phase were excluded as causes. The differential 
proliferation patterns described previously were correlated to effector cell differentiation.  
Several approaches were used to elucidate how this phenomenon might be regulated. 
Antigen-independent proliferation of CD8+ T cells was found to be independent of the 
formation of homotypic T cell clusters and of triggering with self-peptide-MHC complexes. 
Antigen dependency of CD4+ T cell proliferation on the other hand was unchanged in an 
inflammatory environment or following blockage of coinhibitory signaling pathways and was 
observed in memory and in Th1/Th2 differentiated CD4+ T cells. Therefore, differential 
antigen dependency of CD4+ and CD8+ T cells seems to be T cell intrinsic. 
The analysis of the proliferation kinetics of both subsets showed that the antigen-
independent proliferation phase of CD8+ T cells is time-limited. Additionally, CD8+ T cells 
stayed in active stages of the cell cycle for longer periods of time if the stimulation persisted, 
pointing towards intrinsically distinct proliferative capacities of both subsets. Gene expression 
profiles of in vitro-stimulated T cells of both subsets were very similar. This indicates that the 
regulatory mechanisms causing the differential proliferation patterns and also the different 
functional properties of the subsets are not exclusively located at the transcription level, but 
may include the activity of micro RNAs, posttranslational protein modifications and 
epigenetic processes. Interestingly, CD8+ T cells displayed a higher spare respiratory capacity 
(SRC) compared with CD4+ T cells following in vitro stimulation. This parameter was 
suggested to correlate with the high proliferative potential of memory T cells and this 
observation might thus be correlated with the enhanced proliferative capacity of CD8+ T cells.  
Abstract 
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Finally, differential T cell proliferation patterns seemed to reflect the biology of MHC I 
and MHC II molecules, as MHC II but not MHC I antigen presentation was found to be 
maintained on the surface of activated dendritic cells for prolonged periods of time in vivo.  
Taken together, the data presented here suggest that CD4+ T cells rely on continuous 
antigen presentation to expand and develop effector function, whereas their CD8+ 
counterparts can be programmed to expand and differentiate in response to a transient antigen 
stimulus.  
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2 Zusammenfassung 
Die Expansion antigen-spezifischer T-Zellen ist eine wesentliche Voraussetzung für eine 
effektive Immunantwort. Obwohl es Hinweise auf eine differentielle Antigenabhängigkeit 
von CD4- und CD8-T-Zellen in der Literatur gibt, wurden die Proliferationsmuster beider T-
Zell-Populationen bisher nur selten direkt miteinander verglichen. In einer vorangegangenen 
Studie wurde eine differenzielle Antigenabhängigkeit von CD4- und CD8-T-Zell- in vivo 
beobachtet. Eine antigenunabhängige Proliferationsphase konnte für CD8-, aber nicht für 
CD4-T-Zellen beobachtet werden, wenn in vitro-aktivierte T Zellen in Mäuse transferiert 
wurden. 
Unter Verwendung desselben experimentellen Systems wurde diese unterschiedliche 
Abhängigkeit beider T-Zell-Populationen von der Dauer der Antigenpräsentation in der 
vorliegenden Arbeit reproduziert. Zusätzlich konnte bestätigt werden, dass die 
antigenunabhängige Proliferation von CD8-T-Zellen mit der Entwicklung ihrer 
Effektorfunktionen einhergeht.  
Daraufhin wurde die Robustheit des beobachteten Phänomens in verschiedenen 
experimentellen Ansätzen geprüft. Die antigenunabhängige Proliferation von CD8-T-Zellen 
beruhte nicht auf unspezifischer Stimulation durch Selbstpeptide im Kontext von MHC I oder 
der Bildung homotypischer T-Zell-Cluster während der in vitro-Stimulation. Weiterhin 
konnte eine antigenunabhängige Proliferation von CD4-T-Zellen weder im Kontext einer 
Entzündung noch unter Blockade costimulatorischer Signalwege beobachtet werden und blieb 
auch in CD4-Gedächtnis-T-Zellen und Th1- und Th2-Zellen aus. Die differentielle 
Antigenabhängigkeit von CD4- und CD8-T-Zellen scheint daher zellintrinsisch zu sein.  
Die Analyse der Proliferationskinetik beider Subpopulationen offenbarte eine zeitliche 
Begrenzung der antigenunabhängigen Teilungsphase von CD8-T-Zellen. Zudem fanden sich 
unter persistenter Stimulation CD8-T-Zellen über einen längeren Zeitraum in aktiven Phasen 
des Zellzyklus, ein Hinweis auf grundsätzlich verschiedene proliferative Kapazitäten beider 
T-Zell-Populationen. Die Genexpressionsprofile von in vitro-stimulierten CD4- und CD8-T-
Zellen unterschieden sich nur marginal. Dieser Umstand macht eine ausschließliche 
Regulation dieses Phänomens auf der Transkriptionsebene unwahrscheinlich. Ergänzend 
könnten posttranslationale Proteinmodifikationen, micro RNAs oder epigenetisch Prozesse an 
der Regulation der differenziellen Antigenabhängigkeit beteiligt sein. In diesem 
Zusammenhang erscheint es interessant, dass CD8-T-Zellen im Vergleich zu CD4-T-Zellen 
Zusammenfassung 
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eine höhere spare respiratory capacity (SRC) aufwiesen. Dieser Parameter wird unter 
anderem in Zusammenhang mit der schnellen Expansion von Gedächtnis-T-Zellen gebracht 
und könnte daher auch mit der erhöhten proliferativen Kapazität von CD8-T-Zellen korreliert 
sein. 
Schließlich schienen die unterschiedlichen Proliferationsmuster von CD4- und CD8-T-
Zellen die Biologie der entsprechenden MHC Moleküle widerzuspiegeln, da MHC II-
Peptidkomplexe in vivo für längere Zeiträume auf der Oberfläche aktivierter dendritischer 
Zellen präsentiert wurden als MHC I-Peptidkomplexe. 
Zusammenfassend legen die hier gezeigten Daten nahe, dass CD4-T-Zellen stärker von 
kontinuierlicher Antigenpräsentation abhängig sind als CD8-T-Zellen, deren Proliferation und 
Differenzierung durch einen starken Antigenstimulus programmiert werden kann.  
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3 Introduction 
3.1 The role of T cells in the adaptive immune system 
The synergy of antigen receptor rearrangement, clonal selection and long term 
maintenance of antigen-experienced memory cells enables the adaptive immune system to 
effectively eliminate pathogens as well as infected cells and to establish protection against 
reinfection and cancer. In contrast to the antigen receptors of the innate immune system, 
which recognize conserved structures associated with infections (pathogen associated 
molecular patterns, PAMPS) or general “danger signals”, the antigen receptors of B cells and 
T cells can potentially recognize an enormous variety of molecular structures. Therefore, both 
B and T cells have to be selected against self-reactivity in the organs where their antigen 
receptors are generated, i.e. the bone marrow for B cells, and the thymus for T cells (central 
tolerance induction) and their reactivity must further be monitored by peripheral tolerance 
mechanisms after they left these organs. Upon infection with a pathogen, T cells bearing a 
cognate T cell receptor (TCR) will be activated, proliferate extensively, develop effector 
functions and eventually differentiate into long-lived memory cells.  
Defined by the expression of the TCR coreceptors CD4 or CD8, CD8+ Cytotoxic T cells 
(CTLs) and CD4+ T-helper T cells (Th) are distinguished. CD8+ T cells specialize in killing 
pathogen-infected or neoplastic cells. CD4+ T cells are able to promote B cell responses by 
providing them with stimulatory signals and thereby allowing and directing antibody class 
switch in a process known as T cell help. T cell help is also necessary to optimize the 
functions of macrophages and enables them to kill phagocytosed pathogens efficiently. 
Additionally, CD4+ T cells have the capacity to shape immune responses by a broad range of 
regulatory functions mainly mediated by the secretion of cytokines, which act on components 
of both the innate and adaptive immune system.  
Both subsets of T cells and their sophisticated interactions with each other and with 
components of the adaptive and innate immune system are of paramount importance for the 
maintenance of immune integrity.  
 
3.2 The context of T cell antigen recognition 
The TCR recognizes protein-derived peptide antigens presented in the context of Major 
Histocompatibility Complex (MHC) molecules on the surface of antigen presenting cells 
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(APCs). CD4+ and CD8+ T cells recognize peptides in the context of different classes of MHC 
molecules. The CD4 coreceptor limits peptide recognition to the context of MHC class II 
molecules (MHC II), whereas T cells bearing the CD8 coreceptor recognize peptides in the 
context of MHC class I (MHC I). MHCs are found in all vertebrates and comprise a 
multigenic region in which not only MHC I and MHC II molecules but also genes associated 
with molecular assembly and peptide loading of these molecules are located. In mice, the 
MHC locus is called H-2 and contains two to three MHC I genes (H-2D, H-2K and in some 
strains H-2L) and two MHC II genes (H-2A, H-2E). MHC molecules are highly polymorphic 
and a given inbred mouse strain is therefore characterized by its MHC haplotype. The 
sequence variation is mostly concentrated in the regions that interact with the presented 
peptides.  
MHC I and MHC II molecules display structural differences. MHC I consists of an α-
chain containing one membrane-proximal domain anchoring the complex in the cell 
membrane and two membrane-distal domains that form the peptide-binding grove. 
Additionally, a β-chain (β2-microglobulin, β2m) is essential for the stability of the 
heterodimer but not involved in peptide binding or membrane anchoring. MHC II consists of 
one α- and one β-chain, each comprising a membrane-distal domain and a membrane-
proximal-domain. Both domains are involved in peptide-binding.  
Peptides presented by MHC I and MHC II derive from different subcellular 
compartments. MHC I molecules are loaded with peptides originating from cytosolic proteins 
that have been degraded by the proteasome. The resulting peptides are transported into the 
endoplasmic reticulum, where the loading takes place, in a TAP (transporter associated with 
antigen processing) dependent manner. Thus, MHC I peptides mirror the repertoire of 
cytoplasmic proteins and, in the case of a viral infection, also viral proteins. MHC II loading 
on the other hand occurs in late endosomes. Extracellular proteins are taken up by several 
pathways including endocytosis, pinocytosis and phagocytosis. Subsequently, they are 
degraded by lysosomal enzymes in the respective membrane compartments, which eventually 
fuse with endosomes. Thus, MHC II molecules are loaded with peptides derived from 
extracellular proteins and phagocytosed material.  
There are exceptions to the general rules described above. MHC II molecules can be 
loaded with intracellular proteins if these were subjected to lysosomal degradation. On the 
other hand, extracellular protein-derived peptides can be presented on MHC I via a pathway 
termed cross-presentation. Specific subsets of dendritic cells (DCs) display a pronounced 
Introduction 
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ability to crosspresent antigen and are thus able to initiate CD8+ T cell responses in situations 
where antigenic proteins are not directly targeted to APCs, i.e. some viral infections or tumors 
(Blum et al., 2013).  
Both MHC classes are expressed differentially on APCs. MHC I molecules are expressed 
on all nucleated cells, MHC II expression on the other hand is limited to professional APCs, 
which are comprised of B cells, macrophages and DCs.  
DCs, whose name derives from their morphology (Steinman and Cohn, 1973), are of 
critical importance for the induction and direction of both adaptive immune responses and 
tolerance mechanisms. They are an important interface between the adaptive and the innate 
immune systems. Being located in peripheral tissues, they constantly take up extracellular 
proteins and present them on MHC molecules. If an infection occurs, DCs are activated via 
Toll-like receptors (TLR), C-type lectin receptors (CLRs) and chemokine receptors following 
ligation with their respective ligands. Subsequently, DCs mature and migrate to the T cell 
areas of draining lymph nodes. In contrast to the immature state, mature DCs drastically 
reduce phagocytosis and in turn upregulate cell surface expression of peptide-loaded MHC II 
and MHC I molecules. Additionally, mature DCs express the costimulatory molecules CD80 
and CD86 that deliver a second signal to T cells, which is necessary for their productive 
activation. Furthermore, DCs translate stimuli perceived during their activation into the 
expression of cytokines, which tailor the subsequently induced T cell responses (Mellman and 
Steinman, 2001; Steinman et al., 2003). 
 
3.3 T cell development: the generation of a functional T cell repertoire 
The development of T cells takes place in the thymus. Bone morrow derived early 
lymphoid progenitors enter the thymus and are committed to the T cell linage following 
Notch-signaling (Robey and Bluestone, 2004). During T cell development, each T cell 
precursor has to generate functional α- and β-chains of the TCR by genetic rearrangement of 
gene segments. This process is dependent on recombination-activating genes 1 and 2 (RAG-1 
and RAG-2). 
After entry into the thymus and commitment to the T cell lineage, all T cell precursors 
are negative for CD4 and CD8 and thus called double negative (DN) thymocytes. Upon 
generation of a functional TCR β-chain (tested by its pairing with pre-TCR α-chain), 
thymocytes express both CD4 and CD8 (double positive (DP) thymocytes). Subsequently, the 
Introduction 
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TCR α-chain is rearranged and thymocytes become either CD4+ or CD8+ (single positive, SP) 
and will leave the thymus after several days. Importantly, thymocytes expressing a TCR with 
a high affinity for self-peptides presented on MHC molecules are deleted by a process called 
negative selection. If a TCR is unable to interact with peptide-MHC (pMHC) complexes at all, 
the T cell dies by neglect (Starr et al., 2003).  
During the process of TCR rearrangement, signaling via the pre-TCR made up of a 
functionally rearranged TCR β-chain and the pre-TCR α-chain commits thymocytes to the αβ 
T cell lineage. Alternatively, productive rearrangements of γδ TCR chains can occur and 
subsequently direct thymocytes to the γδ T cell lineage. γδ T cells are thought to provide 
immediate protection for a variety of tissues from pathogen invasion by recognition of 
microbial and damage-induced molecules (Jameson et al., 2002). The present study is focused 
on αβ T cells. 
 
3.4 The physiology of T cell responses 
The dynamics of cell populations are a key feature of the immune system. The 
rearrangement of TCRs during T cell development provides the adaptive immune system with 
an enormous spectrum of different TCRs. On the other hand, this process results in very low 
precursor frequencies of antigen-specific T cells (sometimes less than ten T cells per mouse, 
(Moon et al., 2007; Tubo et al., 2013)). Therefore, a large expansion of these rare cells 
following their activation is essential to the development of an effective immune response. 
However, as the body can only sustain the survival of a limited number of lymphocytes, the 
huge populations of effector cells generated during an immune response need to contract 
following clearance of the infection.  
Accordingly, T cell responses are characterized by proliferation and contraction. By 
recognition of their cognate antigen on an APC, T cells become activated (priming phase), 
proliferate extensively and develop their effector functions (expansion and effector phase). 
After pathogen clearance, most antigen-specific T cells will die (contraction phase), leaving 
only a small population of memory T cells behind to provide immediate protection in the case 
of reinfection (memory phase). 
 
Introduction 
 
 9 
3.4.1 T cell priming 
Mature T cells circulate through blood and lymphoid tissues, scanning APCs for the 
presence of cognate pMHC complexes. If such a complex ligates their TCR, T cells will stop 
migrating and form stable contacts with the respective APC, which last a couple of hours. 
Subsequently, T cells will resume motility and begin to proliferate and develop effector 
functions (Bousso and Robey, 2003; Mempel et al., 2004). The successful activation of T 
cells requires signaling via the TCR and costimulatory receptors. 
 
3.4.1.1 TCR ligation 
T cells recognize peptides presented by MHC molecules via the TCR, a heterodimeric 
molecule embedded into a complex of signaling molecules. TCR α- and TCR β-chains 
interact with peptides that are non-covalently bound to the peptide-binding groove of MHC 
molecules. Both chains possess only very short intracellular domains without signaling 
capacity. The associated CD3 complex that consists of one δ-chain, one γ-chain and two ε-
chains mediates signaling together with two ζ-chains.  
These signaling molecules contain a total of ten immunoreceptor tyrosine based 
activating motifs (ITAMs), which are recognized and phosphorylated by the lymphocyte-
specific protein tyrosine kinase (Lck) that is brought into close vicinity of the ITAMs 
following TCR ligation. Subsequently, a zeta chain associated protein of 70 kDa (Zap70) is 
recruited to the TCR complex. This starts a complex downstream signaling sequence 
including the formation of adaptor protein nucleated multimolecular signaling complexes and 
regulatory feedforward and feedback loops. These events finally result in the activation of the 
transcription factors activator protein 1 (AP-1), nuclear factor of activated T cells (NFAT) and 
nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-κB) and induce T cell 
proliferation and differentiation (Lin and Weiss, 2001). 
The concrete mechanism by which TCR ligation and the subsequent formation of the 
immune synapse initiate signaling events in the TCR complex remains under discussion 
(Smith-Garvin et al., 2009), even though the model of “kinetic segregation” is supported by a 
recent publication (James and Vale, 2012). In this model, the ligation of the TCR leads to its 
partitioning into plasma membrane domains which contain Lck but not the phosphatase CD45 
that prevents phosphorylation of ITAMs in the steady state. 
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3.4.1.2 Costimulation and coinhibition 
Besides TCR triggering, the ligation of costimulatory receptors is a necessary prerequisite 
for productive T cell activation. The lack of such signaling results in unresponsiveness of T 
cells to further stimulation (anergy). APCs upregulate costimulatory molecules if they are 
activated in the presence of infection or danger-associated signals. If sensed by T cells via 
dedicated receptors, costimulatory signaling results in the amplification of the TCR signal.  
Most prominently, the ligation of CD28 (expressed by T cells) by CD80 and CD86 
(expressed on activated DCs) results in the recruitment and enhanced activation of 
phosphoinositide-3 kinase (PI3K). This signal is integrated together with the TCR signal and 
will finally result in increased engagement of the NFκB pathway. Additional costimulatory 
receptors such as CD40L, CD134 or inducible T cell co-stimulator (ICOS) are upregulated 
following CD28 ligation and further support T cell activation if triggered by their respective 
ligands (Acuto and Michel, 2003).  
Cytotoxic T-lymphocyte antigen 4 (CTLA-4), an inhibitory receptor of CD80/CD86, 
competes with CD28. Its ligation results in T cell tolerance, inhibition of interleukin-2 (IL-2) 
production and cell cycle arrest. Further coinhibitory signals are mediated by the ligation of 
programmed cell death 1 (PD-1) and its ligands PD-L1 or PD-L2 and this is thought to 
participate in the maintenance of self-tolerance, as illustrated by the severe autoimmune 
phenotype of Pd1−/− mice (Acuto and Michel, 2003; Sharpe and Freeman, 2002). A delicate 
balance of costimulatory and coinhibitory signaling is essential to mediate immunity and 
protection from autoimmunity. 
 
3.4.2 T cell effector functions 
Following successful activation, T cells will proliferate extensively and develop their 
effector functions. As outlined above, CD4+ and CD8+ T cells possess fundamentally different 
effector functions. 
3.4.2.1 CD4+ T cell effector functions 
Based on the expression of key transcription factors and cytokines, CD4+ T cells can be 
further divided into subpopulations. CD4+ T cell responses are polarized by the cytokines 
present during their activation. These cytokines are produced by APCs or by other cells in the 
priming microenvironment. 
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The first subsets defined by their distinct cytokine profiles were the Th1 and Th2 T cells 
(Mosmann et al., 1986). Interferon gamma (IFNγ) polarizes CD4+ T cell responses towards 
the Th1 phenotype and is the key cytokine produced by these cells. IL-4 is of analogous 
importance for the differentiation and effector function of Th2 cells. The activity of key 
transcription factors (T cell-specific T-box transcription factor (T-bet) for Th1 and GATA 
binding protein 3 (Gata3) for Th2 T cells) is essential for the polarization of CD4+ T cells. 
Subsequent epigenetic modifications result in the distinct effector functions of Th1 and Th2 
cells (Grogan et al., 2001; Pipkin and Rao, 2009).  
Th1-derived IFNγ has pleiotrophic effects, which synergize to induce the effective 
destruction of microbial pathogens by phagocytic cells and include the increase of NK cell 
cytotoxicity, the enhancement of phagocytosis and microbicidal activity of macrophages and 
the production of opsonizing immunoglobulin (Ig) G (Schroder et al., 2004).  
Th2 cells on the other hand coordinate immune responses against parasites at mucosal 
and epithelial barriers. IL-4 recruits mast cells, eosinophils and basophils and activates mast 
cells, epithelial cells and smooth muscle cells in order to support parasite removal. 
Furthermore, IL-4 induces antibody class switch to IgE. These functions are mediated in 
concert with IL-13, IL-5 and several other cytokines produced by Th2 cells (Nair et al., 2006). 
The subset of regulatory CD4+ T cells (Treg) is recognized to be of paramount 
importance for the induction and maintenance of tolerance to self. The production of IL-10 
and tumor growth factor beta (TGFβ) is essential for this function but the mechanistic details 
remain incompletely understood (von Boehmer, 2005). The expression of the transcription 
factor forkhead box p3 (Foxp3) is a hallmark of Tregs. Their development is dependent on 
TGFβ and IL-2 and their regulatory potential is impressively illustrated by the strong 
autoimmune phenotype of Il-2−/− mice (Sadlack et al., 1993).  
A subset of IL-17A and IL-17E producing CD4+ T cells (Th17) has been described to be 
induced by TGFβ and IL-6 and to be dependent on the transcription factor RAR-related 
orphan receptor gamma 2 (RoRγt). Th17 cells have been reported to orchestrate the clearance 
of extracellular bacterial and fungal infections. This effect is mediated by IL-17A and IL-17E. 
The secretion of these cytokines results in the recruitment and activation of neutrophils. 
Additionally, Th17 cells are potent inducers of autoimmune disease (Basu et al., 2013; Korn 
et al., 2007).  
More recently, follicular helper T cells (Tfh) were identified due to their localization in B 
cell follicles. They express the surface markers chemokine (CXC-motif) receptor 5 (CXCR5) 
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and ICOS, the transcription factor B cell leukemia/lymphoma 6 (BCL6) and produce IL-21. 
These cells are specialized in providing B cell help. It remains unclear if they originate from 
CD4+ T cells polarized into one of the above subsets and subsequently acquire the Tfh 
phenotype, or if they represent an autonomous subset. Tfh development requires contact with 
cognate antigen presenting B cells and the presence of IL-6 and IL-21 (Ma et al., 2012a).  
It is currently thought that CD4+ T cell subsets do not represent strictly separate lineages 
but rather display a certain plasticity so that the differentiation into one subset is not 
necessarily terminal (O'Shea and Paul, 2010). This phenomenon might be particularly 
pronounced for the Th17 and Tfh subsets (Basu et al., 2013). 
 
3.4.2.2 CD8+ T cell effector functions 
In contrast to the many potential outcomes of CD4+ T cell activation described above, the 
CD8+ T cell effector functions are much less diverse. The predominant function is the direct 
killing of host cells infected with viruses or bacteria invading the cytoplasm (such as Listeria 
(L.) monocytogenes and Salmonella spec.) and neoplastic cells.  
The secretion of IFNγ and tumor necrosis factor alpha (TNFα) induces anti-microbial 
responses mediated by cells of the innate and the adaptive immune system but also by 
epithelial cells. Furthermore, target cell apoptosis is induced by the delivery of granules 
containing perforin and granzymes. Following TCR ligation with cognate pMHC I complexes 
on the surface of a target cell, primed CD8+ T cells release perforin and granzymes into the 
immune synapse formed between the cells. The change in pH induces perforin to polymerize 
and form pores in the cell membrane of the target cells. Through these pores, granzymes enter 
the cell and rapidly induce apoptosis via both caspase-dependent and -independent pathways. 
Additionally, CD8+ T cells deliver death-signals by ligation of Fas (Trambas and Griffiths, 
2003; Wong and Pamer, 2003a). 
Besides cytotoxic CD8+ T cells, a subset of CD8+ T cells displaying regulatory functions 
may play a role in immune homeostasis, maintenance of immune privileged sites (Niederkorn, 
2008; Vinay and Kwon, 2010) and the regulation of germinal center reactions (Ramiscal and 
Vinuesa, 2013). The importance of this subset is by far not as well understood as that of 
regulatory CD4+ T cells. 
 
Introduction 
 
 13 
3.4.3 Generation and maintenance of memory T cells 
As a pathogen is cleared and both antigen presentation and the supply of T cell growth 
factors such as IL-7 ceases, up to 95% of effector T cells die. The causative relationships 
between these observations are difficult to assess and the effects of antigen persistence and 
cytokine presence on cell survival vary depending on the microenvironment and the type of 
infection. A metabolic switch is required for the successful transition from effector to memory 
cell status (Marrack et al., 2010). 
 The requirements for memory formation and maintenance of CD4+ and CD8+ T memory 
cells are distinct. For CD4+ T cells, sufficient costimulation and IL-2 signaling during the 
initiation of the primary response is one prerequisite for effector to memory transition but the 
extent of this effect varies between CD4+ T cell subsets. The time point of recruitment into 
the immune response and the associated changes in the microenvironment of priming might 
be critical, as CD4+ T cell effector functions differ between cells that were engaged early or 
late during the course of an infection. Nevertheless, a specific effector differentiation or a 
minimal number of divisions is not essential for the transit to the memory stage. The long-
term survival of CD4+ T cells is dependent on IL-7 but not on TCR stimulation, as memory 
cells are maintained in the absence of MHC II (McKinstry et al., 2010). 
A subset of CD8+ effector T cells, characterized by high expression of the IL-7 receptor 
and low expression of KLRG1 (Killer cell lectin-like receptor subfamily G member 1), is is 
especially prone to transit to the memory stage. These cells are thus called memory precursor 
effector cells (MPEC). For long-term maintenance, CD8+ T cells rely on the presence of both 
IL-7 and IL-15 (Kaech and Cui, 2012).  
In general, memory T cells of both subsets are characterized by rapid unfolding of 
effector functions following restimulation. For both CD4+ and CD8+ T cells, at least two 
subtypes of memory cells have been described: central memory cells (Tcm), that express both 
L-selectin (CD62L) and C-C chemokine receptor type 7 (CCR7) at high levels, and effector 
memory cells (Tem), which display low expression of CCR7 and CD62L. Whereas Tcm cells 
are located in lymphoid organs, possess a high proliferative capacity and display effector 
functions only following stimulation, Tem cells are found in tissues, proliferate less but 
express effector molecules constitutively. Differential localization and functional properties of 
memory T cell subsets are thought to enhance the efficiency of memory T cell responses 
(Lanzavecchia and Sallusto, 2005; Sallusto et al., 2004). 
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3.4.4 T cell exhaustion 
In many chronic viral infections and during cancer, a gradual loss of effector T cell 
functions is observed that finally leads to T cell deletion. This state of T cell dysfunction is 
called exhaustion and is described for both CD4+ and CD8+ T cells. The effect of persistent 
antigen presentation on the more diverse functions of CD4+ T cell subsets are not as 
extensively studied as phenotypic changes associated with CD8+ T cell exhaustion. The 
severity of T cell exhaustion is strongly correlated with the strength of T cell stimulation and 
the duration of the infection. Both cell-intrinsic (e.g. PD-1 signaling) and extrinsic negative 
regulatory pathways (e.g. cytokine mediated signals) are known to be involved in T cell 
exhaustion. In contrast to T cell anergy, a dysfunctional state induced during the initial 
antigen contact, exhausted T cells have experienced productive priming and effector 
differentiation before loosing their functionality. Both conditions are at least partially distinct 
at the gene expression level (Wherry, 2011). 
 
3.5 The influence of antigen stimulus duration on T cell responses 
In order to maintain immunity and prevent autoimmunity, T cell responses have to be 
both autonomous and controllable. This apparent contradiction is resolved in a concept where 
T cell functions are partially programmed during lineage commitment or priming and 
additionally tunable by cell extrinsic regulatory pathways. Besides costimulatory signals, 
whose impact on the subsequent T cell response is quite extensively studied, the influence of 
the duration of antigen stimulus on the fate of T cells is only incompletely understood.  
The influence of TCR stimulus duration on the proliferation and differentiation of murine 
CD4+ and CD8+ T cells has been studied in several experimental models but only rarely in a 
comparative manner. A major experimental caveat is controlling the termination of antigen 
presentation. If T cell proliferation was analyzed in vitro, T cells were physically separated 
from the antigen. In vivo, treatment with antibiotics was used to limit antigen expression 
during bacterial infections. Alternatively, T cells stimulated in vitro or isolated from infected 
mice were adoptively transferred into uninfected mice. Furthermore, TCR interaction with 
cognate pMHC complexes was terminated by the administration of blocking monoclonal 
antibodies (mAbs) directed against these pMHC complexes.  
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3.5.1 The importance of antigen persistence for CD4+ T cell responses 
Several studies observed the proliferation of CD4+ T cells in vitro to be antigen-
dependent. Iezzi at al. showed that the proliferation and survival of naïve CD4+ T cells 
depends on at least 15-20 h of antigen presentation (Iezzi et al., 1998). Stimulating TCR 
transgenic (tg) CD4+ T cells with peptide-loaded macrophages, Schrum et al. observed that 
their proliferation is dependent on prolonged antigen stimulation, as the extent of CFSE 
dilution increased with prolongation of the stimulation period. In this study, the antigen 
presentation was interrupted by the removal of the T cells from the APCs in combination with 
the addition of a MHC II blocking mAb (Schrum and Turka, 2002). In a setup where the 
stimulation of TCR tg CD4+ T cells was terminated with a mAb blocking the interaction of 
the TCR with its cognate pMHC complex presented by a B cell line, Huppa et al. 
demonstrated that CD4+ T cell proliferation was gradually diminished with shortened 
stimulation periods (Huppa et al., 2003).  
In contrast, other in vitro studies observed CD4+ T cell proliferation to be rather 
independent of prolonged antigen presentation. Two phases of CD4+ T cell proliferation were 
found by Jelley-Gibbs et al. in a study where the proliferation and effector functions of TCR 
tg CD4+ T cells were assessed following stimulation with antigen expressing fibroblasts: an 
initial, antigen-dependent phase and a subsequent, cytokine-dependent but antigen-
independent phase (Jelley-Gibbs et al., 2000). Lee at al. observed antigen-independent 
proliferation of TCR tg CD4+ T cells following 60 h of antigen stimulation and further 
coculture with unpulsed APCs (Lee et al., 2002). Also Bajénoff et al. al found that CD4+ T 
cells were able to proliferate without further antigen stimulation following 48 h in vitro 
priming with peptide-pulsed irradiated splenocytes (Bajénoff et al., 2002).  
Taken together, these in vitro studies provide contradictory data. Some studies found that 
CD4+ T cells are dependent on prolonged antigen presence, whereas others observed that 
CD4+ T cells are able to proliferate even upon discontinued antigen presentation.  
 
The assessment of CD4+ T cell proliferation in vivo presents a more homogenous picture. 
The proliferation of TCR tg CD4+ T cells was observed to depend on prolonged antigen 
presentation in an in vivo model of doxycycline-dependent antigen expression (Obst et al., 
2005) that will be used in the present study. The repeated immunization with antigen 
presenting DCs enhanced the expression of the high affinity IL-2 receptor (CD25) and IFNγ 
on TCR tg CD4+ T cells, but did not increase the number of cell divisions at an early time 
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point (38 h after the initial immunization) (Celli et al., 2005). Injection of peptide-immunized 
mice with a mAb blocking the TCR-pMHC interactions showed that the proliferation of TCR 
tg CD4+ T cells decreased gradually with shortening of the in vivo stimulation period (Celli et 
al., 2007). In a similar approach, Yarke et al. stimulated TCR tg CD4+ T cells in vitro, 
transferred them into mice immunized with the cognate antigen and terminated TCR 
stimulation by injection of a mAb blocking TCR-pMHC interactions. Here, CD4+ T cells did 
not divide upon transfer into naïve mice and the extent of proliferation was dependent on the 
length of antigen stimulation allowed in vivo (Yarke et al., 2008). Additionally, Jusforgues-
Saklani et al. observed that prolonged periods of antigen presentation to CD4+ T cells were 
necessary for the induction of DC-crosspresentation. Here, splenocytes from male mice were 
used to immunize female mice. The NK cell-mediated rapid depletion of these cells hindered 
efficient cross presentation, an effect that could be abrogated by depletion of NK cells in the 
recipient females (Jusforgues-Saklani et al., 2008). Baumgartner et al. showed that the 
expansion of TCR tg CD4+ T cells is directly correlated to the dose of cognate peptide 
immunization. This effect was more pronounced for a peptide that forms low-stability 
complexes with MHC II, indicating that CD4+ T cells rely on repeated contacts with pMHC 
for their expansion (Baumgartner et al., 2010).  
Taken together, all in vivo studies discussed above showed that the proliferation of CD4+ 
T cells is dependent on the persistence of antigen.  
 
3.5.2 The importance of antigen persistence for CD8+ T cell responses 
In several studies, an antigen-independent phase of CD8+ T cell expansion has been 
observed. The termination of L. monocytogenes infection by ampicillin treatment did not 
result in a diminished expansion and differentiation of CD8+ T effector cells if this treatment 
was started 24 h post infection (Mercado et al., 2000). If TCR tg CD8+ T cells were 
stimulated in vitro with a fibroblast cell line expressing cognate antigen and costimulatory 
molecules, 2 h of stimulation were sufficient to induce proliferation and effector 
differentiation (van Stipdonk et al., 2001). In the same experimental setup, 20 h of in vitro 
stimulation were sufficient to allow the expansion and the development of effector functions 
in wild type (wt) mice (van Stipdonk et al., 2003). In another in vitro system, the number of 
peptide-pulsed APCs cocultured with TCR tg CD8+ T cells correlated with the percentage of 
activated T cells, whereas the extent of proliferation and the acquisition of effector functions 
were independent of APC numbers (Kaech and Ahmed, 2001). In agreement with these 
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findings, the percentage of TCR tg CD8+ T cells activated in a L. monocytogenes infection 
model was dependent on the infectious dose, but proliferation and effector functions of the 
recruited CD8+ T cells were uniform (Kaech and Ahmed, 2001). If CD8+ T cells isolated from 
L. monocytogenes infected mice were cultured in the absence of antigen stimulation, 
proliferation continued. Similarly, in vitro stimulated CD8+ T cells kept on dividing if they 
were removed from the source of antigen (Wong and Pamer, 2001). In a different approach, 
Prlic et al. limited antigen presentation in vivo by diphtheria toxin mediated depletion of 
peptide-pulsed DCs. In the context of a L. monocytogenes infection, the depletion of DCs 1 h 
after transfer of TCR tg CD8+ T cells resulted in 7 h of effective antigen presentation but still 
allowed complete proliferation and effector differentiation of CD8+ T cells. Even though 
CFSE dilution and IFNγ production were not affected by shortened antigen presentation, the 
total expansion of CD8+ T cells was reduced, indicating that antigen persistence supports the 
survival of differentiated CD8+ T cells (Prlic et al., 2006). Following 20 h of in vitro 
stimulation with cognate peptide-loaded APCs and transfer into naïve mice, TCR tg CD8+ T 
cells were able to proliferate extensively (van Stipdonk et al., 2008). Kalia et al. showed that 
virus-specific CD8+ T cells isolated from lymphocytic choriomeningitisvirus (LCMV) 
infected mice expand similarly in secondary hosts infected with or immune to this virus 
(Kalia et al., 2010). Finally, in a viral meningitis model of intra cerebral LCMV infection, 
Kang et al. observed actively dividing CD8+ T cells not only at the site of infection and 
antigen presentation but also in the blood, where antigen presentation is assumed not to take 
place. Furthermore, deficiency of MHC I did not abrogate but only reduced cell cycle activity 
of CD8+ T cells in the infected brain (Kang et al., 2011). The increasing number of studies 
observing an antigen-independent proliferation phase for CD8+ T cells led to the hypothesis 
that CD8+ T cells proliferate “on autopilot” (Bevan and Fink, 2001).  
In contrast, a similar number of publications observed that the proliferation of CD8+ T 
cells is at least partially dependent on prolonged antigen presentation. In an in vitro setup 
where latex-microspheres coated with pMHC complexes and costimulatory ligands were used 
to stimulate CD8+ T cells, Curtsinger et al. observed that the expansion of TCR tg CD8+ T 
cells depends on the inflammatory cytokine IL-12. This dependency on IL-12 could be 
overcome by higher antigen doses in the culture, but the development of effector functions 
remained IL-12-dependent even following high-dose stimulation. In an in vivo immunization 
protocol, CD8+ T cell expansion but not effector function became independent of IL-12 by 
increasing the antigen dose (Curtsinger et al., 2003). Storni et al. utilized replication deficient 
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virus-like particles (VLPs) to deliver antigen in a duration-limited manner in vivo. If mice 
received VLPs 1-3 d before transfer of cognate TCR tg CD8+ T cells, the production of IFNγ 
was gradually reduced, accompanied by a slight impairment of proliferation (Storni et al., 
2003). Shaulov et al. transferred in vitro-stimulated OVA-specific TCR tg CD8+ T cells into 
naïve, LCMV infected or LCMV infected and OVA-immunized mice. In naïve and LCMV 
infected recipients, the proliferation but not the effector functions of CD8+ T cells were 
reduced compared with mice that were immunized with OVA in the context of LCMV 
infection (Shaulov and Murali-Krishna, 2008). This finding points towards a differential 
antigen dependency of proliferation and effector differentiation of CD8+ T cells. Tseng et al. 
assessed CD8+ T cell proliferation in mice infected with L. monocytogenes and treated with 
ampicillin to terminate antigen presentation. In contrast to the studies discussed above, 
abrogation of infection 24 h after its onset reduced the expansion and the percentage of IFNγ 
positive endogenous listeria-specific CD8+ T cells (Tseng et al., 2009). Aiming to optimize an 
immunization protocol, Johansen et al. observed that CD8+ T cell responses to peptide 
immunization were maximal if repeated injections with increasing vaccine doses were applied. 
In comparison, a single bolus injection of peptide and adjuvant resulted in decreased IFNγ 
production and proliferation of specific CD8+ T cells (Johansen et al., 2008). Abrogation of 
TCR stimulation can also be achieved by controlling TCR signaling pathways. Using a 
transgenic mouse where the expression of the TCR proximal kinase Lck can be regulated in a 
doxycycline-dependent manner, Tewari et al. observed that CD8+ T cell expansion is 
dependent on prolonged Lck expression following viral infection (Tewari et al., 2006).  
In conclusion, the literature on CD8+ T cell antigen dependency is more heterogeneous 
than that for CD4+ T cells. Between studies data are not always consistent and in some cases 
the use of similar experimental systems leads to different conclusions. An antigen-
independent proliferation phase of CD8+ T cells is supported by a similar number of studies 
as the antigen dependency of CD8+ T cell expansion. 
 
3.5.3 Comparative studies on CD4+ and CD8+ T cell antigen dependency 
Even though many studies have analyzed the proliferative requirements of CD4+ and 
CD8+ T cells separately, a direct comparison has only rarely been done. Gett et al. transferred 
in vitro-stimulated CD4+ and CD8+ T cells into naïve mice and observed enhanced 
proliferation of CD8+ T cells following 24 h of in vitro stimulation (Gett et al., 2003). Using L. 
monocytogenes infection, Corbin and Harty observed that the expansion and IFNγ production 
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of both subsets was only slightly affected if the infection was terminated by ampicillin 
treatment 24 h after its onset. Nevertheless, ampicillin application at the time point of 
infection led to a weaker expansion of CD4+ compared to CD8+ T cells (Corbin and Harty, 
2004). Using the same experimental system, Williams and Bevan reported contradictory data. 
They showed that the magnitude of CD4+ but not CD8+ T cell responses is reduced following 
ampicillin treatment 24 h after the infection of the mice (Williams and Bevan, 2004). In 
contrast, Tseng et al. reported that the expansion of both CD4+ and CD8+ T cells was 
diminished upon ampicillin treatment of L. monocytogenes infected mice at the same time 
point (Tseng et al., 2009). Alternatively, Blair et al. used blocking mAbs against pMHC 
complexes to limit TCR triggering during a viral infection in vivo. In this system, the 
expansion of CD4+ and CD8+ T cells was observed to depend on prolonged antigen 
stimulation in vivo (Blair et al., 2011). Furthermore, a doxycycline regulated system of in 
vivo antigen expression to cognate TCR tg CD4+ and CD8+ T cells demonstrated antigen 
dependency of CD4+ but not CD8+ T cell proliferation during the expansion phase 
(Rabenstein, 2012). As this system is used in the present study, it will be described in detail in 
the results section (see section 5.1).  
Thus, a small number of studies directly comparing the antigen dependency of CD4+ and 
CD8+ T cell expansion provide contradictory data.  
3.5.4 The influence of antigen persistence on the formation of T cell memory 
Many of the studies described above assessed the influence of restricted antigen 
presentation on secondary T cell responses. In some studies, the expansion and functionality 
of CD8+ memory responses was unaffected by premature termination of antigen presentation 
during the primary response (Mercado et al., 2000; Tewari et al., 2006; van Stipdonk et al., 
2008), whereas others reported impaired memory responses (Johansen et al., 2008; Kaech and 
Ahmed, 2001; Shaulov and Murali-Krishna, 2008; Storni et al., 2003; Tseng et al., 2009). 
Alternatively, prolonged antigen presentation to CD8+ T cells during the primary response 
was reported to increase the magnitude but not the functionality of CD8+ memory responses 
(Prlic et al., 2006). Recently, Henrickson et al. showed that the immunization with low doses 
of peptides impairs the CD8+ memory response (Henrickson et al., 2013). Kim et al. provide 
data that indicate the requirement of sustained TCR-pMHC interactions for the transition of 
effector CD4+ T cells into the memory pool (Kim et al., 2013). 
The comparative analysis of CD4+ and CD8+ T cell memory generation also revealed a 
heterogeneous picture. Corbin et al. and Williams et al., even though using the same 
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experimental setup, reported contradictory observations of unaffected (Corbin and Harty, 
2004) or impaired formation of both memory subsets (Williams and Bevan, 2004) following 
premature termination of L. monocytogenes infection during the primary response. Blair et al. 
observed that the secondary responses of both subsets were reduced if antigen presentation 
was curtailed during the primary response (Blair et al., 2011).  
 
Thus, it remains incompletely understood how the duration of the antigen stimulus affects 
primary and secondary responses of CD4+ and CD8+ T cells. In vivo-studies on CD4+ T cells 
do consistently report the enhancement of their proliferation if antigen persists. Studies on 
CD8+ T cells come to more heterogeneous conclusions, possibly indicating that the 
proliferative capacity of this subset is more dependent on the experimental context or that 
different proliferative programs might be induced in the respective settings. Comparative 
studies present contradictory data, which cannot be explained by differences in experimental 
settings.  
 
3.6 Aim of this thesis 
A doxycycline-regulated system of in vivo antigen expression has recently been used to 
assess the requirement for continued antigen presentation during the expansion of CD4+ and 
CD8+ T cells (Rabenstein, 2012). In this system, CD4+ T cells were found to depend on 
prolonged antigen presentation for strong proliferation in three independent experimental 
approaches. CD8+ T cells on the other hand were able to proliferate extensively after a strong 
in vitro stimulation and transfer into antigen-free mice. The mechanisms responsible for this 
differential antigen dependency of CD4+ and CD8+ T cells remained to be analyzed in detail.  
Therefore, potential causes of the differential proliferative patterns will be assessed in the 
present study. Given the broad expression of MHC I molecules and the relatively restricted 
expression of MHC II molecules in the body, antigen-independent proliferation of CD8+ T 
cell could be due to self-peptide triggering of the TCR. CD4+ T cell proliferation on the other 
hand might be dependent on proinflammatory cytokines, caused by coinhibitory signaling or 
might be related to a particular differentiation state of CD4+ T cells. Furthermore, gene 
expression, proliferation kinetics and the metabolic capacities of both subsets will be studied 
in order to approach an understanding of the mechanisms responsible for differential antigen 
dependency of CD4+ and CD8+ T cells.  
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4 Material and Methods 
4.1 Material 
4.1.1 Chemicals and solutions  
 
2-Mercaptoethanol Carl Roth, Arlesheim, Switzerland 
Agarose Peqlab, Erlangen, Germany 
Antibiotic/antimycotic GE Healthcare, Chalfont St Giles, UK 
Brefeldin A Sigma-Aldrich, St. Louis, MO, USA 
CFDA-SE Cell Tracer Kit Invitrogen, Carlsbad, CA, USA 
Chloroform Carl Roth, Arlesheim, Switzerland 
DAPI Invitrogen, Carlsbad, CA, USA 
DMEM (powder) AppliChem, Darmstadt, Germany 
DMEM, unbuffered Seahorse Bioscience, North Billerica, MA, USA 
DMSO Sigma-Aldrich, St. Louis, MO, USA 
dNTPs Peqlab, Erlangen, Germany 
Doxycycline AppliChem, Darmstadt, Germany 
EDTA (Gibco) Life Technologies, Carlsbad, CA, USA 
Ethanol Diagonal, Münster, Germany 
Ethidium bromide (1% solution) AppliChem, Darmstadt, Germany 
FCS (Gibco) Life Technologies, Carlsbad, CA, USA 
Ficoll (PAA) GE Healthcare, Chalfont St Giles, UK 
FVD (eFlour450 and eFlour660) eBioscience, San Diego, CA, USA 
Gelatin Sigma-Aldrich, St. Louis, MO, USA 
Gene ruler (Fermentas) Thermo Fisher Scientific, Waltham, MA, USA 
Glycerin AppliChem, Darmstadt, Germany 
HEPES (PAA) GE Healthcare, Chalfont St Giles, UK 
IL-2 (recombinant murine) Immunotools, Friesoythe, Germany 
IL-12 (recombinant murine) Immunotools, Friesoythe, Germany 
IL-4 (recombinant murine) Immunotools, Friesoythe, Germany 
IL-7 (recombinant murine) Immunotools, Friesoythe, Germany 
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Ionomycin Diagonal, Münster, Germany 
Isopropanol Diagonal, Münster, Germany 
L-Glutamine (PAA) GE Healthcare, Chalfont St Giles, UK 
MEM non-essential amino acids (PAA) GE Healthcare, Chalfont St Giles, UK 
Neomycin AppliChem, Darmstadt, Germany 
OVA257-264 Peptides & Elephants, Potsdam, Germany 
Orange G Sigma-Aldrich, St. Louis, MO, USA 
PCR Buffer Peqlab, Erlangen, Germany 
PCR Enhancer Peqlab, Erlangen, Germany 
PCR Water AppliChem, Darmstadt, Germany 
PMA Diagonal, Münster, Germany 
Polymycin B AppliChem, Darmstadt, Germany 
Proteinase K Diagonal, Münster, Germany 
RCB Lysis Buffer Biolegend, San Diego, CA, USA 
Streptavidin (APC-Cy7, PE) Biolegend, San Diego, CA, USA 
Taq polymerase Peqlab, Erlangen, Germany 
TRIS AppliChem, Darmstadt, Germany 
Triton X-100 (Fluka) Sigma-Aldrich, St. Louis, MO, USA 
Trypan Blue Carl Roth, Arlesheim, Switzerland  
XF Cell Mito Stress Kit Seahorse Bioscience, North Billerica, MA, USA 
 
4.1.2 Consumables 
Cell culture plate, 6-well Sarstedt, Nümbrecht, Germany 
Cell culture plate, 96-well round bottom Sarstedt, Nümbrecht, Germany 
Cell strainer (100 µm, sterile) BD, Franklin Lakes, NJ, USA  
Cover slides (glass) Diagonal, Münster, Germany 
FACS tubes Sarstedt, Nümbrecht, Germany 
Luminometer-plates, 96-well Nunc, Penfield, NY, USA 
Microfine Syringes for i.p and i.v. injections BD, Franklin Lakes, NJ, USA 
PCR-plates, 96-well Diagonal, Münster, Germany 
Polyamide-mesh, pore size 150 µm  RCT, Heidelberg, Germany 
Polyamide-mesh, pore size 80 µm  RCT, Heidelberg, Germany 
Reaction tubes 1.5 ml Sarstedt, Nümbrecht, Germany 
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Round-bottom tubes 4 ml and 14 ml BD, Franklin Lakes, NJ, USA 
Serological pipettes (5 ml, 10 ml, 25 ml) Sarstedt, Nümbrecht, Germany 
XF96 Analyser Cell Culture Microplates and Sensor 
Cartridges  
Seahorse Bioscience, North Billerica, 
MA, USA 
 
4.1.3 Oligonucleotides  
All oligonucleotides were derived from Eurofins MWG Operon, Ebersberg, Germany.  
 
Target gene/construct Primer name Sequence (5’-3’) 
li-rTA 
RO83 CTGGGAGTTGAGCAGCCTAC 
RO84 CTCCTGTTCCTCCAATACGC 
li-rTA 
RO281 GTCTCAGAAGTGGGGGCATA 
RO282 GGACAGGCATCATACCCACT 
TIM 
RO235 CTCATCTCAAACAAGAGCCA 
RO236 CACTGCTTACTTCCTGTACC 
TIM 
RO298 AGAGAGCCAGAAAGGTGCAG 
RO299 AGCAGATGCATCACATGGTC 
TSO 
RO267 TGTAAGCTCTTGGGAATGG 
RO268 TGGAGGGTGTCGGAATAGAC 
TSO 
RO267 TGTAAGCTCTTGGGAATGG 
RO288 GCATCCACTCACGGATTTCT 
Act-mOVA 
RO264 TTATTCGTTCAGCCTTGCCAGTAG 
RO265 GCTCCAGGATCTTCATTTTCTCAG 
Cd274tmLpc 
RO368 
RO369 
RO370 
AGAACGGGAGCTGGACCTGCTTGCGTTAG 
ATTGACTTTCAGCGTGATTCGCTTGTAG 
TTCTATCGCCTTCTTGACGAGTTCTTCTG 
KRAB 
RO405 
RO406 
GAGTGGAAGCTGCTGGACAC 
CAGGATGGGTCTCTTGGTGA 
 
4.1.4 Antibodies for flow cytometry and cell sorting 
Specificity Clone Conjugate(s) Source 
CD11b  M1/70 bio Biolegend, San Diego, CA, USA 
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CD11c  N418 bio Biolegend, San Diego, CA, USA 
CD16/32  93 unconjugated eBioscience, San Diego, CA, 
USA 
CD25  PC61 PE Biolegend, San Diego, CA, USA 
CD4  RM4-5 bio, AL647, PerCP, 
Brilliant Violett 510 
Biolegend, San Diego, CA, USA 
CD4  Gk1.5 Al647 eBioscience, San Diego, CA, 
USA 
CD4  Gk1.5 PerCP/Cy5.5 Biolegend, San Diego, CA, USA 
CD44  IM7 FITC Biolegend, San Diego, CA, USA 
CD45.1  A20 Al647, PerCP Biolegend, San Diego, CA, USA 
CD45.2  104 Al647 Biolegend, San Diego, CA, USA 
CD49b  DX5 bio Biolegend, San Diego, CA, USA 
CD5 53-7.3 bio Biolegend, San Diego, CA, USA 
CD62L  MEL-14 PE Biolegend, San Diego, CA, USA 
CD69  H1.2F3 PE Biolegend, San Diego, CA, USA 
CD71 RI7217 PE Biolegend, San Diego, CA, USA 
CD8α 53-6.7 Al647, bio, PerCP Biolegend, San Diego, CA, USA 
CD90.1  OX7 Al647, PerCP Biolegend, San Diego, CA, USA 
Eomes  DAN11MAG Al647 Biolegend, San Diego, CA, USA 
FC-receptor  2.4G2 unconjugated BioXcell, West Lebanon, NH, 
USA 
IFNγ  XMG1.2 PE Biolegend, San Diego, CA, USA 
IL-2  JES6-5A4 PE eBioscience, San Diego, CA, 
USA 
Isotype control 
(CD5) 
MOPC-173 Al488 Biolegend, San Diego, CA, USA 
Isotype control 
(Ki67) 
RTK2758 bio Biolegend, San Diego, CA, USA 
Ki67  B56 Al488 BD, Franklin Lakes, NJ, USA 
T-bet  
 
eBio4B10 Al647 eBioscience, San Diego, CA, 
USA 
TCR β-chain H57-597 AL488 Biolegend, San Diego, CA, USA 
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Ter119 TER-119 bio Biolegend, San Diego, CA, USA 
TNFα  MP6-XT22 PE Biolegend, San Diego, CA, USA 
Vα2 CL7213F FITC Cedarlane, Burlington, Canada 
Vβ3 Kj25 FITC Kindly provided by N. 
Asinovski, C. Benoist and D. 
Mathis (Harvard Medical 
School, Boston, MA, USA) 
 
4.1.5 Antibodies used in vitro or in vivo 
All antibodies used in vitro or in vivo were obtained from BioXcell, West Lebanon, NH, USA.  
 
Specificity Clone 
LFA-1 M17/4 
Isotype control (LFA-1) 2A3 
CD3 145-2C11 
CD28 37.51 
IFNγ XMG1.2 
IL-4 11B11 
PD-1 J43 
PD-L1 10F.9G2 
CTLA-4 UC10-4F10-11 
CD40 FGK45.5 
 
4.1.6 Buffers and media 
CFSE Medium PBS 
0.1% BSA (w/v) 
DMEM DMEM 
10 mM HEPES 
FACS Medium DMEM 
10 mM HEPES 
1% BSA (w/v) 
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Gene ruler 100 µl Marker 
700 µl TAE 
200 µl Loading Buffer 
Gitocher Buffer (10x) H2O 
670 mM TRIS, pH8.8 
166 M (NH4)2SO4  
65 mM MgCl2 
0.1% Gelatin 
Loading Buffer (6x) 
(Gel electrophoresis) 
250 mg Orange G 
30 ml Glycerin 30% 
70 ml H2O 
MACS Buffer PBS 
0.5% BSA (w/v) 
1 mM EDTA 
PBS EDTA PBS 
5 mM EDTA 
Seahorse Assay Medium DMEM (unbuffered) 
25 mM Glucose 
1 mM Pyruvate 
2 mM L-Glutamine 
T cell Medium RMPI 1680 
10 % FCS (v/v) 
2 mM Glutamine 
MEM non-essential amino acids 
5 µM 2-Mercaptoethanol 
TAE 242 g TRIS  
57.1 ml acetic acid 99% 
100 ml EDTA 0.5 M, pH8  
add up to 1 l with H2O 
TE 1 M TRIS, pH7.6 
0.5 M EDTA 
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Tissue digestion buffer PCR H2O 
1x Gitocher buffer 
0.3 mg/ml Proteinase K 
0.5% Triton X-100 
Trypan Blue Solution (10x) PBS 
0.05% Trypan Blue (w/v) 
 
4.1.7 Laboratory equipment 
BD FACSCalibur BD, Franklin Lakes, NJ 
BD FACSCanto II BD, Franklin Lakes, NJ 
Camera Olympus E-330 (for Labovert 
FS)  
Olympus, Hamburg, Germany 
Centrifuge 5417R Eppendorf, Hamburg, Germany 
Centrifuge Rotanta 46 RS Hettich, Tuttlingen, Germany 
Electrophoresis Power supply (EPS200) Pharmacia Biotech, Upsalla, Sweden 
Gamma-cell 40 AECL, Chalk River Laboratories, Canada 
Gel-documentation system Intas, Göttingen, Germany 
Incubator 5% CO2, 3% O2 Heraeus, Hanau, Germany 
Incubator 5 % CO2 Heraeus, Hanau, Germany 
Laminar airflow cabinet HeraSafe Heraeus, Hanau, Germany 
Luminometer Berthold Technologies, Bad Wildbad, Germany 
Microscope Labovert FS Leitz, Wetzlar, Germany 
Multichannel pipette Brandt, Wertheim, Germany 
Pipettes  Gilson, Middleton, WI, USA 
Seahorse XF96 Extracellular Flux 
Analyzer and Prep Station 
Seahorse Bioscience, North Billerica, MA, USA 
Thermocyler T1 Biometra, Göttingen, Germany 
Water bath  Lauda, Lauda-Köningshofen, Germany 
 
4.1.8 Software 
BD cell quest BD, Franklin Lakes, NJ, USA 
FACSDiva (Canto II) BD, Franklin Lakes, NJ, USA 
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FACSDiva (Aria II) BD, Franklin Lakes, NJ, USA 
Flowjo 8.8.7 for Mac Treestar Ashland, OR, USA 
GenePattern 3.7.0 Broad Institute, Cambridge, MA, USA 
(Reich et al., 2006) 
Prism 5.0c for Mac GraphPad, La Jolla, CA, USA 
Seahorse XF 96 Software Seahorse Bioscience, North Billerica, MA, USA 
Gel Documentation System Intas, Göttingen, Germany 
 
4.1.9 Statistic analysis 
Statistic analysis was performed using the Prism 5.0c software. If not indicated otherwise, 
means, standard deviation and p values from unpaired two-tailed Student’s t-test are shown.  
 
4.2 Mice and treatments of mice 
All mice were bred and maintained at the animal facility of the Institute for Immunology, 
Ludwig-Maximilians-University of Munich, Munich, Germany. All experiments were 
performed in compliance with German federal guidelines.  
 
4.2.1 Wild type mice and congenic markers 
Mice of B10.BR/SgSnJ (B10.BR, originally received from The Jackson Laboratory) 
C57BL/6 (B6) and BALB/c backgrounds were used. The congenic markers CD45.1 and 
CD90.1 used for the identification of adoptively transferred cells were originally derived from 
B6.SJL-Ptprca Pepcb/BoyJ and B6.PL-Thy1a/CyJ mice received from The Jackson 
Laboratory. BALB/c mice were obtained from Prof. Ludger Klein and Ksenija Jovanovic 
(Ludwig-Maximilians-University Munich, Munich, Germany). 
 
4.2.2 T cell receptor transgenic mice 
AND T cell receptor (TCR) transgenic (tg) animals (Tg(TcrAND)53Hed) display 
predominant expression of a MHC II-restricted TCR consisting of a Vα11 and a Vβ3 chain, 
recognizing a peptide derived from moth cytochrome c (MCC93-103) in the context of H-2Ek 
(Kaye et al., 1989). The Vα11 (derived from the CD4+ T cell clone AN6.2) and Vβ3 
constructs (derived from the CD4+ T cell clone 5C.C7) containing endogenous promotor and 
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enhancer elements were coinjected to generate these mice. AND mice were received from 
Diane Mathis and Christophe Benoist (Harvard Medical School, Boston, MA, USA) and were 
maintained on the B10.BR background. 
For some experiments, AND mice crossed to mice expressing the IL-4 reporter Il4tm1Lky 
(4get, (Mohrs et al., 2001)), received from David Vöhringer, Friedrich-Alexander University 
Erlangen-Nürnberg, Erlangen, Germany) were used. The 4get transgene contains the murine 
IL-4 locus with an IRES (internal ribosomal entry site)-EGPF (enhanced GFP) construct with 
the polyadenylation signal from bovine growth hormone inserted just downstream of the 
translational stop and upstream of the polyadenylation site of intron 4. Thus, IL-4 is co-
expressed with GFP in AND;4get mice. 
T cells of OT1 TCR tg animals (Tg(TcraTcrb)1100Mjb) predominantly express a TCR 
that is specific for SIINFEKL peptide of chicken ovalbumin (OVA257-264) in the context of H-
2Kb and consists of a Vα2 and a Vβ5 chain (Hogquist et al., 1994). The TCR chains were 
derived from an OVA-specific CD8+ T cell clone (149.42). OT1 mice were generated by 
coinjection of constructs coding for the α- and β-chains. OT1 mice were received from 
Thomas Brocker (Ludwig-Maximilians-University Munich, Munich, Germany) and were 
maintained on the B6 background.  
TCR tg animals were crossed with mice expressing congenic markers (CD45.1 or 
CD90.1) in order to allow their tracing following adoptive transfer.  
 
4.2.3 Double transgenic mice allowing doxycycline-dependent antigen expression  
Double transgenic (dtg) dtg-M mice were obtained by crossing Ii-rTA tg mice (Tg(Cd74-
rtTA)#Doi) (Obst et al., 2005) with mice carrying the TIM transgene (tetracycline inducible 
invariant chain with MCC93-103, Tg(tetO-Cd74/MCC)#Doi)(van Santen et al., 2004), resulting 
in doxycycline-dependent expression of MCC93-103 in the context of H-2Ek in MHC II positive 
cells and therefore cognate antigen presentation to AND TCR tg CD4+ T cells (Obst et al., 
2005). Dtg-M mice were received from Diane Mathis and Christophe Benoist (Harvard 
Medical School, Boston, MA, USA) and were maintained on the B10.BR background. For 
detailed descriptions of the Ii-rTA and TIM constructs and their functional properties refer to 
section 5.1. 
In some experiments, dtg-M mice crossed to PD-L1-deficient Cd274tm1Lpc mice were used 
(dtg-M;PD-L1o/o, received from David Vöhringer, Friedrich-Alexander University Erlangen-
Nürnberg, Erlangen, Germany). In these knock out mice, the signal peptide with the ATG 
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start codon and a large proportion of exon two of the CD274 gene was deleted by homologous 
recombination with a construct containing a neomycin cassette (Dong et al., 2004).  
In Dtg-O mice, the Ii-rTA transgene is combined with the TSO transgene (tetracycline 
regulated signal sequence with OVA257-264), resulting in doxycycline-dependent expression of 
OVA257-264 peptide in MHC II positive cells and therefore cognate antigen presentation to 
OT1 TCR tg CD8+ T cells (Rabenstein, 2012). Dtg-O mice were maintained on the B6 
background. For detailed descriptions of the TSO construct and its functional properties refer 
to section 5.1. 
In order to reduce the background expression of the TSO transgene in the absence of 
doxycycline, dtg-O mice were crossed to mice expressing the KRAB transgene (HPGKtTR-
KRAB) coding for a tetracycline-dependent transrepressor under the control of the promotor 
of human phosphoglycerate kinase (hPGK) (Barde et al., 2009). For detailed description of 
the transgene and its supposed effect on OVA257-264 expression in dtg-O;KRAB mice, refer to 
results section 5.7. KRAB mice were received from Andreas Trumpp (German Cancer 
Research Center, Heidelberg, Germany). 
 
4.2.4 Mice expressing antigen constitutively  
Ii-MCC mice (tg(H2-Ea-Cd74/MCC)37GNnak) constitutively express the Ii-MCC 
transgene, a fusion protein of invariant chain (Ii) of MHC II and the MCC88-103 peptide under 
the control of H-2Eα promotor elements, thus providing cognate antigen expression for AND 
TCR tg CD4+ T cells on all MHC II expressing cells (Yamashiro et al., 2002). Ii-MCC mice 
were received from Diane Mathis and Christophe Benoist (Harvard Medical School, Boston, 
MA, USA) and were maintained on the B10.BR background. 
Act-mOVA (Act-OVA, Tg(CAG-OVA)916Jen) mice constitutively express membrane-
bound chicken ovalbumin under the control of β-actin promotor on all body cells (Ehst et al., 
2003). In these transgenic mice, the leader sequence from H-2Kb gene, containing a short 
extracellular spacer and the transmembrane region, is linked to the coding sequence of OVA 
under the control of CMV-immediate-early(IE)-enhancer and chicken-β-actin promotor, 
followed by a rabbit polyA sequence. Act-OVA mice were received from The Jackson 
Laboratory and were maintained on the B6 background. 
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4.2.5 MHCI−/− and MHCI−/−DC-MHCI mice  
In B2mtm1Jae mice (Zijlstra et al., 1989), the gene coding for the beta-2 microglobulin 
(β2m) is replaced with a construct containing a neomycin cassette by homologous 
recombination. Therefore, these mice are deficient for the β-chain of MHC I and thus lack 
MHC I on the surface of all body cells. Crossing them to mice that express β2m under the 
control of the human keratin 14 (K14) promotor (K14-β2m, (Capone et al., 2001)) allows for 
the surface-expression of MHC I in the thymus and thus undisturbed development of the 
endogenous CD8+ T cell compartment. The K14-β2m construct consists of the K14 promotor, 
β-globulin intron, the murine β2m cDNA and the K14 polyA sequence. B2mtm1Jae;K14-β2m 
mice are called MHCI−/− mice in this study. The combination with the CD11c-β2m transgene 
(Kurts et al., 2001) allows for additional expression of MHC I on DCs in B2mtm1Jae;K14-
β2m;CD11c-β2m (MCHI−/−DC-MHCI) mice (Gruber et al., 2010). The CD11c-β2m transgene 
consist of the β2m cDNA ligated with the CD11c promotor region (Brocker et al., 1997).  
Thomas Brocker and Caroline Bernhard (Ludwig-Maximilians-University Munich, 
Munich, Germany) kindly provided genotyped mice of both lines.  
 
4.2.6 Genotyping of mice 
Except for TCR tg animals, all mice were typed by polymerase chain reaction (PCR) 
using the primers and protocols described in sections 4.1.3 and 4.3.1.2. Ii-MCC mice were 
typed with the primers also used for identification of the TIM transgene. AND TCR tg mice 
were typed by surface staining of peripheral blood for the β-chain of the AND TCR (Vβ3) 
and flow cytometric analysis as described in section 4.3.3.1. Surface staining of the α-chain 
(Vα2) of OT1 TCR was utilized for the genotyping of OT1 TCR tg animals. In addition to the 
PCR, surface staining for PD-L1 was used for typing of PD-L1o/o mice. Congenic marker 
expression (CD45.1, CD90.1) was also assessed flow cytometrically.  
For flow-cytometric typing, 2-3 drops of blood were collected from the tail vain and 
processes as described in section 4.3.2.1 and 4.3.3.1. 
 
4.2.7 Mouse cytomegalovirus infection 
If indicated, mice were infected with 2 x 106 plaque forming units (pfu) mouse 
cytomegalovirus (MCMV, obtained from Thomas Brocker, Ludwig-Maximilians-University 
Munich, Munich, Germany) diluted in PBS by intra peritoneal (i.p.) injection. 
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4.2.8 Intra peritoneal application of monoclonal antibodies 
Sterile dilutions of monoclonal antibodies were prepared in PBS and a maximum of 200 
µl per mouse injected i.p.. 
 
4.2.9 Doxycycline treatment 
If indicated, mice were provided with 100 µg/ml doxycycline diluted in water low in 
divalent cations (Volvic, Danone Waters, Frankfurt, Germany) ad libitum. 
 
4.2.10 Generation of bone marrow chimeras 
Recipient mice were irradiated (5 Gy) twice at least 6 h apart and received 5 x 106 bone 
marrow cells from congenically distinct donors the same day. Recipient mice were supplied 
with 2 mg/ml neomycin and 0.1 mg/ml polymyxin B in their drinking water for the following 
6 weeks. The chimerism was analyzed flow cytometrically when performing the final analysis 
of the experiments, using antibodies for the congenic markers of the recipients and the bone 
marrow donors and was higher than 97% in the B cell compartment (CD45R+) in all 
experiments. 
 
4.3 Methods 
 
4.3.1 Molecular biology 
4.3.1.1 Tissue digestion 
For genotyping of mice, DNA from tail tissue (2-3 mm length) of mice was used. The 
tissue was digested in 100 µl tissue digestion buffer for 6 h at 56°C, followed by 10 min at 
90°C for protein denaturation. For PCR, the lysate was diluted 1:10 in TE. 
 
4.3.1.2 Polymerase chain reaction (PCR) 
For PCR typing of transgenic mice, 24 µl of the master mix described below and 1 µl of 
diluted tissue lysate were used. Following initial DNA denaturation (5 min at 95 °C), 35 
cycles of denaturation (30 sec at 95 °C), primer annealing (45 sec at 55 °C) and DNA 
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elongation (45 sec at 72 °C) were performed, followed by a final elongation period (5 min at 
72 °C) and a cooling period (10 sec at 20 °C).  
 
PCR master mix  
PCR H2O  
PCR Buffer 1x 
PCR Enhancer 0.5x 
Oligonucleotide 1 0.5 µM 
Oligonucleotide 2 0.5 µM 
dNTPs 0.2 mM 
Taq polymerase 0.026 U/µl 
 
4.3.1.3 Gel electrophoresis 
Agarose gels (TAE, 1.5% agarose, 0.005% ethidiumbromide) were used for size 
separation of PCR products, with a DNA marker (100 bp ladder) allowing for the 
determination of the PCR product size. The PCR products were mixed with loading buffer in 
a 1:5 ratio, loaded to gels and electrophoresis performed at 120 V in a horizontal gel chamber. 
The results were visualized using a UV light source and a gel documentation system. 
 
4.3.1.4 RNA isolation 
7-9 x 104 CD4+ or CD8+ T cells were directly FACS-sorted into 1 ml TRIzol (Invitrogen, 
Carlsbad, CA, USA) per sample and stored at −80 °C until further processing. Samples were 
thawed, 200 µl chloroform added and mixed for 15 sec, followed by 2 min incubation at room 
temperature. Samples were centrifuged at 12,000 g for 15 min at 4 °C. The RNA containing 
upper phase was transferred to a new tube, 500 µl isopropanol were added and incubated for 
10 min at room temperature, followed by another 10 min centrifugation step. The supernatant 
was discarded and the pellet washed with 70% ethanol. The RNA was air-dried, resolved in 
20 µl PCR H2O and stored at −80 °C. RNA isolation was carried out by Simone Pentz 
(Ludwig-Maximilians-University Munich, Munich, Germany). 
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4.3.1.5 Gene expression analysis 
The purity of the RNA isolated from sorted T cells was controlled with a 2100 
Bioanalyzer (Agilent, Böblingen, Germany) and only samples with an RNA integrity number 
(RIN) > 7 used. The RNA was amplified using the two-cycle MessageAmp II aRNA 
Amplification Kit and further processed using the Message Amp II-Biotin Enhanced Kit 
according to manufacturer’s instructions (both Ambion, Life technologies, Carlsbad, CA, 
USA). Samples from three independent experiments were hybridized on Affymetrix Mouse 
Genome 430 2.0 arrays (Affymetrix, Santa Clara, CA, USA), using a GeneChip Hybrization 
oven 645. Microarrays were washed and stained using the GeneChip Fluidics Station 450 and 
scanned with the GeneChip Scanner 3000 (all from Affymetrics, Santa Clara, CA, USA). The 
above steps were carried out by Marion Horsch and Johannes Beckers (Helmholtz Center 
Munich, Munich, Germany).  
The data were analyzed using the GenePattern platform (Reich et al., 2006). The 
Expression File Creator module was used to normalize .cel files, using Robust Multiarray 
Average background correction method (RMA, (Irizarry et al., 2003)). Subsequently, 
redundant probe sets were collapsed using the CollapseDataset module. The Multiplot module 
was used to visualize the data. A set of 128 genes specific for B cells (Painter et al., 2011) or 
encoded on the X- and Y-chromosome were excluded from visualization.  
 
4.3.1.6 ATP Assay 
The ATP Bioluminescence Assay Kit (Roche, Basel, Switzerland) was used to measure 
the ATP content of T cells in a 96-well format. According to manufacturers instructions, cells 
were lysed and the equivalent of 2.5 x 104 cells per well analyzed in triplicates for the ATP 
mediated bioluminescence of luciferase in a luminometer.  
 
4.3.1.7 Seahorse XF96 Extracellular Flux Analyzer 
The Seahorse XF96 Extracellular Flux Analyzer allows the measurement of changes in 
dissolved O2 (O2 consumption rate; OCR) and pH (extracellular acidification rate; ECAR) in 
the culture medium of live cells in vitro (Wu et al., 2007). In dedicated 96-well plates, a 
transient micro-chamber of 2.6 µl volume is generated above a monolayer of cells of interest 
in each well and changes in dissolved O2 and pH are determined using optical fluorescent 
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biosensors during measuring cycles typically lasting 5-8 min. Between measuring cycles, 
mixing periods allow for the normalization of analytes in the medium. As cells stay alive and 
undisrupted, they can be maintained for hours in the analyzer (at 37 °C), and OCR and ECAR 
can be measured repeatedly. Four injection ports allow the application of drugs or inhibitors 
during the course of an experiment. 
The Seahorse XF96 analyzer was used to perform a Mitochondrial Stress Test on 
stimulated T cells. As the XF96 analyzer relies on a monolayer of adherent cells for analysis, 
stimulated T cells (see section 4.3.2.3) were immobilized on the surface of XF96 Analyzer 
Cell Culture Microplates pretreated with 3.5 µg/cm2 BD Cell Taq (BD, Franklin Lakes, NJ, 
USA) according to manufacturers instructions. To achieve monolayers, 0.8-1.6 x 106 
unstimulated and 2-8 x 105 stimulated T cells were seeded in 80 µl Seahorse Assay Medium 
per well, centrifugated for 1 sec at 40 g and after reversion of plate orientation in the plate 
carrier for 1 sec at 80 g (both without brake) and incubated for 25 min at 37°C without CO2 in 
the XF Prep Station. 120 µl of prewarmed Seahorse Assay Medium were added carefully and 
cells were incubated for further 15 min at 37 °C without CO2 in the Seahorse XF Prep Station 
before the measurement was started. Three min mixing periods were alternated with 5 min 
measurement periods. After 5 measuring cycles for baseline acquisition, the H+ pump 
inhibitor oligomycin was injected at a final concentration of 1 µM. With a delay of three 
measuring cycles each, FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone, a 
decoupling agent, 1.5 µM final) and rotenone together with antimycin A (inhibitors of 
electron transport chain, both 1 µM final) were injected. The non-mitochondrial respiration 
was determined as the minimum of three rates measured following injection of antimycin A 
and rotenone and subsequently subtracted from all rates used for calculation of further 
parameters. Basal OCR and ECAR were calculated as the maximum of the 3 rates acquired 
before injection of oligomycin, OCR/ECAR as the rate of both independently calculated 
parameters. The ATP production was calculated as the minimum of three rates measured 
following oligomycin injection, the maximal respiration as the maximum of three rates 
measured following FCCP injection. The spare respiratory capacity (SRC) was calculated as 
the deviation of maximal respiration and basal OCR.  
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4.3.2 Cellular methods 
 
4.3.2.1 Organ removal and generation of single cell suspensions 
Mice were sacrificed in accordance with the German Protection of Animals Act by CO2 
fumigation. Lymph nodes (axillary, inguinal, brachial from recipients of T cell transfer, 
axillary, inguinal, brachial and cervical from T cell donors) and spleens or hind limb bones 
(femur and tibia, for generation of bone marrow chimeras) were removed under unsterile 
conditions after surficial disinfection of mice with ethanol. Lymph nodes and spleens were 
mechanically disrupted using sterile cell strainers if intended for adoptive T cell transfer or 
cell culture. If intended for flow cytometric analysis, organs were disrupted using glass cover 
slides and filtered trough a mesh (pore size of 150 µm). Splenocyte suspensions were 
centrifuged through a Ficoll cushion (10 min 2,000 rpm/984 g, brake grade 5 of 9) and the 
interphase harvested. Hind limb bones were mechanically disrupted in a sterile mortar, 
filtered trough a cell strainer and subjected to red blood cell lysis using RBC lysis buffer 
(Biolegend, San Diego, CA, USA) according to manufacturer’s instructions.  
Blood samples were collected directly into PBS/EDTA and erythrocytes removed using 
RBC Lysis Buffer according to manufacturer’s instructions.  
Single cell suspensions were pelleted (1,500 rpm/554 g, 4 min) and resuspended in a 
defined volume for cell counting using a Neubauer chamber and Trypan Blue solution. For 
organ collection and the generation of single cell suspensions, FACS medium or DMEM (if 
cells were intended for adoptive transfer without further processing) were used.  
 
4.3.2.2 Magnetic-activated Cell Sorting (MACS) 
Magnetic-activated Cell Sorting (MACS) was used to purify AND CD4+ and OT1 CD8+ 
T cells or polyclonal CD4+ and CD8+ T cells. This technic uses paramagnetic α-biotin-beads 
to separate cells labeled with biotinylated antibodies from unlabeled cells by passage over a 
column placed in a strong magnetic field. The cells of interest were negatively selected. 
Single cell suspensions from lymph nodes and spleens were incubated with a mix of 
biotinylated mAbs as indicated below. Incubation was carried out in a total of 200 µl FACS 
medium per donor mouse for 15 min on ice. Cells were washed twice with FACS medium 
and incubated with 10 µl α-biotin-beads (Milteny, Bergisch-Gladbach, Germany) + 190 µl 
FACS medium per donor mouse for 20 min at 4 °C (in the fridge). Cells were washed twice 
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with MACS buffer, resuspended in 0.7-2 ml MACS buffer per donor mouse and transferred 
onto equilibrated MACS LS-Columns (Milteny, Bergisch-Gladbach, Germany) at 2 ml (cells 
of 1-3 donor mice) per column. Columns were subsequently washed twice with 3 ml MACS 
buffer and the flow-through was collected. The obtained cells were washed once and counted. 
For quality control, an aliquot of purified cells was stained with α-CD4-PerCP, α-CD8-Al647 
and SA-PE and analyzed by flow cytometry as described in section 4.3.3.1. A purity of 95% 
was routinely achieved.  
 
Biotinylated mAb specificity Target cells µl/donor mouse 
GR-1 Granulocytes 5 µl 
Ter119 Erythrocytes 5 µl 
CD49b Natural killer (NK) cells 5 µl 
CD11b Macrophages 5 µl 
CD11c Dendritic cells 5 µl 
CD45R B cells 8 µl 
CD4 or CD8 respectively CD4+ or CD8+ T cells 
respectively  
8 µl 
 
4.3.2.3 T cell stimulation with plate-bound α-CD3 and α-CD28 mAbs 
96-well round bottom plates were incubated with 70 µl/well PBS containing 10 µg/ml α-
CD3 and α-CD28 mAbs each for at least 90 min at 37 °C and 5% CO2. The plates were 
washed twice with cold PBS. T cells were cultured in T cell medium with 5 ng/ml IL-7 added 
to increase survival of unstimulated cells during the 2 d culture period. T cells were seeded at 
105 cells and 200 µl per well and cultured at 37 °C and 5% CO2 unless otherwise indicated. 
 
4.3.2.4 T cell stimulation with antigen presenting cells 
For the restimulation of T cell primed in vitro with plate-bound α-CD3 and α-CD28, a 
coculture with antigen presenting cells (APCs) was used. Splenocytes from wt or antigen-
expressing mice (Ii-MCC for AND T cells, Act-OVA for OT1 T cells) were irradiated (10 
Gy). Stimulated T cells were mixed with a known number of congenically distinct naïve wt 
splenocytes before CFSE labeling to provide undivided control cells. After labeling, the 
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equivalent of 104 stimulated T cells and 105 wt or antigen-expressing irradiated splenocytes 
per well were cocultured in 96-well round bottom plates. Culture was performed in T cell 
medium without additional IL-7 at 37 °C and 5% CO2. 3 d later, the cultures were stained for 
respective congenic markers as well as CD4 and CD8 for flow cytometric analysis.  
 
4.3.2.5 T cell restimulation for cytokine staining 
For the quantification of cytokine production on the single cell level, it is necessary to 
block the secretion of cytokines to make them available for intracellular staining with mAbs. 
Therefore, splenocytes of T cell recipients or in vitro-stimulated T cells were cultured with 20 
ng/ml PMA (a protein kinase C (PKC) stimulating agent) and 1 µg Ionomycin (a Ca2+-
ionophore) for 4 h at 5% CO2 and 37 °C, causing very strong and TCR-independent 
(re)activation of T cells. BrefeldinA (an inhibitor of secretory vesicle formation at the Golgi 
apparatus) was added during the last 2 h of culture, leading to accumulation of produced 
cytokines in the T cells. The restimulation culture was performed in 6-well plates with 2-3 x 
107 splenocytes in 3 ml T cell medium per well.  
 
4.3.2.6 Th1/Th2 differentiation culture 
To achieve differentiation of AND CD4+ T cells towards the Th1 or Th2 phenotypes, 
cells were MACS-purified and stimulated with α-CD3 and α-CD28 as in section 4.3.2.3, but 
without IL-7. Additionally, 5 ng/ml IL-12 and 20 µg/ml α-IL-4 for Th1 or 50 ng/ml IL-4 and 
50 µg/ml α-IFNγ for Th2 polarization were added as described in (Grogan et al., 2001). 
Control cells were stimulated as described in section 4.3.2.3. 
 
4.3.2.7 Generation of Rested Effector CD4+ T cells 
Rested Effector (RE) T cells generated in vitro are very similar to in vivo generated 
memory cells (McKinstry et al., 2007). RE T cells were generated by culturing lymph node 
suspensions of AND T cells with irradiated (33 Gy) splenocytes from mice expressing 
MCC88-103 constitutively (Ii-MCC) for 4 d, followed by a resting period of 3 d. Coculture was 
performed in 96-well round bottom plates with the equivalent of 0.25 x 105 AND T cells and 
105 irradiated Ii-MCC splenocytes per well in T cell medium substituted with 80 U/ml IL-2. 
The cell suspensions were centrifuged over a Ficoll cushion as described in section 4.3.2.1 to 
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remove dead cells. As APCs had been irradiated before initial culture, they were removed by 
this procedure. The cells were counted and cultured at 105 cells per well in 96-well round 
bottom plates using T cell medium for 3 d to acquire the RE phenotype. The phenotypic 
similarity of in vivo generated AND memory cells and AND RE cells was described before 
(Tussing, 2008). 
 
4.3.2.8 CFSE labeling 
Carboxyfluorescein succinimidyl diacetate ester (CFDA-SE) is the highly cell permeable 
precursor of a fluorescence dye. Following entry into the cytoplasm, cellular esterases remove 
the acetate residues, generating fluorescent CFSE, which is subsequently covalently coupled 
to amino groups of cytoplasmic proteins. CFSE conjugated to cytoplasmic proteins is stable 
over days to months and in case of cell division symmetrically distributed between daughter 
cells. Therefore, the analysis of the CFSE dilution allows the monitoring of cell proliferation 
(Quah et al., 2007). For the labeling of cells with CFSE, single cell suspensions of 2 x 107 
cells/ml were prepared in prewarmed CFSE medium and incubated with 10 µM/ml 
(lymphocyte or splenocyte preparations) or 5 µm/ml (cultured cells) CFDA-SA for 10 min at 
37 °C. Cell suspensions were underlayed with 1 ml FCS and pelleted, followed by two 
washing steps with DMEM.  
 
4.3.2.9 Adoptive T cell transfer 
Adoptive transfer of T cells or bone marrow cells was performed via the tail vein. Mice 
were placed under a red light source for about 20 sec to allow widening of the tail veins. Cells 
were injected in a maximal volume of 200 µl in DMEM. Before transfer, cells were washed 
twice with DMEM if they had been maintained in medium containing BSA or FCS 
beforehand to remove these potential immunogenic proteins. If not indicated otherwise, 2 x 
106 T cells (or the equivalent of 2 x 106 tg T cells, if unprocessed lymphocyte preparations 
were used) were transferred.  
 
4.3.2.10  In vivo killing assay 
To assess the capability of OT1 T cell to kill target cells presenting their cognate peptide 
(OVA257-264) in vivo, we transferred congenically marked and peptide pulsed splenocytes 
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from wt mice into recipients of OT1 T cell transfer. Wt splenocytes were pulsed with 1 µg/ml 
OVA257-264 in T cell medium for 4 h at 37 °C and 5% CO2 or cultured without peptide 
(unpulsed). Splenocytes were subsequently labeled with 5 µM (pulsed) or 5 nM CFSE 
(unpulsed) as described in section 4.3.2.8, to allow discrimination of the two populations ex 
vivo. Pulsed and unpulsed cells were mixed in a 1:1 ratio and the equivalent of 2.5 x 106 cells 
per population transferred into mice that received OT1 T cell transfer 3 d earlier. 16 h later, 
mice were sacrificed and spleens analyzed by flow cytometry for frequencies of pulsed and 
unpulsed target cells.  
 
4.3.3 Flow cytometry 
The BD FACSCalibur and FACSCanto II flow cytometers were used for data acquisition. 
All stainings were performed in 96-well round bottom plates. All antibody dilutions were 
centrifuged at 21,000 g for 3 min at 4 °C prior to usage in order to remove protein aggregates. 
All incubations were carried out in the dark. Directly before analysis, cell suspensions were 
filtered through a mesh (pore size of 80 µm).  
 
4.3.3.1 Staining of surface molecules 
FACS medium was used for all washing steps, mAb dilution and sample acquisition. 
Cells were washed, pelleted, resuspended in 50 µl mAb solution and incubated for 20 min on 
ice. For staining with biotinylated mAbs, two washing steps and incubation with 
fluorochrome coupled SA-dilution for 10 min was carried out subsequently. All antibodies 
were diluted 1:400 and SA at 1:2,000. DAPI (4,6-diaminidin-2-phenylindol), used for the 
discrimination of dead cells, was applied at 1 µg/ml together with mAbs. Cells were washed 
before analysis. 
 
4.3.3.2 Staining of intracellular markers and cytokines 
The FoxP3 staining kit (eBiocience, San Diego, CA, USA) was used according to 
manufacturer’s instructions for intracellular staining of transcription factors, cytokines, DAPI 
and the cell cycle activity marker Ki67. Beforehand, cells were stained with fixable viability 
dye (FVD) eFlour450 or eFlour660 diluted 1:1.000 in PBS for at least 20 min on ice. Cells 
were washed and stained for surface molecules as described above. Subsequently, cells were 
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fixed and permeabilized in 100 µl Fix/Perm per well for at least 30 min or up to 20 h at 4°C. 
Cells were washed twice with 150 µl Perm/Wash per well. Cells were incubated with an α-
CD16/CD32 or an α-FC-receptor mAb for 5 min on ice to prevent the unspecific binding of 
mAbs later on. Cells were washed and stained intracellulary under the conditions described 
below. Before analysis, cells were washed with PermWash and FACS medium and 
resuspended in FACS medium. Stainings with isotype control antibodies (IC) or FMOs 
(fluorescence minus one; staining for all markers except the one to be analyzed) were used as 
controls.  
 
Specificity/Dye Dilution Staining condition 
T-bet 1:100 1 h, room temperature 
IFNγ, TNFα, IL-2 1:200 20 min, room temperature 
Ki67 1:10 1 h, room temperature 
DAPI 1 µg/ml 10 min, 4 °C 
 
4.3.3.3 Fluorescence-activated Cell Sorting (FACS) 
To remove dead and apoptotic cells and achieve a purity of approximately 100% essential 
for gene expression analysis, AND and OT1 T cells stimulated as described in section 4.3.2.3 
were stained with α-Ter119, α-GR1, α-CD49b, α-CD11c, α-CD11b, α-CD45R and α-CD4 
(OT1 T cells) or α-CD8 (AND T cells) (all biotinylated) and α-CD4-Al647 (AND) or α-
CD8-Al647 (OT1) and SA-PE as described in section 4.3.3.1. 1 µg/ml DAPI was added 
directly before FACS sorting performed at a MoFlo sorter (Beckham Coulter, Indianapolis, 
IN, USA) operated by Joachim Ellwart (Institute for Molecular Immunology, Helmholtz 
Center Munich, Munich, Germany). Single DAPI−PE−Al647+ cells were directly sorted into 
TRIzol (Invitrogen, Carlsbad, CA, USA). One sorting procedure was sufficient to obtain 
~100% purity of CD4+ and CD8+ T cells. 
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5 Results 
5.1 Doxycycline-regulated antigen expression in vivo 
In order to analyze how the duration of antigen presentation affects adaptive immune 
responses, a strict control of antigen expression is an inevitable prerequisite. In previous 
studies on T cell antigen dependency, termination of antigen expression in vivo has been 
achieved in systems of bacterial infection by antibiotic treatment. In this system, the antigenic 
stimulus cannot necessarily be separated from general inflammation and killed bacteria might 
persist for days (Corbin and Harty, 2004; Williams and Bevan, 2004). In addition, replicating 
pathogens add a further layer of complexity, as their antigens are presented by directly 
infected target cells and following phagocytic uptake in professional antigen presenting cells 
(APCs). The involvement of different cell types and antigen processing pathways hampers the 
predictability and also the analytic assessment of antigen presentation kinetics. Therefore, a 
doxycycline-dependent antigen expression system was used in this study to allow antigen 
expression to be tuned at will within a few professional APCs, creating conditions that allow 
the separate in vivo dissection of antigenic stimulation and inflammation. 
To work with T cells of defined specificity, CD4+ and CD8+ T cell receptor (TCR) 
transgenic (tg) T cells were studied: AND TCR tg CD4+ T cells, specific for amino acids 93-
103 of moth cytochrome c (MCC93-103) and OT1 TCR tg CD8+ T cells, specific for amino 
acids 257-264 of chicken ovalbumin (OVA257-264). Both TCRs display high affinities for their 
respective antigens (Alam et al., 1996; O'Donoghue et al., 2013) and are not self-reactive 
(Aichinger et al., 2013; Hogquist et al., 1994). As TCR tg T cells can never completely 
represent the respective polyclonal subsets, the transferability of findings generated with 
AND and OT1 T cells to polyclonal T cells will be assessed later. Both TCR tg strains carry 
congenic markers (CD45.1 or CD90.1) used for the identification of the cells in recipients of 
T cell transfer. 
Two double-transgenic (dtg) mouse lines were used for the expression of cognate 
antigens of AND TCR tg CD4+ T cells or OT1 TCR tg CD8+ T cells respectively (Fig. 1A). 
Both dtg mice carry a transgene coding for the improved S2 mutant of the reverse tet-
transactivator (rtTAS-S2), which consists of a tetracycline binding domain and a transactivator 
domain (Urlinger Hillen 2000). The tet-transactivator is under the control of the invariant 
chain (Ii) promoter and H-2Eα enhancer elements derived from the pDOI-6 transgene expres- 
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Fig. 1: Description of double-transgenic (dtg) mice expressing cognate antigen for AND (dtg-M) or OT1 
T cells (dtg-O) in a doxycycline-dependent fashion. (A) Transgenes of dtg-M and dtg-O mice. In both lines, 
the reverse tetracycline-dependent transactivator (rtTAS-S2) is expressed constitutively under the control of Eα 
enhancer and invariant chain (Ii) promotor elements. In dtg-M mice, this transgene is combined with the TIM 
transgene (tetracycline inducible invariant chain with MCC93-103), where the CLIP region of Ii is replaced with 
the MCC93-103 peptide and expressed under the control of tetracycline operator (TetO) and CMVcore promotor 
sequences. In dtg-O mice, the TSO transgene (tetracycline regulated signal sequence with OVA257-264) contains 
an improved tetracycline response element (pTRE-tight) consisting of tetOshort and CMVshort promotor that 
regulates the expression of the ssOVA minigene consisting of the H-2Kb signal sequence (ss) and OVA257-264 
followed by the human growth hormone splice substrate. In both dtg-M and dtg-O mice, the tet-transactivator 
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binds to the tetO sequences in the presence of doxycycline and induces the expression of the TIM and TSO 
transgenes. (B) Overview of experimental systems of cognate antigen expression. (C) The fluorescent dye 
CFSE quantifies proliferation in vivo (schematic). During each division, CFSE is equally distributed between 
daughter cells, resulting in distinct fluorescence peaks representing respective cell generations. (D) AND and 
OT1 T cells proliferate following adoptive transfer into dtg-M or dtg-O mice treated with doxycycline. Naïve 
CFSE labeled AND and OT1 T cells were adoptively transferred as indicated and the CFSE dilution analyzed 3 
d later in the spleens by flow cytometry. As indicated, dtg mice received 100 µg/ml doxycycline in their 
drinking water during the experiment, starting 1 d before T cell transfer. Data shown have been gated on single 
live cells positive for congenic markers and CD4 or CD8, respectively. BMC: bone marrow chimera, lethally 
irradiated B6 mouse receiving dtg-O bone marrow transfer. 
 
sion vector (van Santen et al., 2000) and thus is called Ii-rTA (Obst et al., 2005). The Ii-rTA 
construct contains intron one of Ii downstream of the transcription start, as introns are 
required for efficient expression of transgenes (Brinster et al., 1988), and the rabbit β-globulin 
polyA sequence.  
In dtg-M mice, the second transgene TIM (tetracycline inducible invariant chain with 
MCC93-103) consists of a modified Ii with the CLIP region replaced by MCC93-103 under the 
control of the CMVcore promoter and seven tetO sequences (van Santen et al., 2004). An 
intron from rabbit β-globulin is inserted downstream of the transcription start site to allow 
efficient transgene expression. Only in the presence of a tetracycline such as doxycycline can 
the tet-transactivator bind to the tetracycline operator sequence (tetO). Together with factors 
bound to the adjacent minimal CMV promotor, expression of downstream genes is induced. 
Therefore, the cognate peptide of AND T cells is directly delivered to MHC II during its 
assembly in the endoplasmic reticulum in cells expressing this transgene. Since the tet-
transactivator is under the control of Ii promoter elements, one would expect expression in 
cells positive for MHC II, i.e., predominantly in B cells and dendritic cells. The doxycycline-
inducible gene expression system used here has been shown to lead to poor expression in B 
cells but efficient expression in dendritic cells (DCs) (Obst et al., 2005). However, for unclear 
reasons tetracycline dependent gene expression could not be observed in mature B cells in 
some studies (Hess et al., 2001; Witherden et al., 2000), whereas others were able to show 
such expression (Geraldes et al., 2007; Refaeli et al., 2005). 
In dtg-O mice, the TSO (tetracycline regulated signal sequence with OVA257-264) 
transgene encodes a minigene combining the H-2Kb signal sequence (mediating translation 
into the endoplasmic reticulum) and OVA257-264 (Rabenstein, 2012) followed by two stop 
codons and the human growth hormone splice substrate (Chaffin et al., 1990) required for 
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efficient expression. The cognate peptide of OT1 T cells is thus expressed without 
proteasomal processing and TAP-transport. Furthermore, crosspresentation of protein 
transferred to APCs besides the ones carrying the TSO transgene is avoided.  
TSO is expressed under the control of an improved tetracycline response element (pTRE-
tight, Clontech) in which an inadvertently included interferon response element (Rang and 
Will, 2000) is removed from the spacers separating the seven tetO sequences. The spacers 
themselves are shortened so that the tetO sequences are now separated by 3.5 instead of 4 
helical turns (tetOshort), causing the transactivator molecules to bind on opposite sides of the 
DNA in an alternating fashion. Additionally, an enhancer element has been removed from the 
minimal CMVcore promotor, resulting in a shorter version (CMVshort). These changes have 
been shown to decrease background expression and increase inducibility of the tetracycline 
response element up to 1,000-fold (Agha-Mohammadi et al., 2004; Pluta et al., 2005). 
In dtg mice, administration of doxycycline via the drinking water converts the tet-
transactivator from an inactive into an active state, inducing the expression of the TIM or 
TSO transgenes, respectively. As AND TCR tg T cells recognize their cognate antigen in the 
context of H-2Ek, dtg-M mice were maintained on the B10.BR background, whereas the 
presentation of OVA257-264 in the context of H-2Kb required the dtg-O mice to be bred on the 
C57BL/6 (B6) background. For an overview of the two systems of TCR tg T cells and 
cognate antigen expressing mice see Fig. 1B. 
To confirm the expression of cognate antigens for AND and OT1 T cells in dtg-M and 
dtg-O mice, respectively, the fluorescent dye CFSE was utilized to measure T cell 
proliferation in vivo following adoptive transfer. CFSE is derived from a colorless, highly cell 
permeable precursor substance by covalent coupling to cytoplasmic proteins during an in vitro 
labeling procedure. The covalently coupled CFSE is highly fluorescent and stable for weeks 
in vivo. During cell division, the dye is distributed equally between daughter cells, resulting 
in the loss of fluorescent intensity in each generation of the daughter cells that is measureable 
by flow cytometry (Quah et al., 2007). A schematic histogram of the CFSE mean fluorescent 
intensity (MFI) of a divided cell population is shown in Fig. 1C. The assumption of the CFSE 
fluorescence being equally distributed to daughter cells allows the assignation of each peak to 
one cell generation. 
The adoptive transfer of naïve CFSE labeled AND T cells into dtg-M mice treated with 
100 µg/ml doxycycline in the drinking water resulted in profound proliferation of these cells 
over 3 d, whereas cells transferred into untreated mice did not dilute CFSE (Fig. 1D, left). 
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This demonstrates the lack of unspecific expression of the TIM transgene in the absence of 
doxycycline, as far as AND T cells can detect it, and the inducible expression of MCC93-103 
following treatment with doxycycline, as shown previously (Obst Benoist 2005, Obst Mathis 
2007, Han Obst 2010, Rabenstein 2012).  
Naïve OT1 T cells diluted CFSE extensively if transferred into dtg-O mice treated with 
doxycycline but in contrast divided also in the spleens of untreated dtg-O mice (Fig. 1D, 
middle). This leakiness of OVA257-264 expression in untreated mice was abolished in bone 
marrow chimeras (BMCs), generated by reconstitution of lethally irradiated B6 mice with 
bone marrow from dtg-O mice, where expression of the TSO transgene is restricted to bone 
marrow derived cells. In these BMCs, proliferation of OT1 T cells is strictly dependent on 
doxycycline treatment (Fig. 1D, right), confirming previous data (Rabenstein, 2012). 
Antigen expression in dtg mice cannot only be induced but also be switched off again. It 
has been shown previously that TIM mRNA disappears following doxycycline removal with a 
half-life of 2.8 h from the lymph nodes of dtg-M mice, following the kinetics of doxycycline 
in mouse serum (Böcker and Estler, 1981; Obst et al., 2005). 
 
It has recently been proposed that CD5, a monomeric cell surface glycoprotein of T and 
B cells with an inhibitory influence on antigen receptor signaling, might be differentially 
expressed not only on CD4+ and CD8+ T cells but also dependent on the H-2 haplotype 
(Mandl et al., 2013). CD5 expression levels have been correlated with TCR affinity (Azzam 
et al., 2001), pointing towards the involvement of CD5 in TCR signal tuning. The hypothesis 
that higher CD5 levels reflect stronger tonic TCR signaling in CD4+ compared with CD8+ T 
cells is supported by higher expression of Nr4a1 (Nur77), a nuclear receptor immediately 
upregulated by TCR stimulation, in this subset (Moran et al., 2011). The higher affinity of 
Lck for the cytoplasmic tail of CD4 than CD8 could be involved in generating these distinct 
prestimulation levels of both subsets (Itano et al., 1996; Wiest et al., 1993) 
As our experimental systems are set up on two different genetic backgrounds displaying 
different H-2 haplotypes (see Fig. 1B), it had to be excluded that CD5 level differences on 
TCR tg AND and OT1 T cells would hamper the interpretation of experiments aimed to 
compare antigen dependency of both subsets. Therefore, the expression levels of CD5 on 
naïve polyclonal CD4+ and CD8+ T cells from B6 (H-2b), B10.BR (H-2k), BALB/c (H-2d), 
AND TCR tg and OT1 TCR tg mice were analyzed.  
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In agreement with previous data (Cho et al., 2010; Mandl et al., 2013), the gMFIs and 
coefficients of variance (CVs) of CD5 were significantly higher on CD4+ compared to CD8+ 
T cells from all tested strains. This observation might point towards a differential TCR 
affinity tuning in CD4+ and CD8+ T cells, with CD4+ T cells adjusting the strength of TCR 
signaling via the expression level of CD5, whereas CD8+ T cells regulate this by modulation 
of CD8 expression levels (Mandl et al., 2013; Park et al., 2007b). 
No differences between geometrical mean fluorescence intensities (gMFIs) were found 
between CD4+ and CD8+ T cell populations from the tested backgrounds using one-way 
ANOVA (Fig. 2). The data shown in Fig. 2 indicate that the differential CD5 levels observed 
by Mandl et al. do most likely result from independent staining procedures.  
On naïve AND and OT1 T cells, the expression levels (gMFI) and the CV of CD5 were 
very similar, indicating similar prestimulation of both subsets by self-pMHC complexes. CD5 
expression on AND T cells is equal to that of polyclonal CD4+ T cells, whereas OT1 T cells 
present higher CD5 levels than the average polyclonal CD8+ T cell. Consistent with previous 
 
Fig. 2: CD5 expression in mice of different genetic backgrounds and TCR tg T cells. Splenocytes of naïve 
mice of B6 (H-2b), BALB/c (H-2d) and B10.BR (H-2k) background as well as TCR tg AND and OT1 lines were 
stained for CD5. Isotype controls are shown in grey. Geometrical mean fluorescence intensities (gMFIs) and 
coefficient of variation (CV) of CD5 expression with means are shown in the graphs. P values were determined 
by unpaired Student’s t-test. Cells shown have been gated on single live cells positive for CD4 or CD8, 
respectively. One of two similar, independent experiments with 3 to 5 mice per group is shown. 
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observations, CVs of CD5 on both TCR tg T cell subsets are reduced compared to polyclonal 
subsets (Mandl et al., 2013). 
In conclusion, it could be assumed that no intrinsically divergent inhibitory signal 
delivered by CD5 would hamper the direct comparison of AND and OT1 T cell proliferation. 
 
5.2 Design and validation of the experimental setup 
As the aim of this study was to compare the dependence of CD4+ and CD8+ T cell 
proliferation on the duration of antigen presentation, a similar activation of both subsets had 
to be achieved beforehand. 
 
5.2.1 Transient and persistent TCR stimulation of AND and OT1 T cells 
In order to compare the antigen dependency of CD4+ and CD8+ T cells as represented by 
AND and OT1 TCR tg T cells, it was important to design an experimental setting that allows 
very similar priming of both subsets. The physiological priming conditions of CD4+ and 
CD8+ T cells differ in the MHC class presenting the cognate peptides, the APC type, the 
density of pMHC molecules on the cellular and the systemic level and the TCR affinity. Even 
though dtg-M and dtg-O mice were generated to express antigen on the same APC population, 
they do not guarantee similar priming conditions due to the above reasons.  
To circumvent these difficulties, AND and OT1 T cells were primed in vitro with a TCR 
independent stimulus (Fig. 3A). CD4+ AND TCR tg or CD8+ OT1 TCR tg T cells were 
isolated by Magnetic-activated Cell Sorting (MACS) from lymph nodes and spleens of TCR 
tg mice carrying a congenic marker (CD45.1 or CD90.1). Negative selection of CD4+ and 
CD8+ T cells routinely yielded cell preparations of more than 95% purity. This was necessary 
to exclude T cell help to CD8+ T cells in the following culture. T cells were stimulated with 
plate-bound α-CD3 and α-CD28 mAbs. This stimulation delivers strong activating signals to 
both CD4+ and CD8+ T cells regardless of their TCR specificity and restriction. To increase T 
cell survival during the stimulation, 5 ng/ml interleukin-7 (IL-7) were added. Cells cultured 
with IL-7 alone were used as negative controls to account for unspecific stimuli in the cell 
culture system. After 2 d, cells were labeled with CFSE and 2 x 106 cells transferred into the 
respective wt (AND into B10.BR, OT1 into B6) mice, representing transient TCR stimulation 
or dtg mice (AND into dtg-M, OT1 into dtg-O) representing persistent TCR stimulation. All 
recipient mice received 100 µg/ml doxycycline in the drinking water during the experiment,  
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Fig. 3: Experimental setup used to assess the antigen dependency of T cells. (A) Congenically marked and 
MACS-purified AND (CD4+) or OT1 (CD8+) T cells were cultured with plate-bound α-CD3 and α-CD28 
mAbs in the presence of 5 ng/ml IL-7 for 2 d. Cells cultured with IL-7 alone served as controls. T cells were 
CFSE labeled and 2 x 106 cells adoptively transferred into respective wt (transient TCR stimulus) or dtg mice 
(persistent TCR stimulus). Cells cultured with IL-7 alone and transferred into respective wt mice served as 
controls. 3 d after transfer, the CFSE dilution was analyzed in spleen and lymph nodes by flow cytometry. (B) 
Analysis of naïve AND and OT1 T cells prepared from lymph nodes of TCR tg animals. Cells were stained 
with the indicated cell surface markers and DAPI for discrimination of dead cells and analyzed by flow 
cytometry. For default analysis, the data were gated as indicated on single, live lymphocytes positive for the 
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congenic marker and CD4 (AND T cells) or CD8 (OT1 T cells). Staining for Vβ3 or Vα2 was used to confirm 
the transgenic identity of the T cells. Staining for CD44 and CD62L indicates the percentage of activated 
(CD44highCD62Llow) T cells that was routinely found to be below 5%. 
 
starting 1 d before T cell transfer. 3 d after transfer, the CFSE dilution of the transferred AND 
or OT1 T cells was analyzed in lymph nodes and spleen. This experimental setup quantifies T 
cell proliferation in the expansion phase in vivo and compares the antigen requirements of 
both subsets directly. 
All mice used as T cell donors in this study were checked for transgene expression and 
phenotype, as depicted in Fig. 3B. An aliquot of single cell suspensions from lymph nodes or 
spleen was stained for the congenic marker (CD45.1 in Fig. 3B), activation markers CD44 
and CD62L and tg TCR chains (Vβ3 for AND, Vα2 for OT1 T cells).  
The gating strategy depicted is representative for all analyses of flow cytometric data in 
this study. A first gate in the forward scatter area (FSC-A) versus forward scatter height 
(FCS-H) plot was set to select single cells and exclude doublets, a procedure especially 
important if the CFSE dilution is analyzed. Next, a lymphocyte gate was set and the DAPI 
(4,6-diaminidin-2-phenylindol)-negative population (live cells) selected. If cells were fixed 
and permeabilized, a fixable viability dye (FVD) was used instead (see section 4.3.3.2). 
Subsequently, cells double positive for the congenic marker (CD45.1 in this case) and CD4 or 
CD8, respectively, were gated.  
Expression of the tg TCR chains Vβ3 and Vα2 was used to confirm transgene expression 
of donor mice, the expression level of CD44 and CD62L were used to identify potentially pre-
activated T cells (CD44high, CD62Llow). The plots in Fig. 3B demonstrate that more than 98% 
of the T cells display a naïve CD44lowCD62Lhigh phenotype. 
 
5.2.2 AND and OT1 T cells are equally activated following in vitro stimulation 
To confirm that the selected stimulation conditions result in similar activation of AND 
and OT1 T cells, both subsets were analyzed for activation marker expression after 2 d of 
culture. Representative histograms and summarizing statistics in Fig. 4A show very similar 
expression of the activation markers CD69, CD44, CD25 (all low on unstimulated and high 
on stimulated cells) and CD62L (high on unstimulated, low on stimulated cells) and metabolic 
activation markers CD71 (transferrin receptor) and CD98 (large neutral amino acid 
transporter, LAT1) on the T cell subsets. Both AND and OT1 T cells increased their cell size  
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Fig. 4: Activation status of AND and OT1 T cells following 2 d of stimulation. AND or OT1 T cells were 
purified by MACS and cultured for 2 d in plates coated with α-CD3 and α-CD28 mAbs in the presence of 5 
ng/ml IL-7. Cells cultured with IL-7 alone served as unstimulated controls (unstim.). (A) Expression of 
activation markers and production of cytokines on d 2. Before intracellular cytokine staining, cells were 
cultured for 4 h in the presence of PMA and Ionomycin, with Brefeldin A added for the last 2 h. A Fixable 
Viability Dye (FVD) was used to allow discrimination of cells that were dead before fixation. Data have been 
gated on single live CD4+ or CD8+ T cells respectively. FMO controls are shown in grey. The graphs show the 
mean values of data from 3-6 independent experiments. RFU (relative fluorescent units) were calculated as 
gMFIsample/gMFIFMO. (B) Proliferation of stimulated AND and OT1 T cells. MACS-purified AND and OT1 T 
cells were labeled with CFSE before culture. CFSE dilution was analyzed on d 2. Unstimulated cells are shown 
in grey. Average division numbers (N) were calculated from MFIs as N = log2(MFIctrl/MFIsample) and are 
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during stimulation, as reflected by the nearly doubled FCS-A (means and SD: 1.99 ± 0.27 fold 
for AND and 1.76 ± 0.15 fold for OT1). Significant differences between AND and OT1 T 
cells were only obvious for TCR-β expression levels, with AND T cells showing higher 
expression with stimulation (gMFIs of 91.2 ± 12.9 and 22.2 ± 2.3, t-test p < 0.0001) and 
without stimulation (gMFIs of 2.8 ± 1 and 1.6 ± 0.2, t-test p = 0.045). This has previously also 
been shown for polyclonal CD4+ and CD8+ T cells (Rabenstein, 2012).  
Additionally, intracellular cytokine staining was performed following in vitro 
restimulation with PMA and ionomycin. Both AND and OT1 T cells showed a high 
percentage of cells positive for tumor necrosis factor alpha (TNFα) following in vitro 
restimulation (58 ± 17.1% and 39.7 ± 7.3%). Interferon gamma (IFNγ) expression was found 
in OT1 but not AND T cells at this time point (39.2 ± 6.8 % in OT1, 2.4 ± 0.3% in AND T 
cells, t-test p = 0.0007), even though the expression levels were rather low compared to later 
time points of the experiment (see section 5.3.2). IL-2 expression was obvious for both 
subsets but in a significantly higher proportion of AND than OT1 T cells (77.4 ± 13.1% and 
28 ± 3.5%, t-test p = 0.003). During the 2 d culture period, AND and OT1 T cells underwent a 
similar numbers of divisions (N = 0.89 and N = 0.8) as determined by CFSE dilution (Fig. 
4B). 
This set of data confirms the equivalent activation of AND and OT1 T cells during in 
vitro stimulation with α-CD3 and α-CD28. Classical T cell activation markers as well as 
metabolic activation markers were equally induced or decreased following culture in the 
presence of α-CD3 and α-CD28 and no difference in the number of divisions during 
stimulation was obvious. Higher TCR expression in the AND T cells following stimulation 
would potentially allow them to react to the presentation of cognate peptide with a higher 
sensibility. Whereas the proportion of TNFα positive AND and OT1 T cells was similar 
following stimulation, the higher percentage of OT1 T cells producing relatively low levels of 
IFNγ most likely illustrated early effector differentiation. IFNγ-positivity of AND T cells 
indicative of Th1 differentiation was not obvious at this time point. As AND T cells expressed 
IFNγ at later time points (see section 5.3.2), this observation seems to be correlated to 
differential differentiation kinetics of the subsets. Finally, a higher proportion of AND than 
OT1 T cells produced IL-2.  
indicated in the histograms. Shown are live cells. Data represent one of two independent experiments. 
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Signaling via the IL-2 receptor has been repeatedly postulated to enhance primary T cell 
responses and CD8+ T cell cytotoxicity in studies using mice or T cells deficient in 
components of this signaling pathway. However, primary T cell responses seem to be broadly 
independent of IL-2 (Malek, 2008). By cotransfer of IL-2 receptor alpha (IL-2Rα) -deficient 
and wt TCR tg CD8+ T cells in a lymphocytic choriomeningitis virus (LCMV) infection 
model, Williams et al. showed that primary T cell expansion and effector function are 
unaffected by the lack of IL-2 signaling. Nevertheless, the lack of IL-2 signaling during the 
primary response strongly affected the magnitude of secondary expansion, suggesting that IL-
2 is dispensable for T cell proliferation during primary but not recall responses (Williams et 
al., 2006). Thus, it seems unlikely that the higher IL-2 expression of AND T cells provides 
them with a proliferative advantage during the primary expansion phase. 
 
5.3 Differential antigen dependency during the expansion phase  
The experimental setup described in the previous section allows for a very similar 
stimulation of AND and OT1 T cells. Subsequently, the proliferation patterns of both subsets 
were compared following transient and persistent TCR stimulation in the expansion phase in 
vivo. 
 
5.3.1 OT1 but not AND T cells continue proliferation if TCR stimulation ceases 
In order to compare the antigen dependency of AND and OT1 T cell proliferation in the 
expansion phase in vivo, in vitro primed AND and OT1 T cells were transferred into wt or 
antigen expressing dtg mice as described in Fig 3A, subjecting them to transient (no antigen 
present in vivo) or persistent TCR stimulation (antigen presentation in vivo). T cells cultured 
without α-CD3 and α-CD28 were transferred into wt mice and served as unstimulated 
controls (ctrl). 3 d after transfer, the CFSE dilution was analyzed by flow cytometry, applying 
the gating strategy depicted in Fig. 3B.  
The histograms in Fig. 5A show the CFSE dilution of AND and OT1 T cells subjected to 
the indicated experimental conditions. As T cells stimulated in vitro are heterogeneous is size, 
they cannot be homogenously labeled with CFSE and therefore the CFSE dilution does not 
result in distinguishable peaks. This circumstance makes software-assisted analysis of 
proliferation indices impossible. Thus, we calculated an average number of divisions (N) from 
CFSE MFIs as follows: N = log2(CFSE MFIctrl/CFSE MFIsample). This parameter is indicative  
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Fig. 5: OT1 but not AND T cells proliferate independently of persistent TCR stimulation during the 
expansion phase. Congenically marked AND or OT1 T cells were MACS-purified and stimulated with α-CD3 
and α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. Cells were labeled with CFSE and transferred into 
wt mice (transient condition) or antigen-expressing dtg mice (persistent condition, AND g dtg-M, OT1 g dtg-
O). T cells cultured with IL-7 alone and transferred into wt mice served as controls (ctrl). All recipients 
received 100 µg/ml doxycycline in their drinking water during the experiment, starting 1 d before T cell 
transfer. (A) 3 d after T cell transfer, the CFSE dilution was analyzed in the spleen (depicted) and lymph nodes. 
The CFSE dilution in lymph nodes was very similar and is therefore not depicted. Shown are single live cells 
positive for the congenic marker and CD4 or CD8, respectively. Average division numbers were calculated 
from MFIs as N = log2(MFIctrl/MFIsample) and are indicated in the histograms. (B) Absolute numbers of 
transferred tg T cells in the spleens of experimental mice. Data from 10 (A) or 30 (B) independent experiments 
with one mouse per condition are shown. Means are indicated by lines, p values were determined by unpaired 
Student’s t-test. Absolute cell numbers presented in (B) include data from experiments shown in Fig. 6, 10, 14 
and 15. 
 
of the average number of divisions undergone by the whole population analyzed and is 
depicted in the histograms in Fig. 5A. AND T cells undergo only 1.5 divisions under the 
transient conditions while they proliferate extensively (5.4 divisions) following persistent 
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TCR triggering. In contrast, OT1 T cells divide to a similar extent in both the transient and the 
persistent conditions (N = 3.4 and 4, respectively). This holds true in the statistic evaluation, 
as average division numbers N of AND T cells are significantly reduced in the transient 
versus the persistent situation (N = 1.8 ± 0.6 and N = 5.2 ± 0.8), while there is no significant 
difference in OT1 T cell proliferation under both regimens (N = 4.1 ± 1.3 and N = 5.5 ± 1.1). 
These data depict the analyses of splenocytes but AND and OT1 T cell proliferation in lymph 
nodes was found to be very similar and is therefore not shown. 
 
These findings are reflected in the absolute numbers of transferred AND and OT1 T cells 
in the spleens. Fig. 5B illustrates the enhanced accumulation of AND T cells in the persistent 
condition, whereas absolute OT1 T cells numbers are not significantly different in the 
transient versus persistent condition. It was noticed that AND T cells accumulated to a greater 
extent than OT1 T cells following persistent TCR stimulation. CD4+ T cells can provide help 
to CD8+ T cells and thus augment their primary responses (Castellino and Germain, 2006). 
However, as the strict separation of both subsets was at the center of interest in this study, the 
question of whether OT1 T cell expansion is impaired by a lack of T cell help was not further 
investigated. 
Here, OT1 T cells were observed to proliferate independently of antigen presentation in 
the expansion phase in vivo following a strong in vitro priming stimulus. In contrast, AND T 
cell proliferation ceased in the absence of antigen in vivo, indicating differential antigen 
dependency of the subsets. The assessment of activation status following in vitro stimulation 
(Fig. 4) did not reveal a potential proliferative disadvantage of AND T cells. Instead, 
stimulated AND T cells displayed higher levels of TCR on the cell surface and an increased 
proportion of IL-2 positive cells compared to OT1 T cells. Thus, if anything, AND T cells 
could have gained a minor proliferative advantage during the stimulation period. This 
circumstance does not relativize but rather increases the significance of the finding of 
differential antigen dependency. 
 
5.3.2 The effector differentiation of OT1 T cells is antigen-independent 
It was unclear if the proliferation of OT1 T cells in the absence of antigen presentation in 
vivo would lead to the differentiation of functional cytotoxic T cells (CTLs) or if 
differentiation would be aberrant. Therefore, the correlation of T cell proliferation with T cell 
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Fig. 6: Effector functions of stimulated AND and OT1 T cells following transient and persistent TCR 
stimulation. Congenically marked AND or OT1 T cells were MACS-purified and stimulated with α-CD3 and 
α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. Stimulated AND or OT1 T cells were transferred into wt 
(transient) or antigen-expressing dtg mice (persistent). Cells left unstimulated during the culture and transferred 
into wt mice served as controls (ctrl). All recipients received 100 µg/ml doxycycline in their drinking water 
during the experiment, starting 1 d before T cell transfer. (A) On d 3 after T cell transfer, splenocytes were 
restimulated in vitro with PMA and Ionomycin. Cells were fixed, permeabilized and stained intracellulary for 
IFNγ. The percentage of IFNγ-positive cells is indicated in the histograms. The graph shows the means and 
Student’s t-test p values of 5 experiments with one mouse per condition. (B) 3 d after transfer, lymph node 
suspensions were fixed and permeabilized for intracellular staining of the transcription factor T-bet. RFUs 
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(relative fluorescent units) were calculated as gMFIsample/gMFIFMO. Data from 4 (AND) or 5 (OT1) independent 
experiments with one mouse per condition and means are shown in the graph. (C) In vivo killing capability of 
in vitro-stimulated OT1 T cells following transfer into wt (transient) or antigen-expressing mice (persistent). 3 d 
after T cell transfer, mice received 2.5 x 106 OVA257-264 pulsed, CFSEhigh splenocytes and 2.5 x 106 unpulsed, 
CFSElow splenocytes from congenically marked wt mice. 16 h later spleens were analyzed for frequencies of 
pulsed and unpulsed target cells by flow cytometry (shown in histograms). Mice that did not receive T cells 
served as controls. Percent killing was calculated as the reduction of target cell percentage relative to the mean 
percentage of pulsed target cells in control mice. The statistics panel shows data and means from 3 independent 
experiments with 2-5 mice per condition. All data shown have been gated on single live cells positive for the 
congenic marker defining target cells and CD4 or CD8, respectively. FMO controls are shown in grey. P values 
were determined by unpaired Student’s t-test. 
 
differentiation had to be assessed. To address this question, we stained transferred AND and 
OT1 T cells for IFNγ following in vitro restimulation. 
Under conditions of transient as well as persistent TCR stimulation, OT1 T cells 
displayed a high percentage of IFNγ-positivity with no significant difference between 
transient and persistent TCR stimulation conditions (74.2 ± 20.5% versus 81.5 ± 11%, Fig. 
6A). AND T cells on the other hand only acquired the ability to produce IFNγ following 
persistent TCR stimulation (56.3 ± 13.7%), with a significantly smaller proportion (9.7 ± 
7.1%) stainable for IFNγ following transient TCR stimulation.  
Additionally, levels of the IFNγ-expression inducing T cell-specific T-box transcription 
factor (T-bet) were examined by flow cytometry and found to be consistent with the IFNγ 
staining. High levels of T-bet were present in OT1 T cells under condition of both transient 
and persistent TCR stimulation, whereas AND T cells displayed lower levels of T-bet protein 
in the transient compared with the persistent situation (Fig. 6B).  
Furthermore, the in vivo killing capacity of transiently and persistently stimulated OT1 T 
cells was analyzed. Wt or dtg-O mice receiving stimulated OT1 T cells 3 d before were 
injected with congenically marked wt splenocytes pulsed with OVA257-264 in vitro and 
unpulsed control cells at a 1:1 ratio. To allow identification of target cells, the pulsed 
population was labeled with a high dose of CFSE before transfer and the unpulsed population 
with a low dose of CFSE. 16 h after target cell transfer, mice were sacrificed and the 
percentage of OVA257-264 pulsed target cells and unpulsed cells analyzed (Fig. 6C). The 
percentage of killing was calculated as the reduction of target cell percentage relative to the 
mean percentage of pulsed target cells in control mice that did not receive OT1 T cells. 
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Following both transient and persistent TCR stimulation, OT1 T cells acquired the ability to 
kill target cells very efficiently (94.9 ± 2.4% and 95 ± 2.4% killing). 
In conclusion, antigen-independent proliferation of OT1 T cells in the expansion phase 
was associated with differentiation into functional effector cells expressing IFNγ and T-bet. 
AND T cells were positive for the Th1 cytokine IFNγ and expressed high levels of T-bet only 
following persistent TCR stimulation. Differential antigen dependency of AND and OT1 T 
cells was therefore not restricted to proliferation as measured by CFSE dilution but extended 
to the differentiation of these cells. 
 
5.3.3 Transiently stimulated polyclonal CD8+ but not CD4+ T cells divide extensively 
To test if the above-described findings apply to polyclonal T cells, the experiment shown 
in Fig. 3 was carried out with polyclonal T cells from different genetic backgrounds. Here, a 
persistent TCR stimulation could not be performed but nevertheless proliferation of 
polyclonal T cells following transient TCR stimulation could be assessed.  
Congenically marked polyclonal CD4+ and CD8+ T cell were MACS-sorted from wt 
mice of different genetic backgrounds (B6, BALB/c, B10.BR) and stimulated with α-CD3 
and α-CD28 mAbs in vitro for 2 d. The T cells were CFSE labeled and transferred into wt 
mice and cultured unstimulated aliquots were transferred into wt mice as controls (ctrl). 3 d 
after transfer, the CFSE dilution was analyzed in the recipients’ lymph nodes and spleen. In 
the experiments on B10.BR and BALB/c mice, congenically distinct naïve wt splenocytes 
were added at a 1:1 ratio to cultured T cells before the CFSE labeling procedure and thus 
served as an improved negative control during the CFSE dilution analysis. These CFSE 
spiked populations are shown in grey in the histograms in Fig. 7 and indicate the precise level 
of fluorescence of undivided cells. 
For all genetic backgrounds, CD8+ T cells were found to undergo more cell divisions 
than CD4+ T cells following transfer into wt mice (Fig. 7). The extent of CD8+ T cell 
proliferation showed small variations between the different genetic backgrounds, which did 
not reach significance (N = 4.7 ± 1.5 in B6, 3.3 ± 0.8 in B10.BR, 4 ± 0.6 in BALB/c). These 
data indicate that the proliferation patterns of TCR tg cells used here are representative for 
polyclonal T cell repertoires. 
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Fig. 7: Antigen-independent proliferation of polyclonal CD8+ but not CD4+ T cells from different genetic 
backgrounds. MACS-purified polyclonal CD4+ or CD8+ T cells from B10.BR, BALB/c and B6 mice were 
stimulated in vitro with plate-bound α-CD3 and α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. Cells 
were labeled with CFSE and transferred into congenically distinct wt recipients of the same strain (transient 
condition). Cells left unstimulated in the culture and transferred into wt mice served as controls (ctrl). For 
experiments on B10.BR and BALB/c mice, stimulated cells were mixed 1:1 with congenically distinct naïve 
splenocytes of the same background before CFSE labeling to provide undivided control cells (shown in grey in 
the histograms). All mice received 100 µg/ml doxycycline in their drinking water during the experiment, 
starting 1 d before T cell transfer. 3 d after transfer, spleens were analyzed for the CFSE dilution of transferred 
cells by flow cytometry. Data shown have been gated on single live cells positive for the congenic marker and 
CD4 or CD8, respectively. CFSE dilution in lymph nodes was very similar and is therefore not shown. Average 
division numbers were calculated from MFIs as N = log2(MFIctrl/MFIsample) and are depicted in the histograms. 
Means from 6 (B10.BR) or 3 (BALB/c, B6) independent experiments with one mouse per condition are shown 
in the graphs. P values were determined by unpaired Student’s t-test. Please note that the data shown for B6 
mice are also presented as control (ctrl) and transient condition in Fig. 12. 
 
5.3.4 Antigen-independent proliferation of OT1 T cells does not occur in vitro 
In order to dissect the factors mediating antigen-independent proliferation of OT1 T cells 
in the expansion phase, the in vitro reproducibility of this phenomenon was assessed. Even 
though less physiologic, an in vitro model of antigen-independent proliferation of OT1 T cells 
would allow direct interference with compounds manipulating potential causative processes 
(e.g. chromatin modification, signaling pathways or metabolic processes).  
AND and OT1 T cells were MACS-sorted and stimulated with α-CD3 and α-CD28 for 2 
d in vitro as before. Cells were CFSE labeled and subjected to a second culture period analo- 
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gous to transient or persistent TCR stimulation as in Fig. 3: Stimulated AND or OT1 T cells 
were cocultured with irradiated splenocytes from either wt (B10.BR or B6, respectively) or 
constitutively antigen expressing mice (Ii-MCC mice expressing MCC88-103 under the control 
of invariant chain promotor elements to stimulate AND T cells, Act-OVA mice expressing 
OVA protein under the control of the actin promotor to stimulate OT1 T cells). Before the 
CFSE labeling procedure, a known number of congenically distinct naïve wt splenocytes was 
added to the T cells to indicate the level of fluorescence of undivided cells during the CFSE 
dilution analysis. After 3 d of coculture, the CFSE dilution of AND and OT1 T cells was 
analyzed by flow cytometry and the average number of cell divisions calculated.  
Neither OT1 nor AND T cells were able to proliferate extensively in the absence of 
antigen during the second culture period (Fig. 8). Both subsets underwent significantly fewer 
divisions if cultured with wt splenocytes compared to antigen expressing splenocytes. The 
lack of antigen-independent proliferation of OT1 T cells in vitro was nevertheless informative, 
as it could be due to factors inhibiting OT1 T cell proliferation following stimulus removal in 
vitro or factors present in vivo but not in vitro, that are essential for antigen-independent 
proliferation of OT1 T cells. Potential candidates for both groups could be cytokines, oxygen 
concentration, flow conditions or a combination of several of these factors. 
 
 
Fig. 8: Antigen-independent proliferation of OT1 T cells does not occur in vitro. AND or OT1 T cells 
were stimulated in vitro with plate-bound α-CD3 and α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. T 
cells were CFSE labeled and cultured with irradiated splenocytes from respective wt or constitutively antigen-
expressing mice (Ii-MCC for AND, Act-OVA for OT1) for further 3 d. Before CFSE labeling, a known 
number of congenically marked naïve wt splenocytes were added to serve as undivided controls for CFSE 
dilution analysis (shown in grey in the histograms). Data shown have been gated on single live cells positive 
for the congenic marker and CD4 or CD8, respectively. Average division numbers were calculated from MFIs 
as N = log2(MFIundivided/MFIsample) and are depicted in the histograms. The graph shows the mean values from 3 
independent experiments with Student’s t-test p values. 
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5.3.5 Proliferation patterns are unchanged if T cells are cultured at 3% O2  
The O2 concentration in standard culture systems equals atmospheric conditions (21% 
O2) whereas oxygen concentrations in lymphoid tissues of mice range from 0.5 to 4.5% 
(Caldwell et al., 2001). As reactive oxygen species (ROS), which are generated under 
oxidative stress, have recently been shown to interfere with the outcome of TCR signaling 
(Sena et al., 2013), the influence of the O2 concentration during in vitro stimulation on the 
proliferation of AND and OT1 T cells was analyzed.  
The experiment depicted in Fig. 3 was therefore repeated with T cells stimulated at 3% 
O2 and 5% CO2 at 37°C. Expression of activation markers CD44, CD62L, CD69, CD25 and 
TCR-β of cultured AND and OT1 T cells on d 2 did not differ from that of cells cultured at 
21% O2 (determined for one out of three experiments, data not shown, see Fig. 4). T cells 
were CFSE labeled and transferred into wt mice (transient TCR stimulation) or dtg mice 
(persistent TCR stimulation) and the CFSE dilution accessed by flow cytometry 3 d after 
transfer. Before CFSE labeling, congenically marked naïve wt splenocytes were added at a 
1:1 ratio to cultured T cells to indicate the level of fluorescence of undivided cells during the 
CFSE dilution analysis. In analogy to T cells cultured at 21% O2, OT1 but not AND T cells 
divided extensively under conditions of both transient and persistent TCR stimulation (Fig. 
9A). 
Furthermore, the antigen dependency of AND and OT1 T cell proliferation during a 
second culture period was tested in analogy to the experiment depicted in Fig. 8. AND and 
OT1 T cells stimulated at 3% O2 were CFSE labeled and cultured with irradiated splenocytes 
of wt or constitutively antigen expressing mice (Ii-MCC to stimulate AND T cells, Act-OVA 
to stimulate OT1 T cells). Congenically marked naïve wt splenocytes were added at a 1:1 
ratio to cultured T cells before the CFSE labeling procedure as controls. After 3 d of coculture, 
the CFSE dilution was analyzed by flow cytometry.  
As observed before at 21% O2, neither OT1 nor AND T cells proliferate extensively if 
antigen was not presented by APCs in the second culture period (Fig. 9B). However, OT1 T 
cell proliferation following persistent TCR stimulation was reduced compared to the second 
culture performed at 21% O2 (N = 4.8 ± 0.5 at 21% O2 versus N = 3.3 ± 0.2 at 3% O2). 
Additionally, AND T cells showed only very limited proliferation following antigenic 
stimulation in the second culture period at 3% O2 compared to 21% O2 (means of N = 1.3 ± 
0.7 at 3% O2versus N = 4.5 ± 0.3 at 21% O2). Therefore, in vitro but not in vivo proliferation 
of both subsets but especially AND T cells seemed to be supported by high O2 concentrations.  
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Fig. 9: In vitro stimulation at physiological O2 concentration does not change the proliferation patterns of 
AND and OT1 T cells. Congenically marked AND or OT1 T cells were stimulated with plate-bound α-CD3 
and α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d at 3% O2, 5% CO2 and 37 °C. Cells were mixed at a 
known ratio with congenically distinct naïve wt splenocytes before CFSE labeling to provide undivided controls 
(shown in grey in the histograms). (A) Stimulated T cells were transferred into wt (transient) or antigen-
expressing dtg mice (persistent). Cells left unstimulated in the culture and transferred into wt mice served as 
controls (ctrl). All recipients received 100 µg/ml doxycycline in their drinking water during the experiment, 
starting 1 d before T cell transfer. 3 d after transfer, splenocytes were analyzed for the CFSE dilution of 
transferred T cells. The CFSE dilution in lymph nodes was very similar and is therefore not depicted. (B) 
Stimulated T cells were cultured for additional 3 d in the presence of irradiated APCs from wt or constitutively 
antigen-expressing mice (Ii-MCC for AND, Act-OVA for OT1). Again, cultures were performed at 3% O2, 5% 
CO2 and 37 °C. Data shown have been gated on single live cells positive for the congenic marker and CD4 or 
CD8, respectively. Undivided control populations are shown in grey. Average division numbers were calculated 
from MFIs as N = log2(MFIundivided/MFIsample) and are depicted in the histograms. Graphs show means and 
Student’s t-test p values from 3 independent experiments. 
 
This phenomenon has been previously described and was correlated with higher intracellular 
NO levels in cells cultured at O2 concentrations close to those found in vivo (Atkuri et al., 
2007). 
- + - +
0
1
2
3
4 ns <0.0001
0.01
2nd culture Ag on APCs
N
ctr
l
tra
ns
ien
t
pe
rsi
ste
nt ctr
l
tra
ns
ien
t
pe
rsi
ste
nt
0
1
2
3
4
5
6
0.029 ns
N
AND OT1 A 
AND OT1 
B 
ctrl 
transient 
persistent 
CFSE 
CFSE 
AND OT1 
2nd culture  
Ag on APCs 
-
+
1st culture  
!-CD3/CD28 
+
+
AND OT1 
!"
#$%&"!"
0.3 0.0 
1.9 3.7 
5.7 4.7 
0.0 0.4 
0.8 3.1 
Results 
 
 63 
In conclusion, the reduction of O2 concentration in vitro did not influence differential 
antigen dependency of AND and OT1 T cells in the expansion phase in vivo or in vitro. Thus, 
the antigen-independent proliferation of OT1 T cells observed in vivo is not caused by high 
O2 concentrations during the culture period. 
 
5.4 Proliferative patterns of AND and OT1 T cells are cell intrinsic 
Differential antigen dependency of AND and OT1 as well as polyclonal CD4+ and CD8+ 
T cells has been shown here. To elucidate how this phenomenon might be regulated, the 
modifiability of proliferation patterns of AND and OT1 T cells was assessed. The influence of 
MHC abundance, homotypic clustering behavior, bystander inflammation, coinhibitory 
signaling and CD4+ T cell differentiation on the phenomenon described above was addressed. 
Additionally, the number of transferred T cells was excluded from impairing T cell 
proliferation. 
 
5.4.1 OT1 T cell proliferation is not dependent on unspecific TCR triggering 
The expression patterns of MHC I and MHC II molecules are broadly different. MHC II 
is only expressed by professional APCs and MHC I is expressed on all nucleated cells. 
Unspecific, low affinity triggering of TCR with self-peptides has been associated with 
homeostatic proliferation and T cell survival (Beutner and MacDonald, 1998; Brocker et al., 
1997; Goldrath and Bevan, 1999; Kirberg et al., 1997; Takeda et al., 1996). Therefore, the 
question arose whether differential antigen dependency of CD4+ and CD8+ T cells is caused 
by the higher frequency of MHC I than MHC II molecules. Assuming that unspecific TCR 
triggering could maintain ongoing T cell proliferation, the higher number of triggering events 
could be responsible for antigen-independent proliferation of OT1 T cells. 
To test this hypothesis, transgenic mice deficient for beta-2 microglobulin (β2m), without 
which MHC I molecules cannot be assembled, were used. As β2m−/− mice are partially 
lymphopenic due to the abrogated positive selection of CD8+ T cells in the thymus, the β2m 
gene was additionally expressed under the control of the human keratin 14 (K14) promotor, 
allowing its expression in the thymus and thus normal peripheral T cell compartments in mice 
that are for brevity referred to as MHC−/− mice. Crossing MHC−/− animals to mice carrying a 
transgene coding for β2m under the control of the CD11c promotor resulted in MHC−/− DC-
MHC I mice expressing MHC I in the thymus and on DCs. These two tg mice allowed analy- 
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Fig. 10: Antigen independency of OT1 T cells does not rely on unspecific TCR triggering by self-peptide-
MHC complexes. Congenically marked OT1 T cells were stimulated in vitro with plate-bound α-CD3 and α-
CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. Cells were CFSE labeled and transferred into wt mice, 
MHCI−/− mice, MHCI−/− DC-MHCI mice (all transient) or antigen-expressing dtg-O mice (persistent). Cells left 
unstimulated in the culture and transferred into wt mice served as controls (ctrl). All recipients received 100 
µg/ml doxycycline in their drinking water during the experiment, starting 1 d before T cell transfer. 3 d after 
transfer, the CFSE dilution was analyzed in the spleen. The CFSE dilution in lymph nodes was very similar and 
is therefore not depicted. Data shown have been gated on single live cells positive for the congenic marker and 
CD8. Average division numbers were calculated from MFIs as N = log2(MFIctrl/MFIsample) and are depicted in 
the histograms. Mean values from 3 independent experiments are shown. P values were calculated by unpaired 
Student’s t-test. 
 
sis of OT1 T cell proliferation in mice devoid of MHC I in the periphery (MHCI−/−) and in 
mice expressing MHC I on DCs only (MHC−/−DC-MHCI), creating a situation very much 
alike that encountered by CD4+ T cells, whose cognate MHC molecules are only present on 
APCs. 
In vitro-stimulated OT1 T cells were CFSE labeled and transferred into wt, MHCI−/−, 
MHCI−/−DC-MHCI mice (all representing transient TCR stimulation) or antigen expressing 
dtg-O mice (representing persistent TCR stimulation). 3 d after transfer, the CFSE dilution 
was analyzed in lymph nodes and spleen. Irrespective of MHC I expression, OT1 T cells had 
divided equally in all mice representing the transient condition, with average division 
numbers being similar compared to persistently stimulated OT1 T cells (Fig. 10).  
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Hence, antigen-independent proliferation of OT1 T cells is not due to unspecific TCR 
triggering mediated by self-peptides presented on MHC I. The differential antigen 
dependency of AND and OT1 T cells is thus not due to differential expression patterns of 
cognate MHC molecules. 
 
5.4.2 The expansion of OT1 T cells is not dependent on homotypic T cell clusters 
The formation of homotypic T cell clusters has been observed following T cell activation 
in vitro and in vivo for both CD4+ (Hommel and Kyewski, 2003; Ingulli et al., 1997; Sabatos 
et al., 2008) and CD8+ T cells (Bousso and Robey, 2003; Hommel and Kyewski, 2003). 
Recently, homotypic clustering dependent on the integrin LFA-1 (Lymphocyte function-
associated antigen 1) has been suggested to enhance activation as well as effector cell 
differentiation and memory formation of CD8+ T cells (Bose et al., 2013; Gérard et al., 2013), 
whereas others reported that T-T cell clusters attenuate CD8+ T cell responses (Cox et al., 
2013; Zumwalde et al., 2013). 
Here, OT1 but not AND T cells were observed to form clusters during the second day of 
in vitro stimulation with α-CD3 and α-CD28 mAbs. This disparity could not be explained by 
differential expression of LFA-1 or ICAM-1 (intercellular adhesion molecule 1) on stimulated 
T cells (see section 5.5.1.2, Tables 1 and 2). The formation of these clusters was abrogated by 
a mAb blocking LFA-1 (Fig. 11A). Activation marker expression (CD44, CD62L, CD69, 
TCR-β) of OT1 T cells cultured in the presence of the blocking mAb was not altered 
compared to cells treated with isotype control (IC) mAb (data not shown) and comparable 
with data shown in Fig. 4.  
To elucidate whether homotypic clusters were essential for antigen-independent 
proliferation, OT1 T cells stimulated in the presence of α-LFA-1 were CFSE labeled and 
transferred into wt (transient TCR stimulation) or antigen expressing dtg-O mice (persistent 
TCR stimulation). Mice received α-LFA-1 blocking mAb i.p. for continued blockage of T-T 
cell interactions. The CFSE dilution of transferred OT1 T cells was analyzed 3 d after transfer 
in lymph nodes and spleens of recipient animals.  
The average number of divisions undergone by OT1 T cells under both transient and 
persistent TCR stimulation was unaffected by the blockage of LFA-1 (Fig. 11B) and very 
similar to that observed for OT1 T cell stimulated in the absence of α-LFA-1 (see Fig. 5; 
Means of N = 4.5 ± 1.3 for transient condition, N = 5.5 ± 1.1 for persistent stimulation). Thus,  
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Fig. 11: LFA-1 dependent T-T clusters are not required for antigen-independent proliferation of OT1 T 
cells. Congenically marked AND or OT1 T cells were stimulated with α-CD3 and α-CD28 in round-bottom 
wells in the presence of 5 ng/ml IL-7 and 10 µg/ml α-LFA-1 or isotype control (IC) mAbs at 0.5 x 105 cells per 
well. After 24 h, 100 µl medium was replaced to maintain levels of mAbs. (A) Appearance of cultures on d 2 at 
10x magnification. (B) OT1 T cells treated with α-LFA-1 during in vitro stimulation were transferred into wt 
(transient) and antigen-expressing dtg mice (persistent). Mice were injected with 200 µg α-LFA-1 i.p. 3 x every 
12 h beginning 4 h before T cell transfer. All recipients received 100 µg/ml doxycycline in their drinking water 
during the experiment, starting 1 d before T cell transfer. 3 d after transfer, the CFSE dilution of transferred 
OT1 T cells was analyzed in the spleen. The CFSE dilution in lymph nodes was very similar and is therefore 
not depicted. Data shown have been gated on single live cells positive for the congenic marker and CD8. 
Average division numbers were calculated from MFIs as N = log2(MFIctrl/MFIsample) and are depicted in the 
histograms. This experiment was performed once. 
 
the formation of LFA-1 dependent homotypic T cell clusters was not responsible for antigen-
independent proliferation of OT1 T cells in the experimental setup used here. 
 
5.4.3 The proliferation of CD4+ T cells is not dependent on inflammatory cytokines 
The antigen-independent proliferation of OT1 T cells described above occurs in a sterile 
environment. Thus, differential antigen dependency of AND and OT1 T cells could be related 
to a differential dependency on inflammatory cytokines or costimulatory signals not provided 
in the experimental system used here.  
To investigate this issue, wt mice were infected with mouse cytomegalovirus (MCMV), a 
pathogen known to cause massive cytokine release in infected animals. In order to circumvent 
potential different crossreactivity of AND and OT1 TCRs towards MCMV antigens, this 
experiment was performed with polyclonal CD4+ and CD8+ T cells from B6 mice. CD4+ and 
CD8+ T cells were stimulated with plate-bound α-CD3 and α-CD28 mAbs for 2 d in vitro.  
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Fig. 12: Antigen-dependent proliferation of CD4+ T cells is not released by bystander inflammation. 
Polyclonal CD4+ or CD8+ T cells from congenically marked B6 mice were stimulated with plate-bound α-CD3 
and α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. Cells were CFSE labeled and transferred into B6 
mice that, if indicated, had been infected with 2 x 106 pfu MCMV 2 d earlier. 3 d after transfer, spleens were 
analyzed for the CFSE dilution of the transferred T cells. The CFSE dilution in lymph nodes was very similar 
and is therefore not depicted. Data shown have been gated on single live cells positive for the congenic marker 
and CD4 or CD8, respectively. Average division numbers were calculated from MFIs as N = 
log2(MFIctrl/MFIsample) and are depicted in the histograms. The graph show means and unpaired Student’s t-test 
results from 3 independent experiments with one mouse per condition. Please note that the data shown for the 
control (ctrl) and the transient condition (without MCMV) are also presented in Fig. 7. 
 
The expression of activation markers (CD44, CD62L, CD25, CD71, CD98, TCR-β) was 
analyzed after the stimulation for two out of three experiments and found to be very similar to 
that of AND and OT1 T cells (data not shown, see Fig. 4). T cells were CFSE labeled and 
transferred into wt mice (representing transient TCR stimulation) infected with MCMV 2 d 
earlier. This time point of MCMV infection was selected for its documented high serum 
levels of the inflammatory cytokines IFNγ, IL-12, TNFα and IL-6 (Krug et al., 2004; 
Mitrović et al., 2012). T cells left unstimulated during culture and transferred into wt mice 
served as controls (ctrl). The CFSE dilution of transferred CD4+ and CD8+ T cells was 
analyzed in lymph nodes and spleens 3 d later. 
MCMV infection did not enhance the proliferation of CD4+ T cells in wt mice, as 
illustrated by very similar average division numbers (Fig. 12). If anything, the proliferation of 
CD8+ T cells in MCMV infected mice was increased slightly but insignificantly. The lack of 
inflammatory cytokines in the experimental system used here was thus not responsible for the 
reduced proliferation of CD4+ compared with CD8+ T cells following transient TCR 
stimulation. 
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Fig. 13: The number of cells transferred does not affect the antigen 
dependency of AND T cell proliferation. Congenically marked AND T 
cells were stimulated with plate-bound α-CD3 and α-CD28 mAbs in the 
presence of 5 ng/ml IL-7 for 2 d. Cells were mixed at a 1:1 ratio with 
congenically distinct naïve wt splenocytes before CFSE labeling to 
provide undivided controls for CFSE dilution analysis (shown in grey in 
the plots). The indicated numbers of AND CD4+ T cells were transferred 
into wt mice (transient) or antigen-expressing dtg-M mice (persistent). 
All recipients received 100 µg/ml doxycycline in their drinking water 
during the experiment, starting 1 d before T cell transfer. 3 d after 
transfer, the CFSE dilution was analyzed in the spleen. CFSE dilution in 
lymph nodes was very similar and is therefore not depicted. Data shown 
have been gated on single live cells positive for the congenic marker and 
CD4. Average division numbers depicted in the histograms were 
calculated from MFIs as N = log2(MFIctrl/MFIsample). 
 
5.4.4 Proliferation of AND T cells is not limited by the number of cells transferred 
Clonal competition induced by transfer of high numbers of TCR tg T cells has been 
demonstrated to hamper proliferation and functionality of CD4+ T cells (Badovinac et al., 
2007; Quiel et al., 2011; Yarke et al., 2008). Hence it was necessary to investigate the 
influence of the number of cells transferred here (2 x 106 T cells per mouse) on AND T cell 
proliferation.  
In vitro-stimulated AND T cells were CFSE labeled and 2 x 106 to 6.25 x 104 cells 
transferred into wt or antigen expressing dtg-M mice. The CFSE dilution was analyzed 3 d 
later in lymph nodes and spleen.  
The number of AND T cells transferred did not have an obvious effect on the extent of 
proliferation, as average division numbers were found to vary only in the range of 0.5 
divisions in animals receiving titrated numbers of AND T cells (Fig. 13). The number of cells 
transferred is thus not responsible for the antigen-dependency of AND T cell proliferation. 
5.4.5 Blockage of coinhibitory signaling does not enhance AND T cell proliferation  
Coinhibitory signals delivered via cytotoxic T-lymphocyte antigen 4 (CTLA-4) and 
programmed cell death 1 (PD-1) are able to modulate the outcome of TCR ligation. They are 
thought to reverse the TCR mediated cessation of T cell migration (Fife et al., 2009; 
Schneider et al., 2006) and therefore shorten the T cell-DC interaction in vivo. The prolifera- 
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Fig. 14: Coinhibitory signaling does not cause the antigen dependency of AND T cell proliferation. (A) 
Congenically marked AND T cells were stimulated in vitro with plate-bound α-CD3 and α-CD28 mAbs in the 
presence of 5 ng/ml IL-7 for 2 d. Cells were CFSE labeled and transferred into wt mice (transient), which 
received 200 µg mAbs i.p. at the time point of T cell transfer as indicated, or antigen-expressing dtg-M mice 
(persistent). Cells left unstimulated during the culture and transferred into wt mice served as controls (ctrl). All 
mice received 100 µg/ml doxycycline in their drinking water during the experiment, starting 1 d before T cell 
transfer. 3 d after transfer, the CFSE dilution was analyzed in the spleen. The CFSE dilution in lymph nodes 
was very similar and is therefore not depicted. (B) Congenically marked naïve AND T cells were transferred 
into antigen-expressing dtg-M mice (PD-L1o/o) treated with doxycycline and injected with 200 µg mAbs i.p. as 
indicated. 3 d after transfer, the CFSE dilution of transferred AND T cells was analyzed in spleens. The CFSE 
dilution in lymph nodes was very similar and is therefore not depicted. Average division numbers depicted in 
the histograms were calculated from MFIs as N = log2(MFIctrl/MFIsample). Data shown have been gated on single 
live cells positive for the congenic marker and CD4. The mean values from 4-7 (A) or 4 (B) independent 
experiments with one mouse per condition are depicted. P values were calculated by unpaired Student’s t-test. 
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tive blockage of AND T cells following transient TCR stimulation had therefore to be 
considered as being induced by coinhibitory signaling via CTLA-4 and/or PD-1 pathways.  
As the in vitro stimulation used here does not contain any APCs that could potentially 
mediate coinhibitory signals, the importance of the CTLA-4 and PD-1 mediated signals was 
first explored in the expansion phase in vivo. AND T cells were stimulated in vitro for 2 d, 
CFSE labeled and transferred into wt (transient TCR stimulation) or antigen expressing dtg-M 
mice (persistent TCR stimulation). AND T cell left unstimulated during the culture and 
transferred into wt mice served as controls (ctrl). At the time point of T cell transfer, recipient 
mice were treated with blocking mAbs against CTLA-4, PD-1 or programmed cell death 
ligand 1 (PD-L1). The CFSE dilution of transferred AND T cells was analyzed in lymph 
nodes and spleens 3 d later. 
The average number of divisions undergone by AND T cells in mice treated with 
blocking α-CTLA-4, α-PD-1 or α-PD-L1 mAbs were unchanged compared with PBS 
injected control mice (Fig. 14A) and remained significantly reduced in comparison to 
persistently stimulated T cells. Thus, proliferation of AND T cells during the expansion phase 
was unaffected by the coinhibitory signaling pathways targeted here. 
To approach the principal possibility of coinhibitory signals mediating their effects 
during the priming phase, advantage was taken of the possibility to switch off antigen 
expression in dtg-M mice. Dtg-M mice provided with doxycycline in the drinking water for 1 
d will display a fade out of antigen expression during the next 4 d (Obst et al., 2005). The 
transfer of naïve AND T cells at the time point of doxycycline removal thus creates a 
condition of transient TCR stimulation that includes the priming phase. To exclude 
coinhibitory signaling delivered by the PD-1 pathway, PD-L1 deficient (PD-L1o/o) dtg-M 
mice were used as T cell recipients. Additionally, dtg-M;PD-L1o/o mice received a blocking 
α-CTLA-4 mAb at the time point of transfer, allowing the simultaneous blockage of both 
coinhibitory signaling pathways. Naïve AND T cells were CFSE labeled and transferred into 
dtg-M;PD-L1o/o mice treated with doxycycline and α-CTLA-4 or isotype control mAbs as 
indicated. Three days after transfer, the CFSE dilution was analyzed in lymph nodes and 
spleen.  
Even during the double blockage of CTLA-4 and PD-1 signals, the difference in average 
division numbers between transient and persistent TCR stimulation was conserved (Fig. 14B). 
Together, these findings exclude that coinhibitory signals mediated by the PD-1 and CTLA-4 
pathways are responsible for the antigen dependency of AND T cell proliferation. 
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5.4.6 Antigen dependency is conserved in Th1 or Th2 polarized AND T cells 
Whereas CD8+ T cell differentiation is limited to effector and memory subpopulations, 
CD4+ effector T cells are known to fall into a variety of subpopulations with distinct cytokine 
profiles and functions. In the experimental system used here, AND T cells are not purposely 
conditioned towards Th1 or Th2 phenotype during in vitro stimulation. They express the 
transcription factor T-bet and produce IFNγ following persistent stimulation (see Fig. 6), 
indicative of preferential Th1 differentiation. When the expression of the Th2 cytokine IL-4 
was analyzed using AND T cells expressing the IL-4 reporter construct 4get, no IL-4 gene 
translation as reported by green fluorescent protein (GFP) expression could be observed 
following transient or persistent TCR stimulation (Fig. 15A). It remained unclear why AND T 
cells show a preferential differentiation to the Th1 phenotype. Following Leishmania 
infection, mice from different backgrounds tend to generate Th1 or Th2-biased T cell 
responses (Locksley et al., 1999), indicating the involvement of genetic factors. Furthermore, 
the polarization of CD4+ T cells might be influenced by gut microbiota (Chappert et al., 2013). 
As the present study was focused on the comparison of CD4+ and CD8+ T cells, this question 
was not further investigated.  
Partially different proliferative capacities of Th1 and Th2 cells have been reported before 
(Grogan et al., 2001). To assess these potentially divergent proliferation patterns, Th1 or Th2 
differentiating conditions were applied to the in vitro stimulation. Partial GPF expression of 
AND;4get T cells on d 2 of stimulation under Th2 differentiating conditions was observed 
(Fig. 15B). Nearly all AND;4get T cells expressed the IL-4 reporter GFP if a second culture 
period with APCs expressing MCC88-103 (from Ii-MCC mice) was carried out under Th2 
polarizing conditions (Fig. 15B), illustrating the susceptibility of AND cells to skew their 
differentiation towards the Th2 phenotype.  
To assess the proliferation patterns of Th1 and Th2 cells, AND T cells were stimulated in 
vitro for 2 d under Th1 or Th2 polarizing conditions, CFSE labeled and transferred into wt 
(transient TCR stimulation) or antigen expressing dtg-M mice (persistent TCR stimulation). 
AND T cells stimulated in the presence of 5 ng/ml IL-7 served as unpolarized controls 
(unpol.) and AND cells left unstimulated during the culture and transferred into wt mice as 
unstimulated controls (not depicted). Three days after transfer, the CFSE dilution was 
analyzed in lymph nodes and spleens of recipient mice.  
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Fig. 15: Antigen dependency is conserved in Th1 or Th2 polarized AND T cells. (A) AND T cells do not 
express IL-4 following transient or persistent stimulation in vivo. Congenically marked AND;4get T cells were 
stimulated with α-CD3 and α-CD28 in the presence of 5 ng/ml IL-7 in vitro for 2 d and transferred into wt 
(transient) or antigen-expressing dtg-M mice (persistent). 3 d after transfer, splenocytes were analyzed for GFP 
expression. Endogenous CD4+ T cells are shown in grey. (B) Congenically marked AND;4get T cells were 
stimulated with α-CD3 and α-CD28 under Th2 polarizing conditions for 2 d. Cells were cultured for further 3 d 
in the presence of APCs from wt or antigen-expressing APCs (from Ii-MCC mice) under Th2 polarizing 
conditions. On d 2 and d 5, GFP expression of AND;4get T cells was analyzed by flow cytometry. Cells 
cultured under non-polarizing conditions are shown in grey. The percentage of GFP+ cells is indicated in the 
histograms. (C) Congenically marked AND T cells were stimulated with α-CD3 and α-CD28 in vitro under 
Th1 or Th2 polarizing conditions for 2 d. Cells were CFSE labeled and transferred into wt (transient) or 
antigen-expressing dtg-M mice (persistent). Cells left unstimulated during the culture and transferred into a wt 
mouse served as controls (histograms not shown). All recipients received 100 µg/ml doxycycline in their 
drinking water during the experiment, starting 1 d before T cell transfer. 3 d after transfer, spleens were 
analyzed for the CFSE dilution of transferred AND T cells. The CFSE dilution in lymph nodes was very similar 
and is therefore not depicted. Average division numbers were calculated from MFIs as N = 
log2( MFIctrl/MFIsample) and are depicted in the histograms. Data shown have been gated on single live cells 
positive for the congenic marker and CD4. The Graph shows means from 3-5 independent experiments with 
one mouse per condition and p values calculated by unpaired Student’s t-test. 
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Th1 or Th2 polarized AND T cells did not display changed proliferative patterns in 
comparison to the unpolarized control (Fig. 15C). Following all culture conditions, the extent 
of proliferation was significantly lower following transient TCR stimulation as compared with 
persistent TCR stimulation. Nevertheless, Th2 polarization did result in fewer divisions 
following transient TCR stimulation (N = 1.1 ± 0.5) compared to unpolarized AND T cells (N 
= 2.1 ± 0.4). In contrast, Th1 polarization seemed to enhance proliferation (N = 2.9 ± 0.3). 
Following persistent TCR stimulation, the degree of proliferation was reduced in Th2 
compared to unpolarized AND T cells (N = 4.6 ± 0.7 versus 5.9 ± 0.3).  
Taken together, these findings indicate a slightly reduced proliferative potential of Th2 
polarized compared with Th1 or unpolarized AND T cells. This disagreement with the study 
of Grogan et al. (Grogan et al., 2001) will be discussed later (see section 6.2). Antigen-
independent proliferation of AND T cells was not observed following any culture condition. 
Therefore, antigen-dependent proliferation was conserved across CD4+ T cell subpopulations. 
 
5.4.7 Antigen dependency of AND T cell proliferation is unchanged in memory cells 
Memory T cells are thought to expand following shorter simulation periods than naïve T 
cells. It was therefore possible that the proliferation of AND memory T cells would not 
depend on prolonged TCR stimulation.  
To address this question, memory-like Rested Effector (RE) CD4+ T cells, whose 
phenotype and gene expression profile have been demonstrated to resemble that of in vivo 
differentiated memory cells (McKinstry et al., 2007; Strutt et al., 2012), were generated in 
vitro. Naïve AND T cells were stimulated with irradiated splenocytes from mice expressing 
MCC88-103 (Ii-MCC) for 4 d in the presence of 80 U/ml IL-2, followed by a 3 d resting period 
without APCs or IL-2. Activation marker expression of RE AND T cells has been shown 
previously to resemble that of in vivo generated memory cells (Tussing, 2008). RE AND T 
cells were CFSE labeled and their proliferative capacity compared with naïve AND T cells in 
dtg-M mice treated with doxycycline 1 d before transfer (transient antigen presentation) or 
continuously during the experiment (persistent antigen stimulation). Naïve or RE AND T 
cells transferred into dtg-M mice not receiving doxycycline served as controls (ctrl). The 
CFSE dilution was analyzed 3 d after transfer in lymph nodes and spleen.  
Both naïve and RE AND T cells displayed significantly diminished proliferation 
following transient as compared to persistent antigen presentation in vivo (Fig. 16). An 
antigen-independent proliferation phase could thus not be observed in memory-like RE AND  
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T cells, again showing the conservation of this phenomenon across the differentiation states of 
CD4+ T cells. 
 
In conclusion, the experiments presented in this section show that the differential antigen 
dependency of AND and OT1 T cells is resistant to all manipulations applied here. Thus this 
phenomenon seems to be intrinsic to AND and OT1 or CD4+ and CD8+ T cells, respectively. 
 
5.5 The Mechanism of differential antigen dependency of AND and OT1 T cells 
The data presented here point towards a cell intrinsic regulation of the differential antigen 
dependency of AND and OT1 T cells. Three strategies were used to approach the mechanism 
that is responsible for the differential antigen dependency of these subsets: gene expression 
 
Fig. 16: The proliferation of Rested Effector (RE) AND T cells is antigen-dependent. Memory-like AND 
RE T cells were generated by culturing AND T cells in the presence of irradiated splenocytes from mice 
expressing MCC88-103 constitutively (Ii-MCC) for 4 d with 80 U/ml IL-2, followed by a 3 d resting period of 
culture without APCs and IL-2. Before the second culture, APCs were removed by centrifugation trough a 
Ficoll cushion. Congenically marked naïve or RE AND T cells were CFSE labeled and transferred into dtg-M 
mice treated with doxycycline as indicated. Cells transferred into mice receiving no doxycycline served as 
controls (ctrl). 3 d after transfer, the CFSE dilution was analyzed in the spleen. The CFSE dilution in lymph 
nodes was very similar and is therefore not depicted. Data shown have been gated on single live cells positive 
for the congenic marker and CD4. Average division numbers depicted in the histograms were calculated from 
MFIs as N = log2( MFIctrl/MFIsample). The mean values from 4-5 independent experiments with one mouse per 
condition are depicted. P values were determined by unpaired Student’s t-test. 
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analysis, the assessment of proliferation kinetics and metabolic characterization of AND and 
OT1 T cells. 
 
5.5.1 Gene expression analysis of AND and OT1 T cells 
5.5.1.1 Gene expression of transiently and persistently stimulated AND and OT1 T cells 
To find out whether the different proliferation patterns of CD4+ and CD8+ T cells are 
reflected at the transcriptional level, gene expression analysis of transiently and persistently 
stimulated AND and OT1 T cells has been carried out previously (Rabenstein, 2012). In that 
study, AND and OT1 T cells subjected to transient or persistent TCR stimulation as described 
in Fig. 3 were sorted from recipient mice 3 d after transfer and RNA isolated for microarray 
analysis. Here, the obtained data were reanalyzed (with the kind permission of H. Rabenstein).  
In order to compare the gene expression of both subsets, the fold change (FC) of mean 
expression values of transiently stimulated versus control T cells was plotted against the FC 
of persistently stimulated versus control T cells (Fig. 17). In FC/FC plots, genes regulated 
similarly under both experimental conditions are located close to the diagonal (X = Y) of the 
plot, whereas genes whose expression is changed in one but not the other condition compared 
to the control condition will cluster around the FC = 1 lines.  
Fold change (FC/FC) plots revealed broadly different gene expression patterns for AND 
and OT1 T cells under conditions of transient compared with persistent TCR stimulation. The 
overall appearance of the FC/FC plot displaying AND T cell gene expression resembled a 
cloud of dots clustered around the horizontal line. A group of genes was only upregulated 
following persistent TCR stimulation and few genes were strongly upregulated under both 
conditions. Gene expression of OT1 T cells on the other hand seemed to be more similar 
under both conditions, with the scatter-plot showing the tendency to locate around the X = Y 
line of the plot and a rather small group of genes upregulated only following persistent TCR 
stimulation (Fig 17). Linear regression analysis (performed by Cheng Guo) was used to assess 
the mathematic significance of this impression. The regression line for the FC/FC plot for 
AND T cells has a ~2-fold smaller slope than the FC/FC plot for OT1 T cells (P = 0.27 for 
AND and P = 0.46 for OT1 T cells). Furthermore, the correlation coefficient of the scatter-
plot representing the gene expression of AND T cells is smaller than that of OT1 T cells (r2 = 
0.14 for AND, r2 = 0.44 for OT1 T cells), indicating that the scatter-plot of OT1 T cell fits 
better to the regression line than that of AND T cells.  
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Fig. 17: Gene expression analysis of transiently and persistently stimulated AND and OT1 T cells. 
Congenically marked AND or OT1 T cells were purified by MACS and stimulated with α-CD3 and α-CD28 
mAbs and 5 ng/ml IL-7 for 2 d, or cultured with IL-7 alone as controls. 4 x 106 Cells were transferred into wt 
mice (transient condition) or antigen-expressing dtg mice (persistent condition, AND gdtg-M, OT1 g dtg-O). 
Unstimulated T cells were transferred into wt mice and served as controls (ctrl). Dtg mice received 100 µg/ml 
doxycycline in their drinking water during the experiment, starting 1 d before T cell transfer. 3 d after T cell 
transfer, lymph nodes and spleens were pooled for FACS sorting. Cells were sorted twice for the presence of 
the congenic marker and CD4 or CD8, respectively, to achieve approximately 100% purity with the second sort 
being directly targeted into reaction tubes containing TRIzol. RNA was isolated, cDNA synthetized and gene 
expression of independent triplicates analyzed by hybridization to the Affymetrics Mouse Genome 430 2.0 
microarray. These experiments were performed by H. Rabenstein (Rabenstein, 2012). Here, data were 
reanalyzed using the Genepattern software. Cheng Guo calculated regression lines using the Matlab software. 
 
A detailed analysis of these datasets identified a small group of genes that were 
upregulated in persistently stimulated AND and OT1 T cells as well as in transiently 
stimulated OT1 but not AND T cells (Rabenstein 2012). Among them was the transcription 
factor T-bet, whose protein levels were demonstrated here to follow the same pattern (see Fig. 
6). This group did not contain genes with a known role in the regulation of T cell proliferation 
and thus no promising candidates for master regulators of the antigen-independent 
proliferation of CD8+ T cells.  
In conclusion, the gene expression analysis of transiently and persistently stimulated 
AND and OT1 T cells revealed broad differences in gene expression patterns of both subsets 
under these conditions. 
 
FC
 tr
an
si
en
t /
 c
on
tro
l 
FC persistent / control 
P = 0.26610 
r2 = 0.1388 
1 
10 
0.1 
1 10 0.1 
P = 0.46303 
r2 = 0.4406 
1 10 0.1 
!"#
$%&'#!"#
AND OT1 
Results 
 
 77 
5.5.1.2 Gene expression of in vitro-stimulated AND and OT1 T cells  
Even though activation marker expression of AND and OT1 T cells was very similar 
following the in vitro stimulation step, it remained possible that the differential proliferation 
and gene expression patterns observed on d 5 were already programmed during the priming 
phase. To address this question, gene expression analysis was performed on d 2 of in vitro 
stimulation, the point where T cell treatments diverged, in the present study. AND and OT1 T 
cells were stimulated with α-CD3 and α-CD28 for 2 d in vitro and FACS sorted to achieve 
approximately 100% purity and to eliminate dead or apoptotic cells. The RNA was isolated 
and independent triplicates used for the gene expression analysis on an Affymetrix Mouse 
genome 420 2.0 microarray. Data were analyzed using GenePattern open source software (for 
details refer to sections 4.3.1.4 and 4.3.1.5). 
 
No genes are regulated in an opposing manner in AND and OT1 T cells 
In order to find genes that could be responsible for the differential proliferation patterns 
of CD4+ and CD8+ T cells, a first analysis was dedicated to the identification of genes that are 
upregulated in one and downregulated in the other subset or vice versa. To visualize the 
changes in gene expression of AND and OT1 T cells following in vitro stimulation, the FC of 
mean expression values in the stimulated versus the unstimulated condition were plotted 
against their p value in so-called volcano plots, that allow for the simultaneous judgment of 
the extent of up- or downregulation of genes and their significance. These plots showed more 
genes to be significantly (t-test p < 0.05) upregulated more than 3-fold following stimulation 
in AND T cells (1,528, highlighted in blue) than in OT1 T cells (809, highlighted in green) 
(Fig. 18, upper panels). If genes upregulated in stimulated AND T cells were projected onto 
the data set of OT1 T cells and vice versa, it was obvious that the majority of genes are 
regulated similarly in the opposing T cell subset (Fig. 18, lower panel). Of the 1,528 genes 
significantly upregulated in AND T cells, only 19 (1.2%) were downregulated in OT1 T cells, 
with none of them reaching significance. Vice versa, of 809 genes significantly upregulated in 
OT1 T cells only 15 (1.9%) were downregulated in AND T cells (all with p > 0.05). Thus, no 
genes with opposing expression patterns in the subsets were identified. 
Critical assessment of gene expression data  
In order to judge the extent of variance between gene expression patterns of AND and 
OT1 T cells, these results were compared with gene expression data generated in an indepen- 
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Fig. 18: Gene expression of AND and OT1 T cells following 2 d of in vitro-stimulation. AND or OT1 T 
cells were MACS-purified and stimulated with α-CD3 and α-CD28 mAbs and 5 ng/ml IL-7 for 2 d, or cultured 
with IL-7 alone as controls. Cells were FACS sorted (directly into TRIzol) to remove dead cells and achieve 
approximately 100% purity. The RNA was isolated and the gene expression in samples derived from 3 
independent experiments analyzed with the Affymetrics Mouse genome 430 2.0 array. Data were processed 
using the Genepattern software. The blue lines mark a fold change (FC) of 3. 
 
dent study. Gene expression data of CD4+ and CD8+ T cells stimulated with α-CD3 and α-
CD28 for 24 h in vitro were recently published (Mingueneau et al., 2013) and would have 
been best suited for this purpose but were not available (as of February 24th, 2013). Instead, 
gene expression data derived from OT1 T cells stimulated with artificial APCs (aAPCs) in 
vitro (Agarwal et al., 2009) were used. In that study, aAPCs were generated by coating latex 
microspheres with the H-2Kb:Ig fusion protein and a CD80/Fc chimeric protein and loaded 
with OVA257-264. OT1 T cells were cultured in the presence of aAPCs and 2.5 U/ml IL-2 for 2 
d. Gene expression was analyzed on an Affymetrix Mouse Genome U74Av2 microarray. 
Naïve OT1 T cells freshly isolated from TCR tg animals were used as controls.  
Here, microarray data from that study were reanalyzed in analogy to that of AND and 
OT1 T cells depicted in Fig. 18 to compare the gene expression of OT1 T cells stimulated 
under the two different conditions. As the data were generated using different Affymetrix 
microarrays, they could not be depicted in one single plot. In addition to different T cell stim- 
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Fig. 19: Comparative analysis of gene expression data derived from OT1 T cells stimulated with two 
different protocols. Gene expression patterns of OT1 T cells stimulated with  α-CD3 and α-CD28 in this study 
and OT1 T cells stimulated with artificial APCs (aAPCS; latex microspheres coated with H-2Kb and B7, loaded 
with OVA257-264) by Agarwal et al. (Agarwal et al., 2009) were analyzed using the Genepattern software. The 
blue lines mark a fold change (FC) of 3. 
 
ulation protocols, the control cells (IL-7 cultured versus naïve OT1 T cells) had to be 
considered as a possible cause of discrepancy. However, volcano plots revealed a similar 
overall impression of OT1 gene expression under both stimulation conditions. In general, 
OT1 T cells stimulated with aAPCs displayed a weaker up- and downregulation of most genes 
illustrated by a narrower distribution of the scatter-plot (Fig. 19, upper panel) that might be 
due to the use of different control cells in both studies. In these cells, 515 genes were 
significantly (t-test p < 0.05) upregulated more than 3-fold, compared to 809 genes in α-
CD3/α-CD28 stimulated OT1 T cells.  
If genes upregulated by one stimulation protocol were projected onto the data set of T 
cells stimulated with the other protocol, a picture similar to that presented for AND and OT1 
T cells (Fig. 18) was observed (Fig 19, lower panel). Only 528 of the 809 genes significantly 
upregulated in α-CD3/α-CD28 stimulated OT1 T cell were also noted in the microarray used 
by Agarwal et al., but most of them (402, 76.2%) were also upregulated in aAPC-stimulated 
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cells. A total of 126 (23.8%) genes were downregulated but only two of them to a FC > 3 and 
reaching significance. The other way around, all 515 genes significantly upregulated in aAPC 
stimulated OT1 T cells could be plotted on the data set of α-CD3/α-CD28 stimulated OT1 T 
cells. Of these genes, 428 (83.1%) were upregulated and 87 (17%) were downregulated but 
only two reached a FC of 3 and significance. Only 149 genes were upregulated significantly 
at least 3-fold in both stimulated OT1 populations. This number is most likely underestimated 
by the fact that different microarrays were compared and different control cells used.  
In the comparison of α-CD3/α-CD28-stimulated and aAPC-stimulated OT1 T cells, more 
genes tended to be regulated in an opposing manner (17% and 23%) than between α-CD3/α-
CD28-stimulated AND and OT1 T cells (1.2% and 1.9%). In conclusion, gene expression 
variances between α-CD3/α-CD28 stimulated AND and OT1 T cells are lower than variances 
between OT1 T cells stimulated using two different protocols, indicating high reproducibility 
of the T cell stimulation used here on both subsets. 
 
Few genes are differentially regulated in in vitro-stimulated AND and OT1 T cells 
To compare the gene expression of in vitro-stimulated AND and OT1 T cells directly, 
mean expression values derived from stimulated AND and OT1 T cells were plotted against 
each other (Fig 20). In this plot, only differential gene expression of AND and OT1 T cells 
was visualized without reference to unstimulated cells set in volcano plots.  
The majority of genes were regulated similarly in AND and OT1 T cells following in 
vitro stimulation. A total of only 58 genes are expressed at higher levels (FC > 3) in AND T 
cells, opposed by 71 genes upregulated specifically in OT1 T cells. These numbers were 
further reduced to 27 genes (AND) and 41 genes (OT1) if a t-test p value smaller than 0.05 
was required, together representing only 0.5% of the genes depicted (Fig. 20, depicted in blue 
(AND) or green (OT1) and Tables 1, 2). Out of 41 genes differentially expressed in OT1 T 
cells, 19 were also upregulated in OT1 T cells sorted from mice infected with OVA-
expressing Listeria monocytogenes 48 after the infection (as retrieved from The 
Immunological Genome Project (Immgen) database (Heng et al., 2008) on January 10th, 2014). 
These genes are marked with an asterisk in Table 2. As the Immgen database did not provide 
data on activated CD4+ T cells at that time point, this validation could not be carried out for 
the genes expressed at higher levels in AND T cells.  
In addition to Cd4 and Cd8, some genes that are associated with the specific effector 
functions of the subsets were differentially expressed. In AND T cells, the genes coding for  
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Fig. 20: Gene expression of AND and OT1 T cells following in vitro stimulation. AND or OT1 T cells were 
MACS-purified and stimulated with α-CD3 and α-CD28 mAbs in the presence of 5 ng/ml IL-7 for 2 d. Cells 
were FACS sorted (directly into TRIzol) to remove dead cells and achieve approximately 100% purity. The 
RNA was isolated and the gene expression in samples derived from 3 independent experiments analyzed with 
the Affymetrics Mouse genome 430 2.0 array. Data were processed using the Genepattern software. 
 
the CD4+ T cell cytokines IL-4 and IL-21 were expressed at higher levels than in OT1 T cells 
(FC of 34.35 and 5.53, respectively) but this did not reach significance. In OT1 T cells, the 
effector molecule granyzme B (Gzmb) and the transcription factor Eomes are significantly 
upregulated. Also the expression of the genes encoding H2-T18 and folate receptor 4 (Folr4, 
FR4) was upregulated in AND compared to OT1 T cells. H2-T18 (a variant allele of thymic 
leukemia Ag, TL) defines the genetic background of AND T cells (B10.BR). FR4 has been 
associated with the regulatory functions of CD4+ T cells (Liang et al., 2013; Yamaguchi et al., 
2007) and recently also with CD4+ T cell anergy (Martinez et al., 2012). In agreement with its 
differential expression in CD4+ T cells observed here, higher levels of FR4 on the surface of 
stimulated CD4+ compared to CD8+ T cells were reported previously (Yamaguchi et al., 
2007).  
Even though IFNγ production was shown to be limited to OT1 T cells following 2 d 
stimulation (Fig. 3), its transcription was not observed to be restricted to OT1 T cells. Besides 
Eomes, no transcription factors with a known role in T cells were found to be differentially 
regulated between AND and OT T cells. The expression of runt-related transcription factor 2 
(Runx2), a transcription factor previously described for its importance in bone development 
(Ducy et al., 1997), was significantly upregulated in OT1 T cells in agreement with data 
available at the Immgen database (as retrieved on January 10th, 2014).  
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Table 1: Genes differentially expressed in in vitro-stimulated AND compared with OT1 T cells 
(highlighted in blue in Fig. 20). All genes with a FC (AND versus OT1) > 3 and Student’s t-test p value < 0.05 
are depicted. For experimental details refer to Fig. 20. P values were generated using the Multiplot module of 
the Genepattern software. 
 
Recently, the expression of Runx2 in CD8+ memory T cells was reported (Hu and Chen, 
2013).  
 Even if no cyclins were differentially regulated in stimulated AND and OT1 T cells, 
three genes whose products could be involved in the regulation of cell cycle progression were 
found to be expressed at higher levels in OT1 T cells: growth arrest and DNA-damage-
inducible 45 beta (Gadd45b), growth arrest and DNA-damage-inducible 45 gamma 
(Gadd45g) and Cdk5 and Abl enzyme substrate 1 (Cables1). AND T cells displayed 
significantly higher expression of sprout homology 1 (Spry1), a gene whose product is 
discussed as a regulator of T cell effector functions (Collins et al., 2012). While some data on 
the role of these genes in T cells are available (see section 6.3.1), their importance for the 
proliferation of T cells is still undefined.  
!!"
Probe name/  
Gene symbol Description 
FC  
AND/OT1 p value 
A630038E17RIK RIKEN cDNA A630038E17 gene 4.63 0.007084 
ADH1 alcohol dehydrogenase 1A (class I), alpha polypeptide 16.82 0.049588 
AK3L1 adenylate kinase 3 alpha-like 1 4.07 0.049588 
AKR1C12 aldo-keto reductase family 1, member C12 4.27 0.014625 
AKR1C13 aldo-keto reductase family 1, member C13 3.42 0.011582 
ASS1 argininosuccinate synthetase 1 4.48 0.006840 
BC021614 cDNA sequence BC021614 3.39 0.035136 
C80638 expressed sequence C80638 3.57 0.019331 
CAP1 CAP, adenylate cyclase-associated protein 1 (yeast) 4.75 0.006840 
CCR8 chemokine (C-C motif) receptor 8 3.06 0.035136 
CD4 CD4 antigen 7.65 0.019331 
CD9 CD9 antigen 3.69 0.000017 
CHST2 carbohydrate sulfotransferase 2 4.73 0.001610 
CKB creatine kinase, brain 5.97 0.000002 
FOLR4 folate receptor 4 (delta) 7.76 0.003587 
H2-T18 /// H2-T3 /// H2-
TW3 /// H2-T3-LIKE /// 
LOC633417 /// 
LOC674370 
histocompatibility 2, T region locus 18 /// histocompatibility 2, T 
region locus 3 /// similar to histocompatibility 2, T region locus 
3 /// MHC class I antigen /// similar to histocompatibility 2, T 
region locus 3 /// similar to histocompatibility 2, T region locus 3 
9.99 0.003587 
H2-T18 /// 
LOC633417 /// 
LOC674370 
histocompatibility 2, T region locus 18 /// similar to 
histocompatibility 2, T region locus 3 /// similar to 
histocompatibility 2, T region locus 3 
12.86 0.000013 
HYI hydroxypyruvate isomerase homolog (E. coli) 3.05 0.000373 
IL12RB1 interleukin 12 receptor, beta 1 3.36 0.000608 
LOC633417 similar to histocompatibility 2, T region locus 3 3.43 0.012419 
MAPRE2 microtubule-associated protein, RP/EB family, member 2 3.78 0.000768 
PTGIR prostaglandin I receptor (IP) 4.30 0.001598 
PTPRF receptor type protein tyrosine phosphatase F 5.17 0.012419 
SPRY1 sprouty homolog 1 (Drosophila) 3.49 0.020067 
SYNPO synaptopodin 3.78 0.004646 
TESC tescalcin 3.15 0.003043 
UBXD5 UBX domain containing 5 5.35 0.000024 
#$%&'"!"
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Table 2: Genes differentially expressed in in vitro-stimulated OT1 compared with AND T cells 
(highlighted in green in Fig. 20). All genes with a FC (OT1 versus AND) > 3 and Student’s t-test p value < 
0.05 are depicted. P values were generated using the Multiplot module of the Genepattern software. For 
experimental details refer to Fig. 20. Genes that are upregulated in OT1 T cells isolated from mice infected with 
OVA-expressing Listeria monocytogenes 48 h post infection (as retrieved from the Immgen database on 
January 10th, 2014) are marked with an asterisk. 
 
Taken together, gene expression analyses confirmed the similar activation of AND and 
OT1 T cells following in vitro stimulation. Only a few genes were differentially expressed 
between the subsets.  
!"#
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Probe name/ Gene 
symbol Description 
FC  
OT1/AND p value 
0610037M15RIK H2-Q6, histocompatobility 2, Q region locus 6 13.87 0.01905 
2810439F02RIK* TTC39C, tetratricopeptide repeat domain 39C 5.78 0.00623 
5730557B15RIK ANKRD33B, ankyrin repeat domain 33B 7.34 0.00002 
ADM* adrenomedullin 4.86 0.00248 
AVPI1* arginine vasopressin-induced 1 3.38 0.00622 
BASP1* brain abundant, membrane attached signal protein 1 4.19 0.00337 
BC016495* cDNA sequence BC016495 7.42 0.00162 
C920025E04RIK RIKEN cDNA C920025E04 gene 14.94 0.00108 
CA2 carbonic anhydrase II 4.89 0.00166 
CABLES1 /// 
LOC635753* 
Cdk5 and Abl enzyme substrate 1 /// similar to Cdk5 and Abl enzyme substrate 
1 6.36 0.00950 
CD8A /// 
LOC636147 /// 
LOC669166 
CD8 antigen, alpha chain /// similar to T-cell surface glycoprotein CD8 alpha 
chain precursor (T-cell surface glycoprotein Lyt-2) /// similar to T-cell surface 
glycoprotein CD8 alpha chain precursor (T-cell surface glycoprotein Lyt-2) 
(CD8a antigen) 
25.53 0.01488 
CRIM1 cysteine rich transmembrane BMP regulator 1 (chordin like) 3.95 0.00166 
CRTAM* cytotoxic and regulatory T cell molecule 3.58 0.00950 
CXCL10* chemokine (C-X-C motif) ligand 10 5.92 0.00119 
EOMES* eomesodermin homolog (Xenopus laevis) 3.43 0.01488 
GADD45B* growth arrest and DNA-damage-inducible 45 beta 5.28 0.01133 
GADD45G* growth arrest and DNA-damage-inducible 45 gamma 3.98 0.00016 
GKAP1* G kinase anchoring protein 1 3.88 0.01132 
GZMB* granzyme B 8.02 0.00035 
H2-D1 histocompatibility 2, D region locus 1 19.83 0.00119 
H2-D1 /// H2-L /// 
LOC547343 /// 
LOC636948 
histocompatibility 2, D region locus 1 /// histocompatibility 2, D region /// similar 
to H-2 class I histocompatibility antigen, L-D alpha chain precursor /// similar to 
H-2 class I histocompatibility antigen, D-B alpha chain precursor (H-2D(B)) 
11.56 0.00735 
H2-K1 Histocompatibility 2, K1, K region 6.10 0.01272 
H2-L histocompatibility 2, D region 9.03 0.00025 
HIST1H4I* histone 1, H4i 7.30 0.02895 
HOD homeobox only domain 3.91 0.03291 
IL6 interleukin 6 5.04 0.04391 
KLRC1 /// KLRC2* killer cell lectin-like receptor subfamily C, member 1 /// killer cell lectin-like receptor subfamily C, member 2 19.04 0.02895 
KLRD1 killer cell lectin-like receptor, subfamily D, member 1 22.83 0.00803 
LOC547343 similar to H-2 class I histocompatibility antigen, L-D alpha chain precursor 17.07 0.01364 
MALAT1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) 3.30 0.00822 
METRNL meteorin, glial cell differentiation regulator-like 12.41 0.00453 
OSTF1 osteoclast stimulating factor 1 3.18 0.00920 
PERP* PERP, TP53 apoptosis effector 4.68 0.00803 
PKIB protein kinase inhibitor beta, cAMP dependent, testis specific 13.24 0.01490 
PLA1A phospholipase A1 member A 3.52 0.02441 
PLAGL1 pleiomorphic adenoma gene-like 1 6.20 0.00822 
RAB34* RAB34, member of RAS oncogene family 3.29 0.00368 
RCN3 reticulocalbin 3, EF-hand calcium binding domain 3.35 0.00568 
RUNX2* runt related transcription factor 2 3.17 0.00568 
SGIP1 SH3-domain GRB2-like (endophilin) interacting protein 1 5.22 0.01491 
UPB1* ureidopropionase, beta 3.48 0.01037 
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In conclusion, a gene possibly responsible for the differential antigen dependency of 
AND and OT1 T cells was not identified by gene expression analysis, even though Spry1 and 
the cell cycle regulatory genes Gadd45b, Gadd45g and Cables1 could be involved in this 
process. Therefore, differential antigen dependency of both subsets is unlikely to be 
exclusively caused by a single gene product at the transcriptional level but might rather be 
elicited by a complex network of regulatory factors spanning transcriptional, translational, 
post-translational, epigenetic and potentially even metabolic processes. 
 
5.5.2 Proliferation kinetics of AND and OT1 T cells differ 
So far, the proliferation of AND and OT1 T cells has only been assessed at one time point 
in the expansion phase (d 5 of the experiment). As the CFSE dilution analysis only provided 
information on how often AND and OT1 T cells divided during the 3 d in vivo portion of the 
experiment (see Fig. 3 and Fig. 5), a strategy for deeper analysis of this issue was sought. 
To access the cell cycle activity of T cells directly at the time point of analysis, the DNA 
stain DAPI was used. If stained on fixed and permeabilzed cells and acquired on a linear scale, 
DAPI gMFI is indicative of cellular DNA content, and therefore enables discrimination of 
cells with a single set of chromosomes (2n, G1-phase of cell cycle) from those currently 
synthesizing DNA (> 2n and < 4n, S-phase) or being about to divide (4n, G2-phase and early 
M-phase). The percentage of cells in these active stages of the cell cycle (% > 2n) is 
indicative of the division pace and cell cycle activity on the population level.  
Furthermore, Ki67, a protein broadly used to identify cells in all active stages of cell 
cycle, was stained with a mAb. DNA content illustrated by DAPI staining and Ki67 protein 
expression was assessed simultaneously by flow cytometry.  
To reveal potential differences in cell cycle activities of AND and OT1 T cells, T cells 
were analyzed directly after the second day of in vitro stimulation, the point of treatment 
divergence. Additionally, cell cycle activity was determined 3 d after transfer (d 5 of 
experiment) or 5 d after transfer (d 7 of experiment) into wt or antigen expressing dtg mice. T 
cells left unstimulated during the cultures and transferred into wt mice were used as controls 
(ctrl). The gate on actively dividing cells was set in a DAPI versus FSC-A plot where the 
increase of cell size during cell cycle progression facilitated the discrimination of this 
population. The quantification of Ki67 was complicated by the fact that following in vitro 
stimulation, T cells were falling into clearly distinct Ki67+ and Ki67? populations, whereas 
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transferred T cells analyzed ex vivo appeared as uniform populations differing in their Ki67 
gMFIs. Therefore, the percentage of positive cells or the relative fluorescent units (RFUs, 
calculated as gMFIKi67/gMFIIC) was used to analyze Ki67 expression in these two situations 
as appropriate. The use of RFUs allowed the comparison of data from independent 
experiments and analysis time points. 
Following in vitro stimulation, AND and OT1 T cells display equal percentages (42.2 ± 
6.7% versus 36.5 ± 8.2%) of cells in S-, G2- and M-phase of cell cycle (Fig. 21A left). The 
percentage of AND and OT1 T cells expressing Ki67 protein was much higher (94.8 ± 3.8% 
versus 81.9 ± 7.6%, Fig. 21B left). This finding had been anticipated as Ki67 protein levels 
were expected to be maintained during the lag phase between two divisions (G1) after a first 
cell cycle was completed. Significantly less AND than OT1 T cells expressed Ki67, most 
likely reflecting the fact that AND T cell proliferation during 2 d stimulation was less 
homogenous with some cells not yet in division, whereas almost all OT1 T cells had divided 
once (Fig. 4B). Thus, while the proliferative activity of AND and OT1 T cells was equal on 
the population level, Ki67 expression seemed to indicate a greater number of AND T cells not 
yet in division compared to OT1 T cells. This finding indicates that AND T cell proliferation 
following in vitro stimulation is induced with a slightly prolonged lag-time. 
3 d after transfer (on d 5 of the experiment) of stimulated T cells, both AND and OT1 T 
cells displayed an equal percentage of cells with more than two chromosome sets following 
persistent TCR stimulation (11.2 ± 6.1% and 9.2 ± 6.5%, Fig. 21A middle). Following 
transient TCR stimulation, both subsets display a significantly smaller proportion of dividing 
cells (1.8 ± 0.8% of AND and 1.8 ± 1% of OT1 T cells). This finding shows that cell cycle 
activity of AND and OT1 T cells at this time point was similar. Thus, antigen-independent 
proliferation of OT1 T cells occurring after transfer into wt mice has ceased 3 d after transfer. 
 In contrast, Ki67 staining revealed no differences corresponding to those detected by 
DAPI staining on d 5 of the experiment. For both AND and OT1 T cells, the RFUs of 
persistently stimulated cells were not significantly elevated compared to transiently stimulated 
cells. RFUs of persistently stimulated AND and OT1 T cells were not significantly different, 
as well as RFUs of transiently stimulated AND and OT1 T cells (Fig. 21B middle). 
5 d after transfer (on d 7 of the experiment) into wt or antigen expressing dtg mice, DAPI 
staining still showed a significantly higher proportion of AND and OT1 T cells actively 
dividing under persistent than under transient TCR stimulation (Fig. 21A, right). Additionally, 
significantly more OT1 than AND T cells showed active proliferation at that time point if  
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Fig. 21: Proliferation kinetics of AND and OT1 T cells following transient and persistent TCR 
stimulation. Congenically marked AND or OT1 T cells were stimulated with α-CD3 and α-CD28 in the 
presence of 5 ng/ml IL-7 in vitro for 2 d. An aliquot was fixed and permeabilized for staining with DAPI (A) 
and for Ki67 (B). Cells were transferred into wt (transient TCR stimulation) or antigen-expressing dtg mice 
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(persistent TCR stimulation) for analysis of DNA content (A) and Ki67 (B) on d 3 after transfer (d 5 of the 
experiment) or d 5 after transfer (d 7 of the experiment) in lymph nodes. Cells left unstimulated and transferred 
into wt mice served as controls (ctrl). All recipients received 100 µg/ml doxycycline in their drinking water 
during the experiment, starting 1 d before T cell transfer. Data shown have been gated on single live cells 
positive for the congenic marker and CD4 or CD8, respectively. IC stainings are shown in grey. RFUs were 
calculated as gMFIKi67/gMFIIC. The mean values from 6-7 independent experiments are shown in the graphs. P 
values were determined by unpaired Student’s t-test. 
 
subjected to persistent TCR stimulation (7 ± 3% of OT1 versus 2.3 ± 0.4% of AND T cells). 
This finding suggests that OT1 T cells are susceptible to TCR triggered T cell proliferation 
for longer periods of time than are AND T cells. 
Ki67 staining at d 5 after transfer reveals a very similar picture: RFUs of persistently 
stimulated AND and OT1 T cells are significantly increased compared to transiently 
stimulated cells and OT1 T cells display significantly higher RFUs under persistent TCR 
stimulation than AND T cells (35.2 ± 8.8 versus 11.2 ± 3.6, Fig. 21B, right). 
Taken together, the DAPI data demonstrate again similar activation of AND and OT1 T 
cells following 2 d in vitro culture. Cell cycle activity on d 5 revealed the antigen-independent 
proliferation of OT1 T cells to be time-limited and lasting for less than 3 d. Additionally, OT1 
T cells seemed to be responsive to TCR stimulation for longer periods of time, indicating 
general differences in proliferation kinetics and capacities of the subsets. 
Considering the kinetics of Ki67 positivity in direct comparison to cell cycle activity 
measured by DAPI staining, Ki67 seemed to be rather slowly fading following cessation of 
proliferation, resulting in disparate findings for both cell cycle activity markers on d 5 and 
accordance on d 7 of the experiment. Despite the fact that Ki67 protein expression has been 
described to be closely linked to cell cycle activity in a tumor cell line (Bruno and 
Darzynkiewicz, 1992) and that it is broadly used for the identification of actively proliferating 
cells, in this study and elsewhere Ki67 protein has been observed to be stable for prolonged 
periods of time following cessation of proliferation (Hettinger et al., 2013; Hogan et al., 2013).  
 
5.5.3 The metabolic capacities of AND and OT1 T cells are partially distinct  
The interest in the correlation of immune cell function and their metabolism is growing. 
Metabolic processes have been reported to influence the translation of TCR signaling into 
gene expression (Sena et al., 2013) and memory T cell formation has been correlated with 
metabolic changes in T cells (Gubser et al., 2013; van der Windt et al., 2013). As differentia- 
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Fig. 22: ATP content of in vitro-stimulated AND and OT1 T cells. 
MACS-purified AND or OT1 T cells were stimulated with α-CD3 
and α-CD28 in the presence of 5 ng/ml IL-7 in vitro for 2 d. The ATP 
content was measured using the ATP Bioluminescence Assay Kit 
(Roche). To allow inter-experimental comparison, the data were 
normalized to the samples with the lowest ATP content in each 
experiment (in all experiments: unstimulated AND T cells). The 
graph shows means and p values (paired Student’s t-test) of data from 
5 independent experiments. 
 
tion and proliferation of T cells relies on and might be limited by their metabolic capacity, the 
differential antigen dependency of AND and OT1 T cells could be correlated with differential 
metabolic capacities. 
To address this possibility, AND and OT1 T cells were analyzed for the amount of ATP 
per cell following 2 d in vitro stimulation, as the ATP content allows for a first estimate of 
metabolic activity of the subsets. As inter-experimental variance of this biochemical assay 
was high, data were related to the lowest value in each experiment (in all independent 
experiments unstimulated AND T cells) to allow statistical analysis of the results. The ATP 
content of in vitro-stimulated AND and OT1 T cells did not differ (Fig. 22). Nevertheless, 
unstimulated OT1 T cells contained significantly more ATP than unstimulated AND T cells, a 
hint of different metabolic states of both subsets following culture in the presence of IL-7. 
In order to assess multiple metabolic parameters of live cells simultaneously, the 
Seahorse XF96 Extracellular Flux Analyzer was utilized. This machine determines dissolved 
O2 and pH in the culture supernatant of live cells in vitro and allows calculation of the O2 
consumption rate (OCR) and the extracellular acidification rate (ECAR) (Wu et al., 2007). In 
a 96-well-format, optical fluorescent biosensors determine both analytes in a transient micro-
chamber generated by lowering the sensor unit close to the bottom of the wells. In between 
measurement periods, the culture supernatant is mixed to allow equation of analyte 
concentrations. The measured OCR (Moles/min) is directly correlated to mitochondrial 
oxidative phosphorylation, whereas the ECAR (pH/min) is correlated to glycolysis-derived 
lactate responsible for the acidification of the culture medium. Additionally, four drug 
injection ports allow the application of components during the measurement period and 
changes in OCR and ECAR in response to the respective substances can be analyzed.  
 To assay the respiratory capacity of mitochondria, the OCR is measured following 
application of substances modifying the oxidative phosphorylation (Fig. 23A). After recor- 
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Fig. 23: Mitochondrial Stress Test using the Seahorse XF96 Extracellular Flux Analyzer. (A) Schematic: 
parameters of mitochondrial respiration accessible by the Mitochondrial Stress Test. (B), (C) Purified AND or 
OT1 T cells were stimulated in vitro with α-CD3 and α-CD28 in the presence of 5 ng/ml IL-7 for 2 d. Cells 
cultured with IL-7 alone served as unstimulated controls. 0.8-1.6 x 106 unstimulated and 2-8 x 105 stimulated T 
cells per well were immobilized to the surface of Seahorse XF96 Cell Culture Microplates using BD Cell Taq. 
Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) were measured in the basal 
state and after separate injection of oligomycin, FCCP and rotenone/antimycin A. Data were normalized to the 
cell numbers in the wells. (B) Kinetic display of OCR data from one of 4 independent experiments. Mean and 
SEM from 5-8 replicates per condition are shown. (C) Statistical evaluation of 4 independent experiments with 
5-8 technical replicates per condition. SRC: spare respiratory capacity. For details on parameter calculation see 
section 4.3.1.7. The mean values are shown in the graphs. P values were determined by Student’s t-test. 
 
ding the basal respiration, the ATP synthetase inhibitor oligomycin is injected, preventing 
phosphorylating respiration and therefore reducing OCR for the amount used for ATP 
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synthesis in the basal state. OCR is not completely reduced by this inhibitor, as protons can 
diffuse into the mitochondrial matrix to a certain extent (proton leak). The addition of the 
uncoupling agent FCCP leads to an increase of OCR to maximal levels, representing the 
maximal respiration that the cells are able to perform. The difference between basal 
respiration and maximal respiration is called spare respiratory capacity (SRC). Rotenone and 
antimycin A are inhibitors of electron transport chain (ETC) complexes I and III and their 
application reduces OCR to the base line representing non-mitochondrial respiration. Changes 
in the ratio of basal ECAR and basal OCR (ECAR/OCR) between experimental conditions 
are indicative of the enhanced use of glycolysis or oxidative phosphorylation in the cells 
analyzed. 
The Mitochondrial Stress Test described above and depicted in Fig. 23A was performed 
on AND and OT1 T cells stimulated for 2 d in vitro with α-CD3 and α-CD28. T cells left 
unstimulated served as controls. Five initial measurement cycles (5 min measurement, 3 min 
mixing) were carried out before injection of oligomycin, with the last three being used to 
calculate basal OCR. After the injection of each drug, three measurement cycles were 
performed. During data analysis, OCR and ECAR were normalized to cell numbers. For 
details on parameter calculation refer to section 4.3.1.7. 
Fig. 23B displays OCR kinetics of one out of four independent experiments. Statistical 
analysis revealed the basal OCR of unstimulated OT1 T cells to be significantly higher than 
that of unstimulated AND T cells (0.03 ± 0.01 fMoles/min and 0.1 ± 0.04 fMoles/min, Fig. 
23C). A similar tendency was obvious for stimulated T cells but significance was not reached. 
Basal ECAR and the ECAR/OCR ratio were higher in stimulated AND and OT T cells than in 
unstimulated T cells, indicating increased glycolysis, but no differences between the subsets 
were detected. The ATP production of OT1 but not AND T cells was slightly but 
insignificantly increased in stimulated cells. The apparent contrast to the amount of ATP 
depicted in Fig. 22 can be explained by the use of two different experimental approaches; a 
correlation between the amount of O2 used to produce ATP and the total amount of ATP per 
cell is not mandatory. Significantly higher maximal respiration was observed for unstimulated 
OT1 compared to AND T cells (0.29 ± 0.05 fMoles/min and 0.43 ± 0.07 fMoles/min). For 
stimulated AND and OT1 T cells, a t-test p value of 0.0525 indicated a strong tendency 
towards statistical significance. The SRC was similar in unstimulated AND and OT1 T cells 
but higher in stimulated OT1 than AND T cells (0.11 ± 0.1 fMoles/min and 0.25 ± 0.03 
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fMoles/min). Furthermore, stimulated AND T cells displayed a reduced SRC compared to 
unstimulated cells (0.11 ± 0.1 fMoles/min and 0.26 ± 0.05 fMoles/min).  
For all parameters assessed, inter-experimental variances were relatively high. Thus, 
these results will require further validation by the future analysis of naïve T cells from both 
TCR tg and wt mice as well as transiently and persistently stimulated AND and OT1 T cells 
isolated from recipient mice (see Fig. 3). 
In conclusion, unstimulated OT1 T cells displayed a higher basal and maximal respiration 
than unstimulated AND T cells. Additionally, the SRC is reduced in stimulated compared to 
unstimulated AND but not OT1 T cells and stimulated OT1 T cells display a higher SRC than 
stimulated AND T cells. This may provide OT1 T cells with a proliferative advantage 
contributing to antigen-independent proliferation of these cells. 
 
Taken together, a mechanism of differential antigen dependency of CD4+ and CD8+ T 
cells could not be identified here. Gene expression analysis did not reveal potential candidates 
for the transcriptional regulation of this phenomenon. Instead, the gene expression patterns of 
AND and OT1 T cells were found to be very similar following two days of in vitro 
stimulation, indicating that the described phenomenon might in addition be regulated on the 
level of protein modifications, by miRNAs or by epigenetic processes. Partially divergent 
proliferation patterns and metabolic capacities could be involved in the differential antigen 
dependency of the subsets, but the causative relationships remain unclear.  
 
5.6 T cell proliferation patterns reflect MHC biology 
Considering the physiological context of T cell proliferation, the differential antigen 
dependency of AND and OT1 T cells might be related to the biology of MHC II and MHC I 
molecules. The stabilization of MHC II but not MHC I on the surface of activated human DCs 
has been reported in vitro (Cella et al., 1997). Subsequently, the reduced turnover of MHC II 
following DC maturation was revealed to be dependent on polyubiquitinylation of MHC II 
(Shin et al., 2006; van Niel et al., 2006) mediated by E3 ubiquitinase March 1 (De Gassart et 
al., 2008; Walseng et al., 2010). Differential stabilization of MHC molecules has so far not 
been demonstrated in vivo. 
To address this question, DCs of dtg-M and dtg-O mice were activated in vivo by 
injection of α-CD40 mAb, a strong DC activating reagent (Hawiger Nussenzweig 2001).  
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Fig. 24: The presentation of pMHC II but not pMHC I is prolonged on activated DCs in vivo. Mice (dtg-
M, BMC: dtg-O g B6) were treated with doxycycline and injected with 50 µg α-CD40 mAb per mouse as 
indicated. Naïve CFSE labeled AND or OT1 T cells were transferred as sensors of respective pMHC complexes 
on d 4 of the experiment. The CFSE dilution of the transferred T cells was analyzed in lymph nodes and spleen 
3 d after transfer. Data shown have been gated on single live cells positive for the congenic marker and CD4 or 
CD8, respectively. The CFSE dilution in lymph nodes was very similar and is therefore not depicted. Average 
division numbers depicted in the histograms were calculated from MFIs as N = log2(MFIctrl/MFIsample). The 
means from 3 (AND) or 4 (OT1) independent experiments are depicted. Student’s t-test was used to determine 
p values. 
 
Starting at the time point of α-CD40 injection, mice were given doxycycline in their drinking 
water for 1 d. As a readout for the presence of pMHC I and pMHC II complexes on DCs, 
CFSE labeled AND or OT1 T cells were injected as sensors of cognate pMHC complexes. T 
cells were transferred 3 d after doxycycline removal, a time point where antigen expression 
has faded in dtg-M mice (Obst et al., 2005). This setup allows the assessment of pMHC I and 
pMHC II complex presence on activated versus immature DCs following transient antigen 
expression (Fig. 24, condition 2 and 3). The background expression of TSO transgene in dtg-
O mice required the use of BMCs (dtg-O g B6) in this experiment. As BMCs on the B10.BR 
background did not display a chimerism of more than 70% (Rabenstein, 2012) and TIM 
expression in dtg-M mice is strictly doxycycline-dependent and antigen turn-off possible (see 
Fig. 1D), these mice where directly used in this experiment.  
CFSE dilution analysis on d 3 after T cell transfer shows no proliferation of AND or OT1 
T cells in negative control animals (condition 1) and strong proliferation in positive control 
animals (condition 4). Transient antigen expression terminated 3 d before T cell transfer alone 
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did not result in the presence of enough H-2Ek/MCC92-103 or H-2Kb/OVA257-264 complexes to 
induce the proliferation of transferred T cells (Fig. 24). If DCs had been activated at the time 
point of antigen turn-on (condition 3), the amount of presented H-2Ek/MCC92-103 complexes 
were sufficient to induce significant proliferation of AND T cells compared with control mice 
receiving PBS (condition 2, N = 2.1 ± 0.7 and N = 0.5 ± 0.3). This was not the case for H-
2Kb/OVA257-264 complexes, as OT1 T cells transferred into mice of condition 3 did not show 
enhanced proliferation compared to cells transferred into mice of condition 2 (N = 0.7 ± 0.4 
and N = 0.1 ± 0.2). These results show the prolonged presentation of pMHC II but not pMHC 
I complexes on activated DCs. 
Therefore, T cell proliferation patterns might be adapted to differential stability of pMHC 
I and pMHC II complexes on DCs in an inflammatory environment. In vivo, CD4+ T cell 
proliferation would subsequently be dependent to the presence of ongoing inflammation. In  
contrast, CD8+ T cell proliferation may be independent of inflammation once it is initiated, 
resulting in a tighter regulation of CD4+ T cell expansion. 
 
5.7 Outlook: improving the tools for the analysis of T cell antigen dependency 
Antigen dependency of CD4+ and CD8+ T cells is insufficiently compared also with 
respect to memory T cell generation and tolerance induction. In principle, doxycycline 
inducible neoself-Ag expression in dtg-M and dtg-O mice would allow the direct comparison 
of dose- and duration-requirements of both processes even in the endogenous polyclonal 
CD4+ and CD8+ T cell compartments. The leakiness of TSO expression in dtg-O mice (see 
Fig. 1D) and the difficulty to generate dtg-M g B10.BR BMCs with a homogenously high 
chimerism (Rabenstein 2012) impaired the design of a truly comparable experimental setup to 
address these questions.  
To allow such experiments in the future, dtg-O mice were crossed to transgenic mice 
expressing the tetracycline-controllable transrepressor (tet-transrepressor) tTRKRAB, a fusion 
protein of the DNA binding domain of the tetracycline repressor (TetR) from E. coli and the 
Krüppel-associated box (KRAB) domain of the human Kox1 zinc finger protein (Deuschle et 
al., 1995), under the control of the human phosphoglycerate kinase (hPGK) promotor (Barde 
et al., 2009) as depicted in Fig. 25 (middle).  
KRAB domains are found in many zinc finger proteins in mice and humans, where they 
mediate transcriptional repression of target genes by recruitment of histone deacetylases and 
 
Results 
 
 94 
 
Fig. 25: Function of the KRAB repressor in dtg-O;KRAB mice. The KRAB transgene encodes the 
tetracycline-controllable transrepressor tTRKRAB, a fusion protein of the DNA binding domain of tetracycline 
repressor (tetR) from E. coli with the KRAB (Krüppel-associated box) domain of the human Kox1 protein 
under the control of human phosphoglycerate kinase (hPGK) promotor, allowing ubiquitous constitutive 
expression. In dtg-O;KRAB mice, the tet-transrepresor binds to tetO sequences in the absence of doxycycline, 
while the tet-transactivator cannot bind. In the presence of doxycycline, the tet-transrepressor is inactivated and 
the tet-transactivator is activated, leading to TSO-expression. For details on Ii-rTAS and TSO transgenes refer to 
Fig. 1 and text section 5.1. 
 
histone methyltransferases and subsequent heterochromatin spreading (Groner et al., 2010; 
Margolin et al., 1994). They can therefore mediate long-term but reversible transcriptional 
repression of target genes in mice (Groner et al., 2012). The tet-transrepressor protein is 
constitutively active in the absence of doxycycline, the presence of doxycycline leads to its 
deactivation. Therefore, in dtg-O;KRAB mice, the tet-transrepressor will be actively 
repressing TSO transgene expression in the absence of doxycycline. If mice are treated with 
doxycycline, the tet-transrepressor will be inactivated and the tet-transactivator will be 
activated, leading to expression of the TSO transgene (Fig. 25, bottom). This double control 
of TSO expression may eliminate the background expression of TSO observed in dtg-O mice. 
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The tight expression of a target gene in a similar triple transgenic mouse model has been 
reported before (Jellison et al., 2012).  
If antigen expression kinetics in dtg-O;KRAB mice turn out to be similar to that of dtg-M 
mice, these two strains will provide a mouse model where the influence of TCR stimulus 
duration on tolerance induction and memory generation of CD4+ and CD8+ T cells can be 
studied. Furthermore, as antigen dose can be modulated in dtg-M mice (Obst et al., 2005) and 
potentially also in dtg-O mice, multiple aspects of antigen dependency of CD4+ and CD8+ T 
cells will be assessable. 
 
5.8 Summary of results 
In this study, differential antigen dependency of AND and OT1 T cells has been observed 
in the expansion phase on the proliferation and differentiation levels (Fig. 5, Fig. 6) and has 
been shown to be applicable to polyclonal CD4+ and CD8+ T cells (Fig. 7). This differential 
antigen dependence is not reproducible in vitro (Fig. 8) and is not induced by high O2 
concentrations during the in vitro stimulation period (Fig. 9), clonal competition (Fig. 13) or 
homotypic clustering of CD8+ T cells (Fig. 11). Several T cell extrinsic factors including 
MHC class expression patterns (Fig. 10), inflammatory cytokines (Fig. 12), coinhibitory 
signaling (Fig. 14) and AND T cell differentiation (Fig. 15, Fig 16) have furthermore been 
shown not to modify the proliferative patterns of AND and OT1 T cells. Gene expression 
patterns reflect the differential antigen dependency of the subsets (Fig. 17) and demonstrated 
little differences between stimulated AND and OT1 T cells following 2 d in vitro stimulation 
(Fig. 18-20, Tables 1 and 2). The analysis of proliferation kinetics showed that the antigen-
independent proliferation phase of OT1 T cells is rather short lasting and that OT1 T cells are 
responsive to TCR triggering for longer periods of time than are AND T cells (Fig. 21). On 
the metabolic level, Mitochondrial Stress Test showed that OT1 T cells possess a higher spare 
respiratory capacity (SRC) following in vitro stimulation (Fig. 23). Finally, T cell 
proliferation patterns have been demonstrated to reflect the biology of MHC I and MHC II, as 
the presentation of pMHC II but not pMHC I complexes was prolonged by the activation of 
DCs in vivo (Fig. 24). In the future, dtg-O;KRAB and dtg-M mice may allow for the 
comparison of the roles of antigen dose and the duration of antigen stimulation on CD4+ and 
CD8+ T cell tolerance induction and memory generation (Fig. 25).  
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6 Discussion 
 
In this study, differential antigen dependency of CD4+ and CD8+ T cells during the 
expansion phase was shown in an experimental setup where both subsets were equally 
activated during the priming phase and the TCR stimulus duration was strictly controlled. 
This phenomenon seemed to be cell intrinsic and was correlated with partially divergent 
proliferation kinetics and metabolic capacities of the subsets. The transcriptional profiles of in 
vitro-stimulated AND and OT1 T cells were very similar. The differential proliferation 
patterns of both subsets seemed to reflect the biology of the respective MHC molecules, as 
pMHC II but not pMHC I complexes were presented for prolonged periods of time on 
activated DCs in vivo.  
 
6.1 Differential antigen dependency of CD4+ and CD8+ T cells 
In the experimental setup used here, the proliferation of CD4+ and CD8+ T cells was 
directly compared. As described in the introduction, such a direct comparison has rarely been 
done before but many studies have provided data on antigen dependency of only one of the 
two subsets. So far, only five studies provided comparative data on this issue. 
Gett et al. stimulated polyclonal CD4+ and CD8+ T cells in vitro with α-CD3 and α-
CD28 mAbs for 24 h and transferred them into naïve B6 mice. They observed slightly 
increased proliferation of CD8+ compared with CD4+ T cells during the following 3 d in vivo 
(Gett et al., 2003).  
Williams et al. used a Listeria (L.) monocytogenes infection model and abrogated 
bacterial replication with ampicillin 24 h after infection to terminate antigen presentation in 
vivo (using BALB/c mice). In agreement with the data presented here, they observed CD8+ T 
effector cell expansion to be unchanged if the bacteria were cleared early after infection, 
whereas CD4+ T cell expansion was strongly reduced (Williams and Bevan, 2004). Even 
though L. monocytogenes infection represents a physiologic mode of TCR stimulation and 
ampicillin treatment was shown to reduce antigen presentation to a level insufficient to prime 
naïve CD8+ T cells, the kinetics of the associated inflammation and its potential to influence T 
cell proliferation was not assessed. In this setup, CD8+ T cell responses could thus not be 
shown to be independent of inflammation, i.e. costimulation and inflammatory cytokines.  
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Corbin et al. performed similar experiments in B6 mice. Antigen presentation was shown 
to persist until d 3 after infection if mice were treated with ampicillin 24 h after L. 
monocytogenes infection and was maintained for 7 d in untreated mice as determined by an ex 
vivo antigen detection assay (Corbin and Harty, 2004). In this study, the primary expansion of 
both CD4+ and CD8+ T cells was slightly reduced and the peak of T cell expansion reached 
one day earlier if ampicillin was administered 24 h after the infection. In another series of 
experiments, the extensive expansion of CD4+ T cells required 48 h of unimpaired infection 
whereas CD8+ T cells were able to expand as much as in control animals if the infection was 
cleared 24 h after the infection. Thus, even though the expansion of both subsets was slightly 
affected by a shortened antigen presentation period, CD4+ T cells were shown to require 
longer antigen presentation for their maximal expansion than CD8+ T cells.  
In the same experimental setup, Tseng et al. observed the expansion of endogenous CD4+ 
and CD8+ effector T cell populations in CB1 mice (the offspring of a B6 x BALB/c mating) 
to be strongly reduced following termination of L. monocytogenes infection 24 h after its 
onset (Tseng et al., 2009). 
Blair et al. used a pMHC-specific mAb to block the interaction of TCR and pMHC 
complexes in vivo and thereby terminated TCR triggering in the context of a vesicular 
stomatitis virus (VSV) infection. The magnitudes of CD4+ and CD8+ T cell effector responses 
were reduced by the application of a pMHC-specific mAb (Blair et al., 2011). In this setting, a 
differential effect of the viral infection on T cells of both subsets could not be excluded. Even 
though the blocking mAbs were shown not to deplete APCs, it was not ruled out that they 
possess different affinities for their targets and therefore block pMHC complexes with 
different efficiency and kinetics in vivo. The antibody used for the blockage of H-
2Kb/OVA257-264 complexes has a rather low affinity (Porgador et al., 1997). Furthermore, the 
responses of endogenous (polyclonal) CD8+ and adoptively transferred TCR tg CD4+ T cells 
were compared in this study. These experimental caveats limit the explanatory power of this 
study.  
In all named studies, CD4+ T cell responses were found to be impaired if the antigen 
presentation was terminated prematurely. The data on CD8+ T cells are contradictory. CD8+ T 
cells were unaffected by a shortened L. monocytogenes infection (Williams and Bevan, 2004) 
or did at least require shorter infection periods to expand as much as in control mice (Corbin 
and Harty, 2004; Gett et al., 2003). In contrast, CD8+ T cell responses were observed to be 
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dependent on prolonged antigen presentation in two studies (Blair et al., 2011; Tseng et al., 
2009).  
 
The methodological caveats of the above studies are circumvented in the experimental 
setup used here. TCR stimulation is strictly separated from inflammation and terminated in a 
way that efficiently avoids residual stimulation. The stimulation of both subsets is carried out 
independently of their TCR specificity, affinity and the APC type. Thus, distinct antigen 
presentation- and costimulatory patterns, which might occur in infection models and may 
result in differential TCR triggering strength, are circumvented. 
With the exception of (Gett et al., 2003), the above studies based their conclusions solely 
on the determination of CD4+ and CD8+ T cell expansion. Besides the extent of proliferation, 
this parameter may also be influenced by divergent survival rates, precursor frequencies and 
precursor commitment. In the present study, the extent of proliferation was quantified using 
CFSE dilution analysis. The additional assessment of cell cycle activity allowed for a detailed 
analysis of the proliferative patterns of CD4+ and CD8+ T cells. 
The differential antigen dependency of CD4+ and CD8+ cells observed here was not 
restricted to TCR tg T cells, as the findings were reproduced with polyclonal T cells. The 
number of T cells transferred, previously observed to hamper T cell expansion (Badovinac et 
al., 2007; Quiel et al., 2011; Yarke et al., 2008) was ruled out to impair CD4+ T cell 
proliferation here. T cell help was suggested to enhance the proliferation of CD8+ T cells by 
supporting the antigen presentation to CD8+ T cells (Jusforgues-Saklani et al., 2008) or by 
CD4+ T cell derived IL-21 (Yi et al., 2009). The use of TCR tg T cells and the separation of 
CD4+ and CD8+ T cells excluded T cell help as a factor enhancing the proliferation of CD8+ T 
cells in the present study. The cytokine IL-7 used here to enhance the survival of unstimulated 
T cells during the in vitro-priming-phase was chosen for its exclusive importance for 
homeostatic survival in vivo (Vivien et al., 2001). IL-7 was observed not to superimpose with 
TCR stimulation effects on T cell survival (Koenen et al., 2013). The O2 concentration in the 
culture system used for T cell priming was, in contrast to previous in vitro-studies (Atkuri et 
al., 2007; Loisel-Meyer et al., 2012), shown not to affect the in vivo-proliferation of T cells. 
Therefore, in the experimental setting used here differential antigen dependency of CD4+ 
and CD8+ T cells during the expansion phase in vivo was shown for the first time in a truly 
comparable manner (Fig. 5-9, (Rabenstein, 2012)), confirming the concept of CD8+ but not 
CD4+ T cell proliferation and differentiation as being set to “autopilot” following successful 
Discussion 
 
 99 
priming (Bevan and Fink, 2001). This observation is in agreement with studies on the antigen 
dependency of CD4+ T cell expansion (see also section 3.5.1). With respect to the substantial 
number of studies demonstrating antigen-dependent expansion of CD8+ T cells, the data 
presented here indicate that CD8+ T cells possess the potential to be programmed to expand 
and differentiate in an antigen-independent manner (see also section 3.5.2).  
 
6.2 The differential antigen dependency of T cells is cell intrinsic 
The experimental setup used here allowed for the further dissection of the mechanism 
causing the differential antigen dependency of CD4+ and CD8+ T cells, which pointed 
towards a cell intrinsic regulation of this phenomenon. 
Homotypic clustering of CD8+ T cells has been observed to regulate their proliferation 
and differentiation in recent studies. Independent studies showed that the abrogation of cluster 
formation reduces the accumulation of CD8+ effector cells, their functionality and the 
protection from secondary infection (Bose et al., 2013; Gérard et al., 2013). In contrast, 
ICAM1-deficient and therefore non-clustering CD8+ T cells showed enhanced effector cell 
accumulation and effector cell function in vivo, rather pointing towards an attenuating role of 
homotypic clusters (Cox et al., 2013; Zumwalde et al., 2013). While the mechanistic 
understanding of the regulatory role of homotypic T cell clusters is still incomplete, they were 
dispensable for antigen-independent proliferation of CD8+ T cells here. 
Tonic TCR triggering has been suggested to be essential for the homeostatic proliferation 
and the survival of naïve peripheral T cells (Beutner and MacDonald, 1998; Brocker, 1997; 
Goldrath and Bevan, 1999; Kirberg et al., 1997; Takeda et al., 1996) and was later shown to 
regulate the responsiveness of CD8+ T cells to antigenic stimulation (Ebert et al., 2009; Lo et 
al., 2009; Santori et al., 2001). Antigen-independent proliferation of CD8+ T cells has been 
observed here even in the absence of peripheral MHC I, segregating this phenomenon from 
homeostatic proliferation and excluding tonic TCR triggering as a cause of this behavior. 
Even though proinflammatory cytokines were repeatedly shown to be required for CD8+ 
T cell expansion (Curtsinger et al., 2003; Curtsinger et al., 1999; Kolumam et al., 2005; Lai et 
al., 2009; Starbeck-Miller et al., 2014), antigen-independent proliferation of CD8+ T cells was 
observed here in a sterile environment. Furthermore, the lack of proinflammatory cytokines 
was not responsible for antigen dependency of CD4+ T cells, as their proliferative block was 
not released in the presence of a bystander infection, contrasting with the dependency of 
CD4+ T cell expansion on cytokines reported previously in an in vitro-study (Jelley-Gibbs et 
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al., 2000). Thus, the differential antigen dependency of T cell subsets seemed to be 
independent of a “third signal” meditated by inflammatory cytokines. 
In opposition to costimulatory signals, coinhibitory signals delivered via CTLA-4 or PD-
1 were observed to regulate T cell responses. The blockage of CTLA-4 signaling augmented 
T cell proliferation in vitro (Krummel and Allison, 1995; Walunas et al., 1994). The ligation 
of CTLA-4 reduced the motility of T cells and increased the duration of their contacts with 
DCs in vitro (Schneider et al., 2006). It was proposed that CTLA-4 signaling limits the in 
vitro-proliferation of CD4+ T cells (Doyle et al., 2001). Signaling via PD-1 has been reported 
to be essential for tolerance maintenance by using knock out mice and blocking mAbs against 
PD-1 and its ligands PD-L1 and PD-L2 (Ansari et al., 2003; Fife et al., 2009; Nishimura et al., 
1999; Salama et al., 2003). In mice deficient for PD-L1 (Cd274−/−), CD4+ and CD8+ T cell 
responses were markedly enhanced (Latchman et al., 2004). Even if this body of literature 
may suggest that the antigen dependency of CD4+ T cells is at least partially dependent on 
these coinhibitory pathways, the blockage of CTLA-4 and PD-1 signaling did not extend the 
proliferation of CD4+ T cells following transient TCR stimulation in the study presented here. 
As a strong TCR stimulus was used here, this finding is in agreement with studies that 
observed the inhibition of T cell proliferation by PD-1 signaling if low antigen- or 
costimulation doses were used (Freeman et al., 2000; Latchman et al., 2001). 
Antigen dependency was observed for both Th1 and Th2 cells in this study. These CD4+ 
T cell subpopulations are distinguished on the functional level, based on the detection of 
distinct cytokine profiles and transcription factor expression (see also section 3.4.2.1). 
Compared to Th1 cells, Th2 polarized cells displayed a slightly reduced proliferative capacity 
in vivo in the present study. This was unexpected, as IFNγ has been suggested to limit the 
proliferation of T cells (Badovinac et al., 2004; Feuerer et al., 2006) and Grogan et al. 
reported more extensive proliferation of Th2 polarized CD4+ T cells compared with Th1 
polarized cells (Grogan et al., 2001). Grogan et al. used T cells from BALB/c mice, which are 
known to have a propensity towards Th2 responses (Locksley et al., 1999) and assessed the 
proliferation of Th1 and Th2 cells in vitro following a 7 d stimulation period. In the present 
study, the proliferation of the subsets was analyzed after a polarizing period of only 2 d and 
subsequent adoptive transfer into mice expressing or not expressing cognate antigen. The lack 
of further data on this issue and the differences in protocols and origin of Th cells make 
further studies necessary to elucidate the cause of these contradictory observations.  
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The proliferative capacity of memory T cells on the other hand has been broadly studied 
and the response to low doses of antigen, rapid proliferation and immediate cytokine 
production are thought to be hallmarks of memory T cell responses. Whereas these paradigms 
are supported by some studies (Rogers et al., 2000; Veiga-Fernandes et al., 2000), the details 
of memory T cell proliferation kinetics are still not fully understood. Macleod at al. observed 
that memory CD4+ T cells expanded less than naïve ones, leaving the higher precursor 
frequencies of CD4+ memory T cells as the cause of their enhanced accumulation (MacLeod 
et al., 2008). Whitmire et al. showed that memory T cell responses are not instantaneous. 
They observed both memory and naïve T cells to proliferate after a lag time of 2-3 d in vivo 
(Whitmire et al., 2008). Thus, in contrast to the paradigm of stronger, faster and higher 
memory responses, the antigen-requirements of memory T cells seem to be similar to that of 
naïve T cells in the described experimental settings. In the experimental system used here, 
antigen dependency of CD4+ T cells was conserved in the memory compartment represented 
by in vitro-generated memory-like Rested Effector cells. These data support the idea that 
besides antigen responsiveness and proliferation rate, further factors, e.g. cytokine 
responsiveness or acquired survival advantages (even on the metabolic level, see section 
6.3.3) may support the secondary responses of CD4+ T cells. Methodological progress that 
facilitates the analysis of very small cell populations (Moon et al., 2007) will foster studies on 
the physiology of memory responses and will allow further elucidation this issue. 
 
6.3 The mechanism of differential antigen dependency 
6.3.1 On the transcriptional level, CD4+ and CD8+ T cells are very similar 
In agreement with a recent publication (Mingueneau et al., 2013), the gene expression 
analysis of CD4+ and CD8+ T cells following in vitro stimulation (at the point of treatment 
divergence), revealed a high similarity of both subsets with only 0.5% of genes being 
differentially regulated. Even though the source of T cells and the stimulus duration limit the 
comparability of the datasets generated by Mingueneau et al. and presented here, the 
similarity of CD4+ and CD8+ T cells is a common feature of both analyses.  
Except for Eomes, no further T cell specific transcription factors were differentially 
expressed in the subsets. Runt-related transcription factor 2 (Runx2), a transcription factor 
initially recognized for its importance in bone development (Ducy et al., 1997; Komori et al., 
1997), was differentially upregulated in CD8+ T cells in agreement with data available from 
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the Immunological Genome Project (Immgen) database (Heng et al., 2008), as retrieved on 
February 24th, 2014). Recently, a role for Runx2 in CD8+ memory T cells has been discussed 
(Hu and Chen, 2013). In that study, the overexpression of Runx2 in in vitro-generated CD8+ 
memory T cells resulted in decreased expansion of these cells in vivo. Thus, Runx2 seems to 
be involved in T cell activation and perhaps also in their proliferation, but the details of its 
function in T cells are still unclear. 
Among the genes differentially upregulated in CD4+ T cell was Sprouty1 (Spry1), a 
homolog of a gene first described to code for an inhibitor of fibroblast growth factor (FGF) 
signaling in Drosophila melanogaster, where it was suggested to be part of a negative 
feedback mechanism in receptor tyrosine kinase (RTK) signaling (Hacohen et al., 1998). 
Spry1 is one of four sprout-homologs defined in mammals and the only one known to be 
specifically upregulated in T cells following their activation (Choi et al., 2006). Whereas 
Spry1−/− CD4+ T cells display enhanced IL-2 expression, IFNγ production is increased in 
Spry1−/− CD8+ T cells, indicating an inhibitory influence of Spry1 on T cell effector functions 
in both subsets. Under physiological conditions, Spry1 is recruited to the immune synapse 
following TCR ligation and its absences results in enhanced phosphorylation of LAT, PLC-γ 
and Erk (Collins et al., 2012; Lee et al., 2009). The role of Spry1 during later phases of the T 
cell response and its influence on T cell proliferation is only poorly studied, but tumor-
specific CD8+ T cells deficient for Spry1 display enhanced expansion compared to wt cells in 
a tumor model (Collins et al., 2012). From the data available to date, it cannot be excluded 
that Spry1 regulates the proliferation of T cells. Despite the lack of data on its differential 
expression in CD4+ and CD8+ T cells in the above studies, it is therefore possible that the 
enhanced expression in CD4+ T cells observed here contributes to the differential antigen 
dependency of CD4+ and CD8+ T cells. 
Two members of the growth arrest and DNA-damage-inducible 45 (Gadd45) gene family, 
Gadd45b and Gadd45g were differentially upregulated in stimulated CD8+ T cells in the 
study presented here. Gadd45 family members are small proteins (18-20 kDa) without 
enzymatic activity that are involved in the regulation of cell cycle arrest, DNA repair, cell 
survival and apoptosis following genotoxic stress in malignant cells (Liebermann et al., 2011). 
They are expressed in many cell types of the innate and the adaptive immune system. The 
expression of Gadd45b and Gadd45g in T cells can be induced by T cell activation and 
proinflammatory cytokines (Schmitz, 2013) or by genotoxic stress (Flint et al., 2005). Both 
molecules were reported to promote the expression of IFNγ in CD4+ and CD8+ T cells (Lu et 
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al., 2004; Lu et al., 2001; Yang et al., 2001). Lu et al. showed that Gadd45β is also important 
for the IL-2 production by CD4+ T cells (Lu et al., 2004). Gadd45γ was observed to be 
dispensable for normal T cell development and proliferation (Hoffmeyer et al., 2001). As 
most of these studies were performed in vitro, the importance of Gadd45 proteins for T cell 
responses in vivo is still unclear. The stimulatory effect that Gadd45β and Gadd45γ have on 
cytokine expression is mediated by the activation of the MAP-Kinase pathway and the 
mitogen-activated protein kinase p38 (Lu et al., 2004; Lu et al., 2001; Yang et al., 2001). Here, 
a higher expression of Gadd45b and Gadd45g in CD8+ compared to CD4+ T cells was 
observed. In agreement with the above-described studies, this differential expression was 
correlated with the secretion of IFNγ in CD8+ but not CD4+ T cells at the time point of gene 
expression analysis. Thus, it seems likely that Gadd45b and Gadd45g expression is correlated 
with the differentiation status of both subsets. 
Another gene differentially upregulated in CD8+ T cells was Cdk5 and Abl enzyme 
substrate 1 (Cables1), a protein found to be interacting with cycline dependent kinases 
(CDKs) and expressed in all tissues but especially in neurons, where its knock-down inhibited 
cell growth (Matsuoka et al., 2000; Zukerberg et al., 2000). Human ovarian and colon cancers 
frequently present a loss of Cables1 expression (Dong et al., 2003; Kirley et al., 2005; Park et 
al., 2007a; Zukerberg et al., 2004). Cables1 seems to be necessary for apoptosis induced by 
genotoxic stress (Wang et al., 2010) and Cables1-deficient mice present higher numbers of 
oocytes with reduced quality compared to wt mice (Lee et al., 2007). It can only by 
hypothesized that the differential upregulation of Cables1 in stimulated CD8+ T occurs in 
response to proliferation-associated stress and may support enhanced DNA-quality control 
during proliferation. The high expression of this gene may provide a proliferative advantage 
to CD8+ T cells during the expansion phase.  
Taken together, gene expression data illustrated the equality of CD4+ and CD8+ T cell 
stimulation reached here and revealed only few genes to be regulated differentially between 
the subsets. The differential expression of genes associated with the genotoxic stress response 
and Spry1 could be correlated with the phenomenon of differential antigen dependency. The 
importance of these genes for the antigen dependency of T cell proliferation might be tested 
in the future with the help of T cells deficient in these genes or on T cells subjected to 
retroviral overexpression- or knock-down of the respective genes.  
With respective to the differential proliferation patterns and the broadly different gene 
expression patterns observed following transient and persistent TCR stimulation (Rabenstein, 
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2012), the very similar gene expression of in vitro-stimulated T cells indicates that the 
differential proliferative response are not sole regulated at the transcriptional level. 
Additionally, potential regulatory mechanisms may include posttranslational protein 
modifications, miRNAs and epigenetic processes.  
Micro RNAs (miRNAs) are emerging as important regulators of CD4+ T cell 
differentiation and function (Baumjohann and Ansel, 2013) and were observed to regulate the 
effector functions of CD8+ T cells (Gracias et al., 2013). However, they might not be essential 
for T cell survival (Jeker and Bluestone, 2013), possibly due to the fact that mRNAs of 
proliferating T cells possess fewer miRNA target sites (Sandberg et al., 2008). Nevertheless, 
miRNAs may be involved in the regulation of T cell proliferation and differentiation under 
conditions of limited antigen access and their role for the differential antigen dependency of 
CD4+ and CD8+ T cells could be addressed in future studies.  
Epigenetic pathways are involved in the differentiation process of Th1 and Th2 cells by 
activating or silencing respective effector genes (Avni et al., 2002; Wei et al., 2009). Recently, 
the histone methylase SUV39H1 has been reported to be necessary for the silencing of Th1 
genes and thus stabilizing Th2 differentiation (Allan et al., 2012). Thus, a specific histone-
modifying enzyme could be required for the commitment towards CD4+ and CD8+ T cell 
phenotype and the programming of proliferative patterns. Mice deficient for chromatin-
modifying enzymes like SUV39H1 can be used to elucidate this question in the future.  
 
6.3.2 Differential proliferation kinetics of CD4+ and CD8+ T cells 
In many viral infection models and following infection with L. monocytogenes, the 
magnitude of the CD8+ responses exceeds that of CD4+ T cell responses (Cauley et al., 2002; 
Foulds et al., 2002; Harrington et al., 2002; Homann et al., 2001). On the base of anecdotal 
data, CD4+ and CD8+ T cells are perceived to divide at different paces (Seder and Ahmed, 
2003). In different experimental systems, CD4+ T cells have been found to divide every 7-12 
h (Gudmundsdottir et al., 1999; Jelley-Gibbs et al., 2000; Lee et al., 2002), whereas CD8+ T 
cells divided every 2-6 h (Wong and Pamer, 2001; Yoon et al., 2010). However, the division 
pace of T cells might vary considerably between clones or depending on the experimental 
context (Hogan et al., 2013; Rai et al., 2009; Yoon et al., 2010), complicating a comparative 
analysis on this issue. The assessment of T cell proliferation kinetics in infection models 
revealed that TCR tg CD4+ T cells expand slower than TCR tg CD8+ T cells (Foulds et al., 
2002), but polyclonal T cell populations displayed no differential kinetics of T cell expansion 
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(Schlub et al., 2011) as would have been suggested by the former study. Thus, the 
inflammatory environment during an infection further limits the explanatory power of these 
types of experiments, as CD4+ and CD8+ T cell might react differentially to the associated 
stimuli. As evidenced by the very similar activation and the extent of proliferation shown by 
both subsets following persistent TCR stimulation, these caveats were circumvented here. The 
combination of the CFSE dilution and cell cycle activity assessment using DAPI and Ki67 
was used for a deeper analysis of proliferation kinetics of both subsets.  
Here, CD8+ T cells were observed to divide faster than CD4+ T cells during the 
expansion phase following transient TCR stimulation, but this antigen-independent 
proliferation phase was time-limited. Additionally, CD8+ T cells remained in active stages of 
the cell cycle for prolonged periods of time following persistent TCR stimulation, pointing 
towards a prolonged sensitivity to TCR triggering-induced proliferation. These findings 
suggest differences in the proliferation kinetics of CD4+ and CD8+ T cells that are more 
complex than previously assumed by Seder et al. (Seder and Ahmed, 2003).  
In the future, the extension of the cell cycle analysis to further time points and the use of 
additional cell cycle activity probes could further complement these findings. If mice are 
treated with the thymidine analogue BrdU for a given time, the proliferation of a cell 
population during this period can be assessed by flow cytometry. Simultaneously, the 
percentage of cells in S- or G2-phase (identified using a DNA dye) in a population that had 
divided during the previous BrdU-feeding period can be determined. The combination of both 
probes would allow for the direct comparison of G1-phase duration of CD4+ and CD8+ T cells 
(Yoon et al., 2010). Contrary to the use of CFSE as a proliferation probe, the treatment with 
BrdU might be started not only at the time point of adoptive transfer but also at several time 
points through the experiment. By using this type of analysis to characterize proliferation 
velocities of T cells during the expansion phase, detailed knowledge of the proliferation 
kinetics of CD4+ and CD8+ T cells could be obtained.  
From the data presented here, it can be hypothesized that CD8+ T cells might divide 
faster during the whole expansion phase. For both subsets, the division pace might be highest 
at the starting point of expansion, with CD4+ T cells slowing down earlier than CD8+ T cells 
irrespective of continued or transient antigen presentation. A delayed responsiveness of CD8+ 
compared to CD4+ T cells to the termination of antigen presentation and an overall enhanced 
proliferative capacity of the former subset would be in agreement with both the phenomenon 
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of differential antigen dependency and the prolonged proliferative response of CD8+ T cells to 
antigen. 
6.3.3 T cell differentiation and proliferation are correlated to metabolic processes 
T cell activation, differentiation, proliferation and the mediation of T cell effector 
functions are metabolically demanding processes. The importance of metabolic adaptations 
for T cell differentiation is receiving increasing interest. Fostered by methodological progress 
(Wu et al., 2007), T cell effector function, differentiation and memory formation have been 
revealed to depend on and be regulated by metabolic processes (Chang et al., 2013; Doedens 
et al., 2013; Man et al., 2013; Powell et al., 2013; van der Windt et al., 2012; Zeng et al., 
2013), adding a new layer of complexity to the regulation of immune responses. Metabolic 
pathways are no longer perceived to be exclusively regulated by allosteric mechanisms but to 
be influenced by other regulatory networks and vice versa (Pearce et al., 2013). 
For rapid proliferation during the expansion phase, T cells rely mainly on aerobic 
glycolysis (Frauwirth et al., 2002; Gerriets and Rathmell, 2012), a process known as the 
Warburg effect and recognized to provide proliferating cells not only with energy but also 
with metabolic precursors for catabolic building blocks. During resting or quiescent 
differentiation phases but also immediately following T cell activation, oxidative 
phosphorylation may be of paramount importance (Chang et al., 2013). Reactive oxygen 
species (ROS) that arise from the premature and incomplete reduction of oxygen during this 
process have been observed to act as secondary messengers. Complex II of the electron 
transport chain has been shown to be an important source of mitochondrial ROS (Tormos et 
al., 2011; Weinberg et al., 2010). T cells with a deficiency for a subunit of this complex 
needed for ROS production showed impaired proliferation and IL-2 production in response to 
in vitro activation and displayed a reduced in vivo-expansion following immunization (Sena 
et al., 2013). Thus, mitochondrial ROS might allow for the integration of metabolic status 
information with T cell activating signals and adapt T cell responses to potential metabolic 
limitations.  
A rapid switch to aerobic glycolysis has repeatedly been shown to be important for 
memory T cells, enabling them to mediate effector functions almost immediately following 
restimulation (Fraser et al., 2013; Gubser et al., 2013; van der Windt et al., 2012; van der 
Windt et al., 2013). In these studies, the mitochondrial spare respiratory capacity (SRC), a 
parameter correlated with cell survival and stress resistance (Yadava and Nicholls, 2007), was 
reported to be a key metabolic feature of memory T cells. A high SRC is thought to provide 
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them with enhanced resistance to metabolic stress and allow them to survive once the 
inflammation is cleared and survival signals are withdrawn. Furthermore, the oxidation of 
fatty acids seems to be of special importance for memory T cells (Pearce et al., 2009). 
Metabolic capacities of CD4+ and CD8+ T cells have so far not been directly compared and it 
can therefore not be excluded that their different functional properties and the differential 
antigen dependency observed here are correlated with distinct metabolic properties.  
In order to determine whether the metabolic capacities of CD4+ and CD8+ T cells differ, 
the mitochondrial stress response of both subsets was analyzed following in vitro stimulation. 
In agreement with the above studies, T cell activation increased glycolysis and to a smaller 
extent also oxidative phosphorylation in stimulated T cells. Stimulated CD8+ T cells 
displayed an increased spare respiratory capacity (SRC) compared with their CD4+ 
counterparts. Following adoptive transfer into antigen-free mice, CD4+ and CD8+ T cells are 
not only confronted with the withdrawal of TCR- and costimulatory signals but also with a 
strong reduction in nutrient- and oxygen concentrations compared to the cell culture system 
(Pearce et al., 2013). It can be hypothesized that in analogy to memory T cells, their enhanced 
metabolic stress resistance might allow CD8+ T cell to continue proliferation following TCR 
stimulus withdrawal, whereas CD4+ T cells, due to the lack of this metabolic property, are 
unable to continue proliferation following transient TCR stimulation.  
In the future, metabolic characterization of naïve CD4+ and CD8+ T cells (both TCR tg 
and polyclonal), as well as transiently and persistently stimulated CD4+ and CD8+ T cells 
sorted from recipient mice may extend the validity of these findings. A metabolic disparity of 
CD4+ and CD8+ T cells may be correlated with their differential functions in the adaptive 
immune response. 
 
6.4 Differential antigen dependency in the context of the immune response 
In this study, the prolonged presentation of MHC II presented MCC93-103 but not MHC I 
presented OVA257-264 peptide on the surface of activated DCs has been shown in vivo, in 
agreement with previous studies (Cella et al., 1997; Obst et al., 2007). In a recent study, 
similar observations were made on human monocyte-derived DCs, using stable isotope 
labeling of nonessential amino acids with heavy water (Robert Busch, London, personal 
communication).  
Differential stability of MHC molecules may not be the only cause of differential 
presentation kinetics of pMHC complexes to CD4+ and CD8+ T cells. When DC subsets were 
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first characterized, they were shown to display distinct antigen presentation capacities. 
Whereas CD8+ DCs were specialized in crosspresentation, CD8− DCs displayed a pronounced 
ability to present peptides in the context of MHC II (den Haan et al., 2000; Dudziak et al., 
2007; Pooley et al., 2001), indicating that CD4+ and CD8+ T cells may be primed by different 
DC subtypes. This hypothesis is supported by a recent study that observed the transcription 
factor interferon regulatory factor 4 (IRF4), on which CD8− DCs rely for their development, 
to be responsible for the expression of components of the MHC II pathway in these cells 
(Vander Lugt et al., 2013). 
Furthermore, the sources of peptide presentation by MHC I and MHC II molecules are 
distinct: MHC I molecules are loaded with peptides derived from proteasomal proteolysis of 
cytoplasmic proteins in the endoplasmic reticulum. MHC II loading takes place in late 
endosomes. Peptides generated by the lysosomal degradation of proteins that have been taken 
up by phagocytosis, macropinocytosis or endocytosis are the main source of MHC II antigen 
presentation (see also section 3.2). Additionally, MHC II presented peptides can also derive 
from cytoplasmic proteins if these are degraded by autophagy and extracellular protein 
derived peptides can be loaded on MHC I molecules by a process called crosspresentation 
(Blum et al., 2013). It has been suggested that MHC I presented peptides derive from 
incompletely translated or misfolded proteins that are quickly degraded and are therefore 
called defective ribosomal products (DRiPs (Yewdell et al., 1996)). Even though there is 
growing evidence for DRiPs as a major source of MHC I presented peptides (Yewdell, 2011), 
some studies show that this is not an exclusive pathway as MHC I molecules can also present 
peptides derived from mature proteins (Colbert et al., 2013; Farfán-Arribas et al., 2012).  
Mackay et al. addressed this question in a comparative manner. They used an in vitro-
system of doxycycline-dependent antigen expression in EBV transformed human B cell lines, 
where they could precisely terminate mRNA transcription and monitor protein stability. They 
observed a clear correlation between active gene transcription and the presentation of pMHC I 
complexes as measured by the response of cognate CD8+ T cell clones. On the other hand, the 
presentation of peptides in the context of MHC II correlated with the stability of mature 
protein (Mackay et al., 2009), thus supporting the concept of MHC I presented peptides being 
derived from active gene expression whereas MHC II peptides originate from mature proteins. 
This concept implies that the antigen presentation to CD4+ and CD8+ T cells display 
intrinsically different kinetics.  
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Such a kinetic difference has in turn been reported to influence T cell responses in 
agreement with data presented here: In an in vivo system of antigen-targeting to DCs by 
mAbs, a strong CD4+ T cell mediated antibody production was elicited by a targeting-mAb 
with a long serum half-life in the absence of adjuvants (Lahoud et al., 2011). This finding 
indicates that DCs can initiate T cell responses even in the absence of “danger signals” and 
challenges the current concept of their role in the mediation of tolerance and immunity 
(Caminschi and Shortman, 2012).  
Increasing the complexity of this issue further, CD4+ T cells have been observed to 
decrease the expression of MHC II on DCs following cognate interaction. This phenomenon 
might be related to cross-linking induced MHC II degradation (Furuta et al., 2012) or 
trogocytosis (the uptake of cell membrane patches containing the TCR-ligated MHC II), a 
process that could in turn lead to prolonged TCR signaling (Osborne and Wetzel, 2012). 
Taken together, the differential antigen dependency of CD4+ and CD8+ T cell 
proliferation observed in this study seems to correlate with the differential kinetics of antigen 
presentation to the subsets. Even though the stabilization of pMHC II complexes following 
DC activation observed here might not be universally transferable to all APCs and antigenic 
epitopes, it can by hypothesized that CD4+ T cells experience prolonged antigenic stimulation 
in the context of an infection due to the stabilization of pMHC II on the surface of activated 
DCs and the stability of mature proteins as the source of peptides. On the other hand, the 
presentation of peptides in the context of MHC I may be limited both by the turnover of 
pMHC I and the dependence on gene transcription for peptide generation.  
The differential proliferation patterns observed here seem to be consistent with the 
distinct functions of CD4+ and CD8+ T cells during adaptive immune responses. CD4+ T cells 
orchestrate adaptive immunity and possess the potential to differentiate into a variety of 
subsets characterized by specific effector and immune regulatory functions (see also section 
3.4.2.1). These subsets display a certain plasticity (O'Shea and Paul, 2010), a potential that 
might require strict regulation in order to prevent dysfunction. The differentiation spectrum of 
CD8+ T cells, on the other hand, appears to be much less diverse with cytotoxicity as the key 
function ((Kaech and Cui, 2012), see also section 3.4.2.2). In order to fulfill their main task, 
the elimination of virus-infected or neoplastic cells, strong expansion of uniform CD8+ T cells 
is sufficient for clearance. Strict control of CD4+ T cell proliferation via antigen presentation 
could thus provide a rheostat to prevent overshooting and deregulated responses, a measure 
that might not be equally important for CD8+ T cells.  
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Additionally, the differential antigen dependency of both subsets might allow for a 
negative feedback of adaptive immune responses, as cytotoxic CD8+ T cells were suggested 
to eliminate antigen presenting DCs (Hermans et al., 2000; Ritchie et al., 2000; Wong and 
Pamer, 2003b) and might thus terminate the antigen-dependent proliferation of CD4+ T cells 
(Ma et al., 2012b), preventing in turn further T cell help to CD8+ T cells. Thus, an antigen-
independent expansion phase of CD8+ T cells could contribute to the prevention of 
overshooting immune responses.  
Recently, even antigen surveillance strategies have been reported to differ between CD4+ 
and CD8+ T cells. Naïve CD4+ T cells were observed to stay in a given lymph node for 
shorter periods of time than CD8+ T cells (~12 h versus ~21 h) and made contact with fewer 
DCs during that time (~160-200 DCs) than their CD8+ counterparts (~300 DCs) (Mandl et al., 
2012). Thus, CD4+ T cells would scan more lymph nodes than CD8+ T cells in a given time 
period but in a less rigorous manner. Interestingly, only for CD4+ T cells was the lymph node 
transit time in the steady state dependent on MHC presence. Additionally, also tissue resident 
CD4+ and CD8+ memory T cells show different migration behaviors: while CD4+ memory T 
cells migrate more freely through tissues after the infections is cleared, CD8+ memory T cells 
seem to be retained at the site of infection in an antigen-independent way (Gebhardt et al., 
2011; Mackay et al., 2012). These findings suggest that CD4+ T cell responses are more 
dependent on MHC/TCR interactions than CD8+ T cell responses, which operate in a more 
programmed way. 
In summary, the primary expansion of CD4+ T cells has been shown to be more 
dependent on antigen persistence than that of CD8+ T cells in the present study. This finding 
is consistent with the differential kinetics of antigen presentation to both subsets and the 
distinct sources of antigenic peptides. The differential antigen dependency of CD4+ and CD8+ 
T cells may enhance the efficiency of adaptive immune responses and might also be important 
for the regulation of T cell responses.  
 
6.5 Outlook 
In the study presented here, differential antigen dependency of CD4+ and CD8+ T cells 
has been shown to be cell intrinsic and correlated with differential proliferation kinetics and 
partial metabolic disparity. Further and more detailed studies on the proliferation kinetics of 
both subsets could expand the findings. A deeper analysis of CD4+ and CD8+ T cell 
metabolism, including further time points and experimental conditions (naïve polyclonal and 
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TCR tg T cells as well as T cells subjected to transient and persistent TCR stimulation), target 
processes (e.g. glycolysis, fatty acid metabolism) and experimental approaches (monitoring of 
the metabolism of CD4+ and CD8+ T cells during the priming phase in vitro (Gubser et al., 
2013)) may provide a deeper understanding of the metabolic requirements of both subsets. 
The potential influence of the RTK-inhibitor Spry1 and the genotoxic stress-associated genes 
Cables1, Gadd45b and Gadd45b on differential antigen dependency of CD4+ and CD8+ T 
cells could be addressed by using T cells deficient in (either from knock-out mice or 
generated by retroviral knock-down) or overexpressing (by retroviral overexpression) the 
respective genes. Even though the existence of one transcriptional master regulator for the 
phenomenon described here is not anticipated from the gene expression data generated in the 
present study, these experiments could allow further insight into the underlying mechanism. 
The background expression of OVA257-264 in dtg-O mice could be abrogated by the 
introduction of a tetracycline-controllable transrepressor, which has been shown to result in 
tight expression of doxycycline regulated gene expression (Jellison et al., 2012). Following 
this improvement, the mouse model of doxycycline-dependent antigen expression could be 
utilized to extend the comparison of CD4+ and CD8+ T cell behavior to the fields of memory 
differentiation and function, T cell exhaustion and tolerance induction. In all of these fields, 
direct comparisons of both subsets have thus far rarely been done despite sustained interest in 
the mechanisms governing the respective differentiation processes. For example, CD8+ 
memory T cells have recently been observed to be sensitive to bystander activation during a 
heterologous secondary infection (Chu et al., 2013). The transferability of these findings to 
the CD4+ T cell compartment could be addressed in dtg mice following the above-described 
modification. 
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